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Abstract
Scanning near-field optical microscopy (SNOM) has been employed to simulta­
neously acquire high-resolution fluorescence images along with shear-force atomic 
force microscopy of cell membranes. Implementing such a technique overcomes 
the limits of optical diffraction found in standard fluorescence microscopy and 
also yields vital topographic information. However, one of the biggest challenges 
of imaging fluorescent biological specimens with SNOM, is the photostability and 
low yield of fluorescent labelling agents. Semiconductor quantum dots are a re­
cently developed class of fluorophores which exhibit superior optical properties. 
They are significantly brighter and more resistant to photo-degradation than or­
ganic fluorophores.
In this study, SNOM has been utilised in conjunction with quantum dot la­
belling to interrogate the biomolecular composition of cell membranes. The tech­
nique has been applied to investigate cell-cell adhesion in human epithelial cells. 
This has been realised through immunofluorescence labelling of the cell-cell adhe­
sion protein E-cadherin. Moreover, a dual labelling protocol has been optimised 
to facilitate a comparative study of the adhesion mechanisms, and the effect of 
aberrant adhesion protein expression, in both healthy and cancerous epithelial 
cells.
This study reports clear differences in the morphology and phenotype of 
healthy and cancerous cells. In healthy prostate epithelial cells (PNT2 cells), E- 
cadherin was predominantly located along the cell periphery and within filopodial 
protrusion. The presence of E-cadherin appeared to be enhanced when cell-cell 
contact was established. Furthermore this study has revealed the interactions of 
filopodia and their functional relationship in establishing adherens junctions in 
PNT2 cells.
In contrast, examination of metastatic prostate cancer cells (PC-3 cells) re­
vealed E-cadherin to be predominantly localised around the nuclear region of the 
cell, with no E-cadherin labelling around the periphery of the cells. This lack 
of functional E-cadherin in PC-3 cells coincided with a markedly different mor­
phology and PC-3 cells were not observed to form tight cell-cell associations with 
their neighbours.
Facilitated by the high-resolution imaging afforded by the SNOM technique, 
this research further highlights the important role tha t E-cadherin plays in the 
development of invasive, metastatic cancers.
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Chapter 1
Introduction
1.1 Classical m icroscopy and the diffraction limit
Optical microscopy has been routinely applied to study the interactions and 
functions of cellular components for centuries. Since its conception, the optical 
microscope has been instrumental in developing our understanding in the field of 
cell biology. However as the demand to increase our knowledge and understanding 
of cellular and molecular biology continues, so does the need to examine samples 
on increasingly smaller dimensions.
Over the years key innovations to improve on the original design have been 
introduced to enable samples to be examined in greater detail. One such example 
is the development of fluorescence microscopy. The technique is a powerful and 
versatile tool which is used extensively in the life and biological sciences. Fac­
tors which have contributed to the technique’s widespread use include its ease of 
use, its availability and its non-invasive nature. When coupled with immunoflu­
orescent labelling, fluorescence microscopy enables specific subccllular compo­
nents to be identifed. Structures ranging from entire organelles to proteins and 
biomolccules, and even DNA can be localised in live or fixed samples.
However, conventional fluorescence micrsocopy techniques are limited by the 
optical diffraction limit. The resolutions achievable are governed by the Rayleigh 
criterion [1] which suggests tha t improvements are possible by using a higher en­
ergy excitation source and lenses with high numerical apertures. Yet a t best, the
1
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optical resolutions attainable are restricted to 200 — 300 nm, which is approxi­
mately half the wavelength of the illuminating light. The limitations imposed on 
fluorescence microscopy by the optical diffraction limit means tha t vital details 
which occur on the nanometer-scale are lost.
1.2 Super-resolution m icroscopy
Over recent years, a series of developments have resulted in the invention 
of a new class of microscopes in a bid to study samples on the nanoscale. The 
electron microscope pioneered the use of electrons rather than photons to irradiate 
a sample. However the technique requires extensive sample preparations and that 
imaging be carried out in a vacuum environment. Consequently imaging of live 
samples using electron micrscopy is not possible.
A number of approaches have been developed which utilise light to illuminate 
a sample but achieve superior resolutions to classical microscopy. Confocal laser 
scanning microscopy (CLSM) employs a tightly focussed laser spot to provide 
point-like illumination of the sample. A small aperture or pinhole is used to 
allow only light emanating from the nominal focus plane to pass. Out of focus 
light from all other planes within the specimen is discarded. The illumination 
spot is scanned across the sample and the detected light is collected at each point 
to build up an image of the sample. A 3-dimensional picture of the sample can 
be constructed using confocal microscopy by imaging through a number of focal 
planes. The resolutions achieved in the sample depth direction are superior than 
those achieved with conventional microscopy. Furthermore, confocal microscopy 
affords slightly enhanced lateral resolution over conventional optical techniques 
since the pinhole also eliminates light from within the focal plane, tha t does not 
originate from the focal point [2].
Total internal reflection fluorescence microscopy (TIRFM) is another notable 
example of developments in optical microscopy. TIRFM relies upon the properties 
of evanescant waves which experience exponential decay with increasing distance 
from their source. Evanescent waves can only penetrate, and therefore cause
2
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excitation, up to a depth of approximately 100 nm within a sample [3, 4]. As with 
confocal microscopy, the technique gives improved depth resolution compared to 
conventional microscopy methods. However TIRFM is limited to examine only 
the surface of samples, the internal structure can not be viewed with this method. 
Furthermore lateral resolutions are still restricted by the diffraction limit.
One major breakthrough was with subsequent development of scanning probe 
microscopy (SPM) techniques in the early 1980’s, which was pioneered by the 
invention of the scanning tunnelling microscope [5]. SPM allows examination of 
samples metrology with nanometre resolution and often enables multiple sam­
ple properties to be studied simultaneously. Samples are scanned using a sharp 
tip which traverses the surface of the sample. The interaction between the tip 
and the sample allows characteristics such as topography, conductivity and even 
fluorescence to be studied at the nanoscale.
For the study of biological materials, the SPM techniques of atomic force 
microscopy (AFM) and scanning near-field optical microscopy (SNOM) are be­
ing increasingly utilised. Each of the techniques have the capacity to provide 
nanometre-scale topography information. Imaging can be performed on a wide 
variety of sample types and under ambient or even liquid environments. When 
combined with immunofluorescence labelling of samples, these techniques allow 
structural and functional information to be correlated. The AFM has to be com­
bined with fluorescence microscopy instrumentation to facilitate this, such as in 
AFM-CLSM [6], and thus the optical information collected is still restricted by 
the diffraction limit. SNOM however has the capacity to provide both high- 
resolution optical and topographical information from a wide variety of sample 
types, and can be adapted to carry out novel imaging approaches [7-9].
Subsequent developments in the field of high-resolution optical microscopy 
have seen the emergence of further techniques, such as stimulated emission deple­
tion (STED), photo-activated localisation microscopy (PALM), stochastic optical 
reconstruction microscopy (STORM) and fluorescence imaging with one nanome­
ter accuracy (FIONA). These methods however are still in their infancy and as yet
3
1.3. SCANNING NEAR-FIELD OPTICAL MICROSCOPY IN BIOLOGY
arc not routinely applied microscopy techniques. Table 1.1 provides a summary 
and comparison of these optical techniques discussed, while a comprehensive re­
view of some of these most recent developments in high-resolution optical imaging 
is given by Schermelleh et al. [2].
Name/ Acronym XY resolution Z resolution Comments
Confocal microscopy 180-250 nm 500-700 nm Resolution diffraction limited
TIRFM 200-300 nm 100 nm Surface technique
Aperture SNOM [10] 
Apertureless SNOM [11]
50-100 nm 
20 nm
10 nm Surface technique
STED 20-100 nm 560-700 nm Live cell imaging restricted, com­
plex instrumentation
STORM/PALM/ 
FIONA [12]
20-50 nm
~ 1  nm
20-75 nm Live cell imaging restricted, re­
quires fluorophores with special 
characteristics
Table 1.1: Comparison of optical microscopy techniques, adapted from [2].
1.3 Scanning near-field optical m icroscopy in 
biology
In recent years, SNOM’s capacity to examine various biological samples has 
been demonstrated. For example, Hoppener et al. [13] demonstrated that SNOM 
can be used to image fluorescently labelled biological samples under physiological 
conditions. Topography and SNOM images of a nuclear envelope were acquired 
and an optical resolution of 55 nm was demonstrated. In another study, Ianoul 
et al. [14] employed SNOM to investigate the distribution of ion channels on the 
membrane of fixed cardiac myocyte cells. Their study resolved localised ion chan­
nel clusters which ranged in size from <60 — 250 nm. SNOM has also been utilised 
to compare the effects of fluorescently labelling whole chromosomes by Baylis et 
al. [15]. The extent of chromatin collapse induced by two fluorescence in situ 
hybridisation methods was investigated; one involving fluorescence signal ampli­
fication and one without. Through utilising both topography and fluorescence 
SNOM modes simultaneously, Baylis et al. found amplification of fluorescence 
resulted in more extensive chromatin collapse. And more recently SNOM has
4
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been utilised as a novel molecular recognition sensor. Hofcr et al. [9] demon­
strated that by functionalising a SNOM probe with bio-recognition molecules 
(biotin), streptavidin molecules on a surface could be identified by monitoring 
the interactions between the surface and the functionalised probe.
One of the biggest challenges of imaging biological samples with SNOM, and 
indeed all fluorescence microscopy techniques, is the availability of bright and 
photostable fluorescent labelling agents. Organic fluorophores that are typically 
used in fluorescence techniques are prone to rapid photobleaching which can hin­
der the acquisition of high quality images with good signal-to-noise levels.
1.4 A new class o f fluorescent probes
The recent development of semiconductor quantum dots has led to a new class 
of fluorescent labels for biological applications. Their superior optical properties 
make them an attractive alternative to organic fluorophores tha t have been tra­
ditionally used in fluorescence microscopy. Quantum dots have a high quantum 
yield making them significantly brighter and more photostable [16, 17].
Although initially their use was limited due to problems creating water- 
soluble, functionalised bioconjugates, quantum dots are increasingly being utilised 
in biological applications. Quantum dots have been succesfully employed in in 
vivo studies [18, 19] and in FRET/biosensing applications [20]. Furthermore the 
use of quantum dots has been demonstrated in immunofluorescent labelling, for 
the detection of individual biomolecules or proteins [6, 16, 18] and in multiplexing 
experiments to identify two or more different targets at the same time [21-24].
However, the use of SNOM to investigate biological materials tha t have been 
immunolabelled with quantum dots has been realised by few groups. In the pub­
lication by Zhong et al. [25], the benefits of fluorescent labelling with quantum 
dots have been combined with SNOM. Their study investigated the location of 
CD3 antigens on the surface of human T-lymphocytes. The antigens were specif­
ically labelled with quantum dot-streptavidin conjugates which in turn bind to 
a biotinylated anti-CD3 primary antibody. Through topographic and fluores-
5
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ccncc SNOM image acquisition, the distribution of CD3 molecules on the surface 
of T-lymphocytes were examined and their investigation demonstrated a spatial 
resolution of approximately 90 nm. Their report presented the first near-field im­
ages of biological samples labelled with quantum dots. In a further publication 
by the same research group, Chen et al. used SNOM imaging of quantum dot 
labelled macaque T-lymphocytes [26]. This study focussed on the distribution of 
two T-ccll surface receptors and reported a best optical resolution of less than 50 
nm.
In 2009, the study carried out by Zhong et al. has been extended to investigate 
the co-localisation of CD3 and CD4 or CD3 and CD8 surface antigens on T- 
lymphocytcs simultaneously. Dual colour detection was carried out to assess 
the distribution and organisation of these antigens [27]. Their study, published 
as our studies in multiplexing were underway, demonstrated for the first time 
SNOM imaging combined with quantum dot based multiplexing.
1.5 Thesis outline
The work presented in this thesis will draw on the advantages afforded by 
quantum dot labelling when combined with SNOM imaging. The application 
of a quantum dot based/SNOM approach has been used to investigate cell­
cell adhesion mechanisms in prostate epithelial cells. This has been achieved 
through immunofluorescent labelling of the cell-cell adhesion protein E-cadherin, 
and analysing its distribution at various stages of epithelial sheet formation using 
SNOM topography and fluorescence acquisitions.
The expression and correct functioning of E-cadherin has been linked to in­
creased invasiveness and tumour grade [28-30]. Thus the lack of E-cadherin has 
important implications in the progression of cancer. Significant progress is un­
derway towards understanding the relationship between cellular adhesion and the 
metastatic capacity of tumours, however many questions remain unanswered.
A standardised and rigorous sample preparation methodology has been de­
veloped to lead this investigation. Moreover, a dual labelling protocol has been
6
1.5. THESIS OUTLINE
optimised to facilitate a comparative study of the adhesion mechanisms, and the 
effect of aberrant adhesion protein expression, in both healthy and cancerous 
epithelial cells.
The multidisciplinary nature of the research requires that this thesis attem pts 
to explain the fundamental principles behind semiconductor quantum dots and 
the techniques employed, whilst also providing biological insight into the mecha­
nisms of cell-cell interactions.
Chapter 2 introduces the principles of fluorescence and describes the photo­
physics behind the phenomena. The physics of semiconductors and the energy 
states of an cxciton in bulk material is briefly described. The effects of quantum 
confinement on the energy states is derived for an exciton which is confined in 
3-dimcnsions. These principles are provided such that the reader may form a 
basic understanding of the concepts tha t are relevant to this work, and form the 
basis of later discussions. This chapter continues by describing the manufacture 
of quantum dots with particular emphasis on suitable adaptations for their use in 
biological applications. A comparison of the optical properties of conventional flu­
orophores and semiconductor quantum dots is provided, and the use of quantum 
dots in biological and medical sciences is reviewed.
The development of the scanning near-field optical micrscopc (SNOM) is dis­
cussed in Chapter 3. The effect of the diffraction limit on conventional optical 
techniques and the concept of circumventing this limit through exploiting the 
properties of evanescent waves is described. The theory of SNOM is treated and 
its applications and typical set-up are reviewed. This chapter also considers the 
design of the SNOM probe and various modes of operation. Finally, the scanning 
technique and the importance of the feedback mechanisms used in this work are 
discussed.
Chapter 4 briefly describes the relevant aspects of cell biology which are nec­
essary to form an understanding of the work carried out in this thesis. Adhesion
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mechanisms in epithelial tissues are the principle focus of this research, thus 
the proteins involved in cell-cell adhesion and their interactions with the actin 
cytoskcleton arc discussed. Aberrant adhesion has important implications in 
disease and has been shown to result in increased invasiveness in cancer. The 
current understanding of the mechanisms involved in cancer progression is ad­
dressed. Particular emphasis is placed on the impact of cell-cell adhesion on the 
progression of prostate cancer, and the current understanding of the role that 
E-cadherin plays is described.
Imaging procedures and the developments in experimental design required to 
lead this work are discussed in Chapter 5. Complete methodologies used for the 
preparation of samples are provided and summarised with the aid of a flow chart 
for the benefit of other researchers.
Chapter 6 explores adhesion mechanisms in healthy prostate epithelial cells 
using SNOM. These are identified through immunofluorescent labelling of E- 
cadhcrin and correlated with the structural information provided by the simul­
taneously acquired topography images. Comparisons are made between various 
stages of epithelial sheet formation and with observations by other researchers.
To continue this study, and extend it to examine E-cadhcrin expression and 
localisation in other cell lines, Chapter 7 details the development of a multiplexed 
approach to sample preparation. A dual labelling methodology was devised to 
facilitate the study of E-cadherin in cancerous cells, where E-cadherin expression 
has been reported to be down-regulated. Important aspects of sample preparation 
are addressed in this chapter.
Finally, Chapter 8 concludes this thesis and evaluates the findings of Chapters 
6 and 7. The successes of this work and future developments to continue such 
studies will be considered.
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Chapter 2
Fluorescence
2.1 Introduction
Fluorescence techniques arc valuable tools applied widely across the biological 
and life sciences. In cellular and molecular biology, fluorescence techniques are 
used to study the interactions of bio-molcculcs and to characterise the function 
of cellular components.
Understanding the priciples of fluorescence becomes important when devel­
oping fluorescence protocols or when faced with imaging problems. This chapter 
attempts to outline these principles and the important optical properties tha t are 
intrinsic to the fluorophorcs commonly used in fluorescent techniques.
Semiconductor quantum dots are a new class of fluorescent labels with superior 
optical properties to conventional fluorophores. Semiconductor physics and the 
effects of quantum confinement are introduced in this chapter in order to provide 
a basic understanding of the properties of quantum dots. Their use in a variety 
of biomedical applications and their optical properties is reviewed and compared 
with conventional organic fluorophores.
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2.2 P r in cip les o f  fluorescence
2 .2 .1  P h o to lu m in e sc e n c e
Photoluminescence is the process where a substance absorbs and subsequently 
rc-cmits photons and is (typically) due to electron transitions within the sub­
stance. Fluorescence is a specific type of photoluminescence which occurs when 
the electrons arc optically excited and undergo internal energy transitions before 
being re-emitted. The mechanisms involved in photoluminescence are graphically 
illustrated in Figure 2.1.
Excited singlet states
Vibrational energy states
Internal conversion (10 s) 
Inter-system crossing
Excitation (10  ^ s)
Ground state
Fluorescence 
(10 9 s)
£
Excited triplet state
Phosphorescence (> 10 6 s)
Radiationlcss decay (<10 “ s)
Figure 2.1: Jablonski diagram showing available energy states within a molecule 
and the possible electronic transitions between states. Adapted from  [1],
W hen aground  state  electron in a fluorescent molecule is irradiated with light, 
all the energy of an incident photon, lw \ , is absorbed. If the energy of the incident 
photon is sufficient, the electrons in the ground state, So, are excited to a higher 
energy orbital, S\. The electrons can be excited to a number of vibrational and 
rotational states within S i, or even excited to a higher energy orbital 52, depend­
ing on the energy of the absorbed photon. However, the electron will rapidly 
relax to the lowest vibrational sta te  within Si via a non-radiative process called 
internal conversion; this excess energy is dissipated through molecular vibrations.
If the electron in the excited orbital is spin paired with the electron in the
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ground state, transition of the excited electron back to the ground state, £>0 , is 
allowed. As the electron relaxes back to the ground state, a photon is emitted. 
This process is called fluorescence. The emitted photon is of lower energy, hv2, 
(longer wavelength) than tha t of the photon which was absorbed, due to the 
non-radiative relaxation of the excited electron to the lowest vibrational state in 
Si (internal energy transitions). The process of fluorescence occurs rapidly and 
fluorescence lifetimes (average time between photon absorption and emission) of 
the order 10 ns are typical for common fluorophores.
There is also the possibility that the excited electron may be converted to 
a parallel spin state (triplet state, represented by 7\), by the process of inter- 
system crossing. Although such transitions are ‘forbidden’ in quantum theory, 
electrons do experience inter-system crossing and in order to return to the singlet 
ground state .So, the electron must again undergo a forbidden transition. Such a 
transition is called phosphorescence and is characterised by much longer lifetimes 
than fluorescence, owing to the unfavourable nature of the process.
2.2.2 F luorescence spectra
A range of energies can be used to excite a fluorescent molecule and these can 
be represented by an absorption spectrum. The absorption and emission spectra 
of the commonly used fluorophore, Alexa Fluor 488, is shown in Figure 2.2. The 
minimum amount of energy required to cause excitation within a fluorophore is 
equal to the difference in energies of the ground state, So, and the first excited 
orbital, S\. This is characterised by a steep cut off at higher wavelength (lower 
energy) scales. The various vibrational and rotational states that an excited 
electron may occupy, are represented by the peaks and troughs present in the 
absorption spectra. However these generally become smoothed out when the 
fluorophore is in solution. The absorption maximum reflects the wavelength which 
is most effective for causing excitation. It is the wavelength tha t results in the 
highest proportion of excited fluorophores.
Similarly, the fluorophore can emit a range of wavelengths as it returns to any 
number of the available states in So- However as mentioned earlier, the emitted
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100
_  Absorption Spectra 
_  Emission Spectra
300 400 500 600 700
Wavelength (nm)
Figure 2.2: Absorption and emission spectra o f Alexa Fluor 488 [2].
photon will in general he of lower energy than th a t which was absorbed, resulting 
in a shift in the maximum. This shift is known as the Stokes shift. For practical 
purposes, a large Stokes shift is desirable as this enables more precise separation 
of fluorescent signals from the illumination source.
2 .2 .3  P h o to b le a c h in g
Fluorophores can undergo many excitation/ emission events; they can repeat­
edly cycle between ground state, excitation and fluorescence emission. However, 
fluorophores can permanently lose the ability to fluoresce if structural damage 
occurs. This is known as photobleaching and can arise as a result of exposure to 
high intensity light or prolonged periods of excitation. Lichtman and Conchello 
discuss the process of bleaching and its implications in fluorescence imaging [1]. 
Although the photophysics of bleaching is not well understood, it is thought to 
be associated with triplet state formation. The triplet state is a relatively long 
lived state, during which time the fluorophore has an opportunity to interact with 
other molecules which may cause irreversible chemical damage.
Even though the Alexa Fluor series of fluorophores are more robust than other
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organic dyes such as fluorescein, photobleaching remains one of the greatest chal­
lenges in fluorescence imaging and there are limited ways in which to reduce 
the rate at which it occurs. One of the most promising developments in com­
batting the limitations imposed by photobleaching is the utilisation of quantum 
dots in fluorescence microscopy [3]. The advantageous optical properties afforded 
by quantum dots are discussed in more detail later in this chapter, (see section 
2.5.4).
2.2.4 Q uantum  yield
The quantum yield of a fluorophore is the proportion of excitation events 
that result in photon emission. It is a measure of the emission efficiency of a 
fluorophore. The quantum yield, 4!>, is defined as:
number of photons emitted
4>=------------ —^  (2.1)number of photons absorbed
Quantum yields vary widely from approximately 0.05 to nearly 1 depending on 
the fluorophore; however this value can be affected greatly by local environmental 
factors. In general, fluorophores with a high quantum yield have high fluorescence 
intensity. Additionally, a high quantum yield means the occurrence of intersystem 
crossing is reduced. As such, the likelihood of associated chemical changes, e.g. 
bleaching, is lessened.
2.2.5 F luorescent lifetim e
The fluorescence lifetime of a fluorophore is the average time an electron will 
remain in the excited state before decaying back to the ground state by pho­
ton emission. The level of fluorescence is directly related to the proportion of 
molecules residing in the excited singlet state, or put another way, the fluores­
cence intensity is proportional to the number of photons emitted. Therefore the 
fluorescence lifetime can be measured experimentally by monitoring the intensity 
in the period immediately following excitation. Doing so reveals tha t the time 
taken to return to the ground state follows an exponential behaviour, and the
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intensity, / ,  can be written as a function of time, t,
I(t)  =  Jo e - t/T (2.2)
where Iq is the intensity at t = 0 and r  is the fluorescence lifetime. Thus the 
lifetime can be measured by calculating the time taken for the intensity to reduce 
by a factor e.
Non-radiative pathways, such as quenching and Forster resonance energy 
transfer (FRET), compete with fluorescence as a mechanism for the fluorophore 
to return to the ground state. Thus the decay time for non-radiation relaxation 
processes, l / n nr, is taken into account in the fluorescence lifetime,
t  = -----   (2.3)
Kif T Kifir
where is the decay rate for radiative relaxation.
2.2 .6  Q uenching
Fluorescence quenching is a process of non-radiative relaxation. It competes 
with fluorescence as a mechanism for excited state decay and can therefore result 
in a dramatically decreased fluorescence intensity and cause a reduction in the 
fluorescent lifetime. Fluorescence quenching is different to bleaching in that it is 
a reversible process and can be exploited as a means to detect the presence of the 
quencher molecule. However for most applications, quenching is an undesirable 
process since it can inhibit the detection of fluorescence.
Collisional quenching of an excited fluorophore in solution occurs following a 
diffusive encounter with another molecule. The fluorophore returns to the ground 
state without emitting a photon. Alternatively, quenching may occur when a non- 
fluorescent complex is formed between a ground state fluorophore and a quencher 
molecule. In either case the quencher molecule may be of the same or different 
species as the fluorophore and may itself be fluorescent or non-fluorcscent. The 
mechanisms involved in quenching are comprehensively described by Lakowicz [4].
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2.2.7 Forster resonance energy transfer (FR E T )
As mentioned previously, there are alternative pathways available for an ex­
cited fluorophore to return to its ground state. FRET is the non-radiative transfer 
of energy from an excited donor fluorophore to an acceptor molecule, which may 
or may not be fluorescent. The process is not due to photon emission by the 
donor and absorption by the acceptor; it is the result of a dipole-dipole interac­
tion between the donor-acceptor pair. The donor fluorophore can be considered 
as an oscillating dipole that can couple to the acceptor with similar resonant 
frequency. This results in energy transfer to the acceptor molecule.
The degree of FRET depends on the physical separation between the donor- 
acceptor pair, r, the relative orientation of the dipoles and the spectral overlap 
between the donor emission and the acceptor absorption as described by R 0, the 
Forster radius. The rate of energy transfer, /c, between an acceptor-donor pair 
is related to the lifetime of the donor in the absence of an acceptor molecule, r , 
and is expressed as:
The efficiency of the transfer process at a distance, r, between the pair is given
From equation (2.5), one can see that the Forster radius, Rq, is equal to the 
distance between the pair at which the energy transfer process is 50 % efficient. 
That is, when r  =  Ro, the donor intensity is half the intensity measured when 
no acceptor molecule is present and the transfer rate is equal to the decay rate
Practically, FRET manifests itself in numerous ways. FRET causes changes 
to the fluorescence lifetime of donor molecules, an increase in acceptor fluores­
cence intensity (coupled with decrease in donor fluorescence intensity) and/or can 
change the polarisation of the emitted light. Detection of FRET may be carried 
out by monitoring one of these physical variables. For example, the lifetime of 
the donor molecules will become shortened in the event that FRET occurs be-
(2.4)
by:
R$E  = ---- -- (2.5)
of the donor in the absence of the acceptor. Rq typically ranges from 2 — 10 nm.
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tween the donor and acceptor molecules. This is dem onstrated by Figure 2.3(a), 
where mCerulean are the donor molecules and mVenus are the acceptor molecules. 
FRET may also be observed spectrally through a reduction in the fluorescence 
intensity of the donor molecule in the prescence of the acceptor molecules. As 
dem onstrated in Figure 2.3(b), the donor fluorescence can be re-instated upon 
photobleaching of the acceptor molecule.
a.) b.)
1.0
mCerulea n-mVen us 
FRET Pair§ 0.8
mVenus Acceptor 
PhotcbleachedE 0.6in w,w
0 0.2
0.0
500 550 600 650
mCerulean
mCerulean-mVenus
3
N
i§
z
0.01-1
0 2 3 5 6 71 4
Time (Nanoseconds) Wavelength (Nanometers)
Figure 2.3: (a) Shortening of fluorescent lifetime o f F R E T  donor molecules
(mCerulean) in the prescence o f acceptor molecules (mVenus). (b) Decrease in in ­
tensity of fluorescence emission from, donor molecules in the prescence o f acceptor 
(red spectra) which is reinstated upon acceptor bleaching (blue spectra) [5j.
The high dependency of FRET on the separation between the donor-acceptor 
pair makes FR ET a valuable tool in a variety of fluorescence applications; from 
biosensing [6], as a spectroscopic ruler [7] and as a novel method of achieving 
higher resolutions in scanning probe techniques [8].
2.3 S em icon d u ctor quantum  d ots
2.3 .1  In tr o d u c t io n
Quantum dots are semiconductor nanocrystals th a t are typically a few nanome­
ters in diameter. Their conduction characteristics and their physical chemistry 
are defined not only by the material they are composed of, but also by their phys­
ical dimensions. Q uantum  dots exhibit atomic-like behaviour in th a t they have 
discrete energy states rather than continuous bands, resulting in unique optical
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properties. Such properties arise as a result of quantum confinement effects and 
can be fine-tuned by simply changing the size of the nanocrystal.
In 1993, Murray et al. [9] reported a procedure for synthesising high optical 
quality, low size distribution CdSe quantum dots dispersed in organic solvents. 
However it was not until 1998 when methods for producing water soluble quantum 
dots were reported [3, 10], did quantum dots emerge as a promising alternative 
to traditional organic fluorophores.
In order to fully understand the properties of quantum dots and their poten­
tial for use in bio-medical applications, some background information on semicon­
ductor physics and the quantum mechanical description of quantum confinement 
shall be introduced.
2.3.2 B ulk sem iconductors
Semiconductors are materials with conduction properties between that of con­
ductors and insulators. In a semiconductor the energy states for electrons form a 
series of allowed energy bands separated by band gaps. W ithin the band there is a 
continuum of energy levels available. This is illustrated in Figure 2.4. The valence
Conduction band
electron
Photon
Band gap
hole
Valence band
 ►
Wavenumber, k
Figure 2.4: Simple illustration of electronic band structure in bulk semiconductors, 
comprising the valence and conduction bands which are separated by forbidden 
energy states which form  the band gap.
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band (VB) is the name given to the uppermost occupied energy states and the 
conduction band (CB) is the name given to the lowest available unoccupied en­
ergy states. These bands are separated by a forbidden energy gap which is called 
the semiconductor band gap, E g. The size of Eg varies according to composition 
and for cadmium sclenide (CdSe) bulk semiconductors, Eg ^  1.7 eV  [9, 11].
When an incident photon with sufficient energy is absorbed, an electron will 
be excited to the CB and an empty state (or hole) is left behind in the VB. 
This hole behaves like a positive charge. The pair will recombine if the electron 
returns to the VB and, if conditions support radiative recombination, a photon 
will be emitted to carry away the excess energy. When such an electron-hole pair 
is formed upon photon absorption, the CB electron is attracted to the positive 
hole in the VB via a Coulomb potential, described by equation (2.6).
V(r) = —A f-  r (2.6)
47re0er |re -  rh|
where e denotes the electron charge, e0 the permittivity of free space, er the 
diectric constant of the material and re and rh the position of the electron and 
hole respectively. This can result in the formation of an exciton: a hydrogen-like 
bound state between an electron and hole. The exciton is free to move through 
the crystal lattice, transporting energy as it does so. An exciton has lower energy 
than the unbound electron-hole pair due to its intrinsic binding energy. Thus 
the exciton exists below the CB and the photon energy required to produce an 
exciton can be less than Eg.
The interaction of the bound electron-hole pair can be described by the Hamil­
tonian,
T T  h 2  T— r2 ^  X - f 2  ^  / O  rr\H  =  V 2  V z ---------------------- r (2.7)
2 m *  e 2 m*h 47re0er|re -  rh |
where the effective mass of the electron is dcscibed by m* and the effective mass
of the hole, m*h and V 2  ^ the differential operators with respect to the electron
and hole positions. The relative position, r, of the electron and hole is given by
equation (2.8) and the position of the centre of mass, R , by (2.9).
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r =  r e — r h (2.8) R  _  m*re +  m*h r h g
m* +  m*h
The full mass, M  and the reduced mass, /i of the system can be introduced,
m c m h , 0  n  1 ,
M  = m'e + m ’h (2.10) f l ~ m e' + m h> '  '
Thus, the Hamiltonian (2.7) can then be expressed as follows,
h2 h2 e
H  = — — V i      (2.12)
2 M  2 n  47reo t rr
The first term in equation (2.12) corresponds to the Hamiltonian of a free particle 
of mass M , the remaining term s descibe the Hamiltonian of a particle of mass //, 
in a Coulomb potential.
In analogy, to the Bohr radius of the Hydrogen atom, the physical separation 
of the bound electron and hole is known as the exciton Bohr radius, an, as 
illustrated in Figure 2.5 and is defined as follows,
4tt e0€rh2
aB = -------^—  (2.13)
( I C Z
Figure 2.5: An exciton, a bound state between an electron, e and hole, h, separated 
by an exciton Bohr radius, aB.
Additionally, we can define the exciton Rydberg energy:
y 87re()era/j
Thus, the energy states of an exciton are derived from the solution to  the Hamil­
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tonian and are described by the following dispersion relation,
(2.15)
with k the exciton wave vector as given by, k =  kg +  kh- The exciton behaves as 
a single, uncharged particle of mass M . Equation (2.15) takes into account the 
kinetic energy associated with motion of the exciton’s centre of mass.
2.4 Effects of quantum  Confinement
It is possible to maufacture semiconductor structures with 1, 2 or all 3- 
dimensions comparable to the size of the exciton bohr radius. When the physical 
dimensions of the structure in a particular direction are smaller than the cxci- 
ton bohr radius, the motion of the exciton becomes confined in this direction. A 
quantum well is a structure which permits motion of the exciton in two directions 
but with restricted motion in the other direction. When the motion of an exciton 
is confined in two directions, the structure is called a quantum wire. While in 
a quantum dot, the exciton becomes restricted in all 3-dimensions. When the 
exciton is confined, the allowed energy levels are no longer continuous as in bulk 
semiconductors, but become discrete. Quantum confinement results in the unique 
optical properties we find quantum dots to exhibit.
In order to derive the allowed states for a quantum dot, a simplified model 
must be used that descibcs a particle confined in a spherical box. The result 
can be then be modified for two limiting cases: weak and strong confinement as 
discussed by Efros and Efros [12].
2.4.1 Q uantum  dots
By considering the Hamiltonian of a particle in a spherically symmetric po­
tential of width a , the following energy levels can be derived:
(2.16)
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where m is the mass of the particle and Xni are the roots of the spherical Bessel 
functions with n  the number of the root and I the order of the function.
When considering an exciton confined in a spherical quantum dot, the energy 
states for a particle in a spherically symmetric potential must be incorporated 
into the dispersion relation for a free exciton.
W eak confinem ent
In the case when the radius of the quantum dot is small, but still larger than 
the exciton Bohr radius, weak confinement exists and the dispersion relation 
(Equation (2.15)), is re-written to include the solution for a particle confined in 
a spherical potential, with width governed by the radius of the quantum dot, R ,
e ^ = e ° -  5 + S I  (2-i7)
In this case, motion of the excitons centre of mass is quantised and the exciton 
is characterised by the quantum numbers n, m, and I. n  descibcs the internal 
states due to the Coulomb interaction (IS , 2S, 2P; 3S, 3P, 3D...,), while m  and 
I arc connected to the states which arise due to the motion of the centre of mass
in the presence of an external potential barrier (Is, Ip, Id..., 2s, 2p, 2d...,). The
energy of the lowest state (n =  l , m  =  l , /  =  0) is  therefore,
7r2h2
E lSu  = Eg - R ;  + (2.18)
where Xio =  ?r was used. Equation (2.18) can be re-written using equations (2.13) 
and (2.14) to give,
£ lsl,  =  Es - * ; ( l - £ ( ^ ) 2)  (2.19)
Strong confinem ent
When the radius, R, of a quantum dot is such tha t the electron-hole pair 
are confined in a space smaller than the exciton bohr radius, a#, the Coulomb 
interaction experienced by the pair is significant. Brus [13] found the energy of
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the ground state electron-hole pair (lsls) is given by,
r2h2 „2
<2'M>
The term e2/eR  desribes effective Coulomb interaction between the electron- 
hole pair which, upon comparison with the exciton Rydberg energy, equation 
(2.14) and taking into account R  <C ao, one can see that the contribution to the 
energy from this term is more significant than for a bulk crystal, as discussed by 
Gaponenko [14].
Confinem ent effects in real quantum  dots
Ekimov et al. [15] examined CdSe nanoparticles with average radii 25, 8, 3.8, 
2.6 and 2.1 nm. They observed that the absorption spectrum for the weakly 
confined 25 nm particles is the same as for bulk CdSe with three absorption 
edges visible. Since a# ~  5.6 nm for CdSe, this result is as one would expect. 
The absorption spectra for the 8 nm particles started to exhibit the effects of 
quantum confinement and only two absorption edges were present in their spectra. 
The confinement effects were clearly visible on the absorption spectra for the 
smaller CdSe nanoparticles, with discrete peaks appearing near the absorption 
edge corresponding to the most prominent exciton transitions.
Figure 2.6 illustrates the absorption (dashed lines) and emission (solid lines) 
spectra of strongly confined CdSe quantum dots with diameters 3.5, 4.5, 6.0 
and 7.0 nm, as observed by Javier et al. [16]. The spectra demonstrate the size 
dependent nature of the optical properties of the quantum dots, with a blue shift 
in the absorption edge as the diameter of the quantum dot decreases. The two 
most prominent transitions are indicated on the absorption spectra for the 3.5 
nm diameter quantum dot. Additionally, and as noted by Ekimov et al. [15], the 
Stokes shift is larger for smaller sized quantum dots.
The commercially available quantum dots used in this study display peak 
emission a t the wavelengths 525, 605 and 655 nm, further information relating to 
their size and composition is included in Appendix 8.4 [2]. The effects of strong
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Figure 2.6: Absorption (dashed lines) and emission (solid lines) spectra for a 
series CdSe nanocrystals of diameters shown. The most prominent transitions 
are indicated for the 3.5 nm quantum dots. Adapted from [16].
confinement can be seen in their optical properties.
2.5 Synthesis and properties of quantum  dots
2.5.1 Solvent synthesis
Although alternative methods have been reported for the synthesis of semicon­
ductor nanocrystals, Murray et al [9] were the first to report a reliable technique 
for producing high optical quality quantum dots with a low size distribution 
(<5 % rms in diameter). The methodology employed by Murry involves injec­
tion of organometallic reagents into a hot coordinating solvent. The growth of 
the nanocrystals is monitored by observing the absorption spectra of aliquots of 
the reaction solution and is controlled by adjusting the temperature and pressure 
conditions. When the desired optical characteristics are observed in the reaction 
solution, small quantities can be removed. This permits a range of sizes to be 
manufactured from a single reaction solution. The size distribution of the these 
nanocrystals can be further reduced with a centrifuge and the remaining quantum 
dots can be dispersed in a number of solvents.
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2.5 .2  C ore/sh ell quantum  dots
The high surface-volume ratio of quantum dots means tha t the surface prop­
erties have important effects on other properties such as optical, structural and 
solubility. The procedure utilised by Murray [9], employs a Tri-n-octylphosphate 
oxide (TOPO) monolayer on the surface of the nanocrystals which prevents their 
aggregation when in solvent. However, TOPO coated quantum dots are prone to 
photooxidation and are therefore unstable and degrade with time.
Alternatively, nanocrystals can be capped with an inorganic shell consisting 
of a thin layer of semiconductor of higher band gap which effectively helps to 
confine the exciton. This process requires a close match in lattice constants of 
the core-shell materials to passivate the interface. The shell reduces the number of 
trap states at the surface of the core which lead to non-radiative recombination of 
the exciton. This promotes band edge emission and results in improved quantum 
yield. Experimental details for the synthesis of ZnS capped CdSe nanocrystals is 
reported by Hines [17] and Dabbousi [18].
2.5 .3  Surface functionalisation  for bio-m edical applications
When the synthesis of quantum dots is carried out, they are typically dispersed 
in a solvent such as toluene or chloroform and they are coated with a surfactant 
layer which renders them hydrophobic. For most biological applications however, 
quantum dots need to be soluble in aqueous solutions. There arc many methods 
tha t have been reported to make quantum dots water soluble. Replacing the 
surfactant layer with molecules that have functional groups reactive towards the 
surface, such as mercapto functionalities (-SH) and hydrophilic tails, such as 
carboxyl functionalities (-COOH), at the other end has successfully produced 
water soluble quantum dots. This method was first described by Chan and Nie [3].
Other options are to grow a hydrophilic silica shell around the surface [10] or 
to coat the dots with a polymer and embed them in phospholipid micelles [19].
Once the quantum dots have been made water soluble, it is then possible to 
conjugate them to various biomolecules such as biotin, antibodies, and proteins
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such as strcptavidin. Such functionaliscd quantum  dots can be used for a wide 
variety of biological applications and a selection of quantum  dot-biomolecule con­
jugates, of various emission wavelengths are available to purchase ‘off-the-shelf’. 
Figure 2.7 depicts the typical layered structure of quantum  dots available to pur­
chase from Invitrogcn, Paisley, UI< [2].
Core 
Shell
Polymer 
coating
Biomolecule
15-20 nm
Figure 2.7: Illstration showing anatomy o f quantum dot conjugate [2j.
2 .5 .4  P r o p e r t ie s  for b io -m e d ica l  a p p lic a t io n s
Quantum  dots have unique optical properties which make them an attractive 
alternative to the traditional fluorophores th a t are routinely utilised in a m ulti­
tude of biological and medical applications. The use of quantum  dots has been 
reported in many recent publications: Fluorescent detection of specific biomarkers 
in immunoassays [3, 19, 20], and other high-affinity interactions [10, 21], including 
real-time and long-term studies of molecule tracking in living cells [21]; in vivo 
studies [19, 22]; genetics [23] and bio-sensing as reviewed by Sapsford et al. [24].
Unlike organic lluorophores, quantum  dots exhibit narrow, symmetric emis­
sion spectra with a large Stokes shift. The effects of quantum  confinement result 
in their emission wavelength being size dependent, as discussed in section (2.4) 
and illustrated in Figure 2.8(a). Thus, changing the size of the quantum  dot, 
changes the band-gap energy and consequently the emission wavelength. More 
specifically, decreasing the size of the nanocrystals will result in a larger band-gap 
energy and therefore the quantum  dot fluorescence will be ‘blue-shifted’.
This ability to precisely tune the emission wavelength, by changing the size
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Figure 2.8: (a) Size dependent fluorescence emission due to quantum confinement 
effects, (b) Broad ahsortion and narrow emission spectra o f 605 nm  emitting  
quantum dots. Data from [2].
an d / or the composition m aterial, allows quantum  dots with fluorescence emission 
ranging from UV - Infrared to be fabricated. Additionally, quantum  dots possess 
continuous, broad absorption spectra which generally extend into the UV. This is 
dem onstrated in Figure 2.8(b) which shows the absorption arid emission spectra 
of red em itting CdSe/ZnS quantum  dots.
These features facilitate multiplexing studies; where a mixed ensemble of 
quantum  dots (with differing emission wavelengths), is simultaneously excited 
with a single light source. The illumination source used in multiplexing studies 
can be selected such th a t its wavelength is far removed from th a t of the emission 
wavelengths of the quantum  dots present. This enables straightforward separa­
tion of fluorescence signals from the illuminating light. Typically, multiplexing 
studies involving organic fluorophores are difficult to implement since they have a 
relatively small Stokes shift. This can make it difficult to spectrally separate the 
emission fluorescence from one type of fluorophore from another, and also from 
the excitation source.
Moreover, quantum  dots are significantly more resistant to photobleaching and 
chemical degradation than organic fluorophores. This has practical implications 
in long term  imaging, for example in studies of transport processes, cell tracking 
and repeated imaging of a single sample. Their photostability is further enhanced 
by the addition of an inorganic capping layer tha t has larger band gap than  th a t
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of the quantum dot core material. This shell increases the quantum yield of the 
dots by reducing the probability of non-radiative recombination and reducing the 
effects of crystal defects a t the surface. They also have a relatively long fluorescent 
lifetime, allowing the effects of background fluorescence to be minimised during 
fluorescence lifetime imaging microscopy (FLIM).
These properties are summarised in Table 2.1 and compared to typical optical 
properties of conventional fluorophores.
Property Fluorophores Quantum dots Reference
Absorption spectra Variable /  narrow Broad spectra, steadily increases to­
wards the UV from the first absorp­
tion band edge
[18, 25-27]
Emission spectra Broad, assymctric red- 
tailed emission
Narrow, Gaussian emission [3, 18, 27]
Stokes shift Generally <100 nm >200 nm possible [27, 28]
Tunable emission NA Unique to quantum dots; can be 
size/composition tuned from the UV 
to IR
[10, 28, 29]
Quantum yield Variable Generally high, 0.2 to 0.7 in buffer 
depending on surface coating
[17, 18, 25, 28]
Fluorescent lifetime Short <5 ns Long 10 - 20 ns or greater [27, 28]
Spectral range Fixed; a different dye 
every 40-60 nm
Tunable from UV - IR depending on 
material, Visible light from CdSe
[10, 18, 25, 28]
Photostability Variable to poor Excellent, strong resistance to photo- 
bleaching several orders of magitudc 
that of dyes
[3, 10, 20]
Multiplexing capabilities Rare Excellent potential, largely unex­
plored
[10, 27, 28]
FRET capabilities Variable, mostly sin­
gle donor-single accep­
tor configurations
Excellent donors, size tunc emission 
to improve the overlap with an ac­
ceptor dye
[30, 31]
Blinking Negligible Problematic in isolated circum­
stances (single molecule tracking)
[27, 28]
Reactivity Multitude of conjuga­
tion chemistries com­
mercially available
Availability of variety of conjugation 
chemistries improving
[2, 27]
Size <0.5 nm 4-7 nm diameter for CdSe core mate­
rial, up to 20 nm when conjugated
[2, 28, 29]
Table 2.1: Comparison of quantum dots with fluorophores. Adapted from [24J-
2.6 Sum mary
Fluorescence techniques are routinely applied in many areas of cell and molec­
ular biology. This chapter has introduced the principles of fluorescence which are
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key to understanding the optical properties of fluorescent labels. Moreover this 
knowledge is necessary when developing protocols that utilise fluorescence, when 
solving imaging problems and are also important when selecting appropriate flu­
orescent labels.
The unique optical properties of semiconductor quantum dots have recicvcd 
much attention from the biomedical research community. Quantum dots axe 
increasingly being used in many biological applications and are emerging as a 
new and improved class of fluorescent labelling agents. This chapter has reviewed 
many of these applications and has discussed the underlying principles tha t are 
respsonsible for their enhanced optical properties.
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Chapter 3 
Scanning near-field optical 
m icroscopy
3.1 Introduction
Advances across the science and engineering disciplines have constantly re­
quired the capacity to study materials on increasingly smaller dimensions. How­
ever, the resolutions achievable in conventional optical techniques are restricted 
by the diffraction limit to 200 — 300 nm, approximately half the wavelength of 
the visible illuminating light source.
The development of scanning probe techniques in the early 1980’s enabled 
samples to be imaged with nanometre resolution and provided the ability to 
examine multiple features simultaneously. The advances in scanning probe mi­
croscopy (SPM) were pioneered by Binnig and Rohrer in 1982 by the invention 
of the scanning tunnelling microscope (STM) [1]. The technologies they devel­
oped in order to facilitate STM, proved to be a catalyst for the advancement of 
other SPM techniques, such as atomic force microscopy (AFM) [2] and scanning 
near-field optical microscopy (SNOM) [3, 4].
SNOM is somewhat unique in tha t it has the capacity to provide high-resolution 
optical and topographical information simultaneously from a wide variety of sam­
ple types. SNOM can be performed under ambient or near-physiological condi­
tions and unlike STM, it does not require the sample to be conducting. Thus,
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in recent years SNOM has emerged as a powerful tool for studying a variety of 
biological samples and is being increasingly applied across the life science disci­
pline [5-10].
3.2 O p tica l reso lu tion
In conventional optical microscopy techniques, much information is lost be­
cause of the lim itations in spatial resolution. In the 19th century, Ernst Abbe [11] 
specified tha t the resolution of a lens, r, is given by the following relationship
(31)
where A is the illuminating wavelength; the numerical aperture, N A  — nsinor, n  
is the refractive index of the imaging medium and a  is half the acceptance angle 
of the lens, as illustrated in Figure 3.1.
NA = n sin (a)
Objective _  ft  j I  0 .25  = 1.0 sin (15 .0  )
Front lens n = Refractive index
= 1.00 (air)
1
-A __aa = 15 .0 C 
/ \
Specim en
Figure 3.1: D etermination o f the numerical aperture o f a microscope objective 
lens. Adapted from  [12].
This limit in resolution was later redefined by Lord Rayleigh [13], to  more 
precisely specify th a t two point sources can be resolved if they arc separated by 
a distance /?, where
h = y ~^(3-2)In  sin a
This fundamental limit is known as known as the Rayleigh criterion. It can 
be seen from this criterion th a t improvements to the resolution can be accom-
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plishcd by using a  shorter wavelength to illuminate; by using a m aterial of higher 
refractive index, for example an oil immersion lens; or by increasing the aper­
ture angle. These changes however, do not result in significant improvements to 
the resolution and a t best a resolving power only slightly better than  0.5A can 
be achieved. Yet this resolution limit is only applicable when considering the 
propagating component of light.
Light is composed of propagating and non-propagating (evanescent waves) el­
ements, thus one key to beating the diffraction limit lies with the ability to detect 
the non-propagating waves. In 1928, Synge [14, 15] proposed tha t this could be 
achieved by passing light through a sub-wavelength aperture in an opaque screen, 
in order to create an evanescent or near-held. As depicted in Figure 3.2, Svngc 
proposed th a t the screen should be positioned within a few nanom eters of the 
sample such th a t the evanescent waves generated at the aperture would interact 
with the surface.
:< ?J2 
< ►
Incident plane  I —— ——— — n
waves  1
Metal screen
Near-field
Specimen
Far-field
Wavelength o f light, A
Figure 3.2: Illustration o f Synge’s proposal. Evanescent field is generated by 
illuminating a sub-wavelength. aperture. The sample is positioned such that in ­
teractions with the evanescent field occur and sub-wavelcngth information can be 
accessed.
If the screen was then scanned across the surface in a raster fashion and the in­
teractions detected, the resolution of the resulting image would be governed only 
by the size of the aperture and sub-wavelength information could be recorded. 
However, Synge realized th a t there were numerous technical difficulties th a t would
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need to be addressed in order for his ideas to be realised: illumination; aperture 
formation and sample positioning. It took many years before technological ad­
vances had made sufficient progress and Synge’s proposal could be implemented. 
In 1984, Pohl et al. [3] and Lewis et al. [4] simultaneously realised SNOM.
3.3 E van escen t w aves
Evanescent waves are non-propagating components of electromagnetic waves 
and exhibit exponential decay with increasing distance from its source. They were 
first recorded by Newton during experiments on total internal reflection (TIR), 
which are illustrated in Figure 3.3.
d » A
Transmitted light has 
larger cross section 
than area in contactr%\
"  -7
d < A
Figure 3.3: Illustration showing Newton’s TIR experiment, (a) A beam of light, 
undergoes total intern,al reflection upon striking the prism  surface (b) Frustrated 
TIR occurs when a second, curved prism is introduced to the first. The area o f 
transmission is found to be larger than the region in contact.
During his studies, Newton found th a t it was possible to totally reflect a beam 
of light inside a prism, providing the angle a t which it strikes the inner surface 
of the prism is greater than  the critical angle. By introducing a second, curved 
prism and placing it in contact with the first, Newton expected th a t the light 
would be transm itted  only at the point of contact. However, he observed th a t 
the transm itted  light had a larger cross-section than the area in contact.
This can be explained by the fact th a t electromagnetic fields must be contin­
uous a t a boundary: If a field exists at or inside a surface, it must also be present 
outside the surface. Such a field is found to propagate along the surface but
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decays exponentially with increasing distance. This evanescent field is converted 
into propagating waves upon coupling to the second prism. The effect is known 
as photon tunnelling and can he generalised to other dielectric materials.
In order to describe the behaviour of an evanescent wave, consider an elec­
trom agnetic wave incident upon an interface, with angle greater than the critical 
angle such th a t T IR  occurs, as illustrated in Figure 3.4. The transm itted  wave
Figure 3.4: Electric field incident on an interface between materials o f differing 
refractive indices.
vector can be expressed as
E t(r, t) = E m exp[z(k- r  -  cjt)] (3.3)
and has components along and perpendicular to the interface. The wave vector 
component along the interface is given by
ktx =  k t sin 0t (3.4)
and the component perpendicular to the interface is
kty =  k t cos 6t (3.5)
Using Snell’s law of refraction, (r^sin#* =  n t s in 6t), one finds th a t the per-
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pcndicular component of the transmitted wave vector can be expressed as
kty = kt cos 0t = k t j  1 -  (—)2sin20i =  ktifi (3.6)
V n t
Therefore equation 3.3 can be re-written
7 1 '
E t(x, y , t) = Eot exp[ -k t/3y\ exp[z(fc* — s in ^ x  -  ut)] (3.7)
nt
Equation 3.7 describes an evanescent wave which decays exponentially with in­
creasing distance from the interface (y-direction) and describes the propagation 
of the field in the plane of the interface (x-direction).
The behaviour of an evanescent field is described more generally by equation 
3.8, as given by Courjon [16], where the field propagates along the surface in the 
(x, y) plane and decays exponentially in the ^-direction. A is the amplitude of the 
field at (x, y, z) and the coefficient a  depends upon the properties of the material 
and upon its spatial structure.
U (x, 2/, z, t) — A(x, y, z, t) cxp[—i(kxx  +  kyy)\ exp[—az] exp[zo;t] (3.8)
^ ^  ^ ^ — m m m m m ^
A m plitude Propagation A ttenuation T im e -
term  term  term  dependence term
3.4 Theory o f SNOM
Newton’s experimental work on frustrated TIR discussed in section 3.3, de­
scribes the formation of evanescent waves based on macroscopic interactions. In 
near-field microscopy, an evanescent field is generated by a sub-wavelength aper­
ture, therefore diffraction effects must be taken into account.
The diffraction of electromagnetic radiation by a sub-wavelength hole in a 
conducting plane was first considered theoretically in a publication by Bethe
[17]. The spatial distribution of the emitted radiation in the vicinity of the 
aperture was calculated, by applying boundary conditions to Maxwell’s equations. 
However, Bethe’s treatm ent of the problem was found not to accurately predict 
the behaviour of the fields in the vicinity of the aperture and was later corrected 
by Bouwkamp [18]. The work of Bethe and Bouwkamp provided a platform
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for further studies tha t more accurately predict the distribution of the radiation 
emitted from a SNOM probe.
The behaviour of evanescent fields in the vacinity of limited objects (ob­
jects characterised by sub-wavelength features) was discussed by Wolf and Nieto- 
Vcspcrinas [19]. Their work shows tha t light incident on a limited object, i.e. 
a sample with sub-wavelength features, is converted into propagating and non- 
propagating components. The diffraction limited propagating components are 
carried away towards a detector, while the non-proagating components are con­
fined to the surface of the object and contain the high spatial frequency informa­
tion relating to the sample.
In order to detect these non-propagating components, the evanescent field 
must in turn be converted into both propagating and non-propagating compo­
nents by a limited object, i.e. a sharp tip. Thus the corresponding propagating 
components can be detected and since the conversion between evanescent field 
and the detected field is linear, sub-wavelength information can be reproduced.
3.5 H eisenberg principle and near-field resolution
In order to determine ultimate resolution capabilities, one must neglect any 
technical difficulties and examine the relationship between near-field resolution 
and the Heisenberg uncertainty principle. Consider a point P (x , y, z) that exists 
in an electric field U (x ,y ,z )  as shown in Figure 3.5. The electric field can be 
described by its amplitude at this point and by a propagation vector k. The field 
strength is given by
2im
k = i r
where n  is the refractive index of the medium through which the wave propa­
gates. Since the electric field varies between two points, the minimum detectable 
variation in the field defines the ultimate resolution capabilities.
If A x , A y, A z  are defined as the uncertainty in the position of point P  and 
A k x, A k y, A k z as the uncertainty in the propagation vector k, one can use the
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k(x, y, z)
y
Figure 3.5: Illustration o f an electric Jield that is described by its amplitude and the 
propagation vector k {x , y, z ) at any point. The smallest detectable field variation 
is given by the Heisenberg principle and governs the near-field resolution.
Heisenberg uncertainty relation to state
A x  A  k x  > 2 t x (3 .ID)
and the same is true for the y and ^-directions. It can be seen from equation 
3.10 tha t A x  only takes small values when A k x is large, i.e. for a field which 
varies rapidly (Ax is small) the light is strongly scattered (A kx becomes large). 
To determine the largest value th a t kx can take, consider the projection of the 
propagation vector onto the x-axis
kx =  \k\ sin 0 (3.11)
thus kx is always smaller than \k\. If 6kx — 2kxMAX, where kXMAX is the largest 
value th a t kx can take, then equation 3.10 can be re-written to reproduce the 
Abbe limit
Sx > X
2 n  sin 0
(3.12)
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However, given that
N  =  v /W 2 -  kl  ~  kl  (3-13)
if either the ky or kz components of the wave vector take complex values, \kx \ 
will not be limited to \k\ as in equation 3.11, i.e. sub-wavelength resolutions can 
be achieved. For the case when kx and ky are real and kz is imaginary, the wave 
propagates in the (x, y) directions and is confined in the plane of the surface 
(z — direction), as was described by equation 3.8.
3.6 D evelopm ent of SNOM
In 1972, Ash and Nicholls [20] were the first to verify Synge’s ideas exper­
imentally, but not with visible light. Using microwave radiation of wavelength 
3 cm to image a metal grating with regular spacings of 0.5 mm, they demon­
strated tha t it was possible to achieve resolutions far beyond the diffraction limit 
of their radiation source. Although Ash and Nicholls recognised that fabricat­
ing apertures small enough for use with visible radiation was not an obstacle, 
they acknowledged tha t the development of a “super-resolution optical micro­
scope” would be hindered by the difficulties in maintaining the sample position 
to within a distance approximately the size of the aperture.
In 1981, Binnig and Rohrcr [1] developed the first STM which exploits the 
piezoelectric effect to achieve precise, nano-scale movements of a metal tip across 
the surface of a conducting or semi-conducting sample. The technological ad- 
vancess required for the STM lead to the development of AFM instruments [2], 
which make measurements of the interactions between a tip and sample.
The ability to achieve such fine movements in tip positioning facilitated the 
progress in developing a scanning near-field optical microscope and in 1984, two 
groups simultaneously reported to have extended the efforts made by Ash and 
Nicholls in order to utilize visible light. Pohl et al. [3] reported a maximum 
resolution of 25 nm using 488 nm radiation. This was realised by scanning a 
metal coated quartz tip with sub-wavelength aperture across a surface containing 
a series of opaque and transparent lines. While Lewis et al. [4, 21] demonstrated
43
3.7. APPLICATIONS AND TYPICAL SET-UP
resolutions of 50 nm using 500 nm radiation with their SNOM set-up.
3.7  A p p lica tio n s and typ ica l set-u p
Since these initial publications, there has been much progress in developing the 
SNOM technique and it has found applications in many disciplines. The original 
experimental set-up has been modified to facilitate a variety of purposes: Single 
molecule detection [22, 23]; fluorescence lifetime measurements [24, 25]; thin film 
analysis [26, 27] and Ram an spectroscopy [28, 29]. In biological sciences, SNOM 
has been utilized for membrane studies [6, 30, 31]; protein localization [32] and 
it has been successfully applied to image in liquid environments [5, 33].
Although the actual experimental set-up employed will depend on the prop­
erties of the sample, a typical arrangem ent is shown in Figure 3.6. Laser light is 
coupled into a single-mode optical fibre and in turn coupled into a SNOM probe. 
Light em itted from the SNOM probe illuminates and excites the sample and the 
resulting fluorescence is collected by the objectives. Laser light can be removed 
from the signal by a Ram an edge filter and in such a set-up any remaining fluores­
cence can be directed towards a detector. Multiple variations for the illumination 
of samples and the collection of fluorescence can be utilised, these are illustrated 
in Figure 3.7.
Feedback loop
Monitor
Fibre optic probe
Tuning fork
Laser
Reflection objective 
Sample
U  U  XYZ Piezo scanner 
Transmission objectiveT
I Raman edge filter
Detector
Figure 3.6: Schematic representation of typical S NO M experimental set-up.
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3.8 S N O M  p robes
As with ther SPM techniques, when imaging with a SNOM the probe is crit­
ical for obtaining high quality images. During the subsequent development of 
SNOM, extensive research on probe design was carried out. Various probe de­
signs have been utilised including tapered optical fibres; pulled micro-pipettes 
and apertureless probes. Although aperture probes can be problematic and have 
numerous issues associated with their use (they are sensitive to heating effects and 
the ultim ate resolution obtained is governed by the aperture size), they remain 
the most popular choice for use with both commercial and home-built SNOMs.
Commercially available, pulled-fibre optic probes were chosen for this work, 
thus their m anufacture and operational modes will be discussed in this section.
3 .8 .1  O p e ra tio n a l m o d e s
There are several modes of operation available when utilising fibre optic probes 
with SNOM. These options provide a flexibility to select the most appropriate 
mode for scanning according to the properties of the sample.
SNOM probe
a ) w b ) lie\ \  j j Z  Laser light\  /  N  .
} Optical response
t d) I
Figure 3.7: Operational modes o f SNO M  when a fibre optic probe is utilised; (a) 
Probe illum ination/Transm ission collection, (b) Probe illum ination/Reflection  
collection, (c) Probe collection, (d) Probe illumination/Probe collection mode.
Illumination mode is implemented by coupling an external light source to the 
tail of the nano-apertured, fibre optic probe. Transmission through the aperture 
is of the order of 10-4 — 10-7 , therefore this method lends itself well for use with 
photosensitive samples. Coupling of the evanescent light into the sample can lead
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to propagating light, which in turn can be transmitted or reflected, as illustrated 
in Figures 3.7(a) and (b) respectively. This light from the sample is collected 
by an objective lens and directed towards a detector. Transmission collection 
mode requires the sample to be transparent, and the reflection collection mode is 
used for opaque samples. Probe collection mode is employed when the sample is 
illuminated externally or when the sample is optically active (for example a laser 
structure) as shown in Figure 3.7(c). Here the optical signal from the sample is 
collected up through the fibre probe and directed on to a detector. A further, 
more difficult, option is illustrated in Figure 3.7(d), where the probe is used 
to both illuminate the sample and to collect the optical response up through 
the fibre. Other options include monitoring sample response to light, for example 
using photocurrents. Filters and spectrometers can also be employed within these 
set-ups.
3.8.2 M anufacture
Fibre optic SNOM probes are routinely manufactured via controlled heating 
and pulling. Single mode optical fibres, with core diameter approximately 3—5 /zm 
are placed in a micro-pipette puller and heated under tension to create a sharp 
drawn taper, until eventually a breakage occurs. The taper and end aperture 
geometries are controlled by the heating and pulling parameters. The method 
results in highly reproducible tapered fibre optic probes.
The optical fibres are subsequently coated with an opaque metal in order to 
confine the light along the sides of the fibre. Aluminium is generally used due 
to its low skin depth for visible light, meaning only a thin coating is required to 
ensure optical opacity. Coating is achieved by thermal evaporation while rotating 
the probe at an angle, directed away from the aluminium source. This creates 
an even film along the length of the fibre and leaves the end aperture uncoated. 
Typically, the thickness of the aluminium coating is approximately 50 — 100 nm. 
Additives, such as chromium, may be involved to improve adhesion of the metal 
coating to the glass fibre taper.
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3.9 Scanning technique
The ability to achieve sub-wavelength resolution when scanning with SNOM 
is subject to numerous technical difficulties. Since the near-field decays exponen­
tially with increasing distance from the aperture of the probe, maintenance of a 
fixed tip-sample separation is vital. This ensures that the sample is positioned 
within, and illuminated by, the near-field and also ensures that the illumination 
power on the sample surface is constant throughout the duration of the scan. 
Maintaining a fixed tip-sample distance is also important to prevent tip damage 
caused by contact with the surface.
3.9.1 Feedback m echanism
As the topography of a sample changes during scanning, the separation be­
tween the tip and the surface is affected. A shcar-force feedback mechanism is 
commonly employed to regulate a fixed tip-sample distance.
The fibre optic probe is mounted onto a tuning fork and oscillated at resonance 
laterally to the surface. As the probe-surface separation decreases, the oscillation 
amplitude becomes damped by the shear-forccs acting between the probe and the 
sample surface. Maintaining a fixed oscillation amplitude forms the basis of the 
feedback signal which regulates the probe-surface separation. Thus, monitoring 
the necessary probe movements required to maintain a fixed separation effectively 
generates a topographic map of the surface.
3.9.2 Signal d etection
Typically, low fluorescent signals axe generated by the sample following exci­
tation by the evanescent field tha t is emitted from the SNOM probe. Efficient 
mechanisms are therefore required to collect the optical signals. High numeri­
cal aperture, achromatic objectives are used to collect transmitted or reflected 
signals. Filters are then used to remove stray light and ensure that high signal- 
to-noise levels axe achieved before the signal is focussed onto a detector. Highly 
sensitive detectors such as avalanche photodiodes (APDs) are typically employed
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to monitor fluorescence. APDs are sensitive to low light levels and can in theory 
count individual photons by internally amplifying the photocurrent generated by 
incident photons.
Two silicon APDs (single photon counting modules from Perkin Elmer), with 
dark counts <100 Counts/s and <50 Counts/s were available for use during this 
study. In general, the APD with dark counts <50 Counts/s was utilised.
3.10 FR ET SNOM
3.10.1 In troduction
The ultimate resolutions achievable with a conventional fibre optic probe are 
restricted. Reducing the aperture size to increase optical resolution results in low 
power throughput and consequently reduced fluorescent response.
The quest to achieve smaller resolutions has resulted in novel modifications 
to the typical SNOM set-up. One such example is the active or functionalised 
probe. This approach relies on Forster resonance energy transfer or FRET, a 
non-radiative energy transfer process between two fluorophores, an excited donor 
molecule and an acceptor molecule. The process of FRET depends highly on the 
physical separation between the donor-acceptor pair. The principles of FRET are 
discussed in more detail in section 2.2.7. By combining FRET with conventional 
SNOM, a powerful tool can be assembled with the ability to provide ultra-high 
resolution imaging. Thus, a FRET SNOM instrument has huge potential for the 
imaging of biological studies.
FRET SNOM was originally proposed as a means to improve the resolutions 
achievable with SNOM in 1991 [34] and has since been realised by numerous 
other research groups. To facilitate FRET SNOM imaging, donor (or acceptor) 
molecules are attached to the apex of a SNOM probe which is then utilised to scan 
a sample containing acceptor (or donor) molecules. Only the donor molecules arc 
excited by the laser light emitted from the SNOM probe. As the tip scans across 
the sample, FRET occurs between the donor-acccptor pairs and the resulting 
acceptor fluorescence is detected. The resolutions are governed by the FRET
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radius, which for good FR ET pairs, is of the order of a few nanometers.
3 .1 0 .2  R e a lisa t io n  o f  a c tiv e  p ro b es
Vickery and Dunn [35] were the first to dem onstrate an improved resolu­
tion directly owing to the occurence of FRET. Acceptor molecules, (Rhodaminc 
dye molecules) were deposited onto the apex of a SNOM probe while donor 
molecules (Fluorosccin) were incorporated into the sample. The acceptor/donor 
molecules were integrated into L-alpha-dipalmitoylphosphatidylcholine (DPPC) 
lipid films in order to ensure th a t the thickness of the dye films could be effec­
tively controlled. A schematic illustration of the tip-sample configuration em­
ployed by Vickery and Dunn is shown in Figure 3.8(i). The sample consists of 
two DPPC/fluorescein layers seperated by three layers of arachidic acid, while a 
single layer of D PPC /rhodam inc has been deposited onto a (non-metal) coated 
SNOM probe.
Figure 3.8: (i) Schematic representation o f tip-sample configuration employed 
during F R E T  SNO M  imaging; (A) 50 p m  x 50 p m  SNOM  image showing donor 
fluorescence; (D) F R E T  SNO M  image showing acceptor fluorescence [35]
Vickery and Dunn dem onstrated improvements in the resolution obtained 
by using a 458 nm excitation source, which predominantly excites the donor 
molecules, to scan the sample with the functionalised probe. The resulting Flores­
cence was collected and passed through a 548 (±5) nm band pass filter, in order 
to observe only the fluorescence originating from the donor, as shown in Figure 
3.8(A). An additional scan of th is area was obtained, shown in Figure 3.8(B),
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however during this scan, the fluorescence was passed through a 590 (±5) nm 
band pass filter in order to observe only the acceptor fluorescence. In this sec­
ond image, fewer fluorescent regions are observed (indicated by arrows in Figures 
3.8(A) and (B)), owing to the fact that FRET is only efficient bewteen the flu­
orescein dye in the upper layer of the sample and the rhodamine dye present on 
the tip apex. Upon comparison of the two circled regions in these images, an ob­
served improvement to the resolution in seen in Figure 3.8(B). This improvement 
can be attributed to the distance dependent nature of the FRET process.
Since this original work by Vickery and Dunn, many other materials have been 
proposed and used to functionalise SNOM probes: Organic dyes [36]; nitrogen- 
vacancy colour centres in diamond [37]; gold nanoparticlcs [38] and F2 colour 
centres in LiF [39]. The use of semi-conductor quantum dots in FRET SNOM 
applications has also been demonstrated. CdSc/ZnS quantum dots embedded in 
a polymer matrix were used to coat a SNOM probe by Shubeita et al. [40]. This 
probe was then used to image a sample doped with OM57 dye molecules and 
to demonstrate the occurence of FRET. In another study, a polystyrene bead 
coated with CdTc quantum dots was attached to the apex of SNOM tip and 
which was subsequently utilised for FRET SNOM imaging [41]. More recently, 
a publication by Sonnefraud [42] has shown SNOM images recorded with the tip 
having a single, active quantum dot at the tip apex, although no FRET SNOM 
images were presented with such a tip.
3.11 Summary
SNOM was originally conceived by Synge [14] in 1928 however, its realisation 
was hindered by numerous technical difficulties. These issues were resolved fol­
lowing the invention of STM by Binnig and Rohrer [1] and the first SNOM was 
developed in 1984 [3, 4]. SNOM has since been increasingly utilised in a variety 
of applications, and undergone further developments to facilitate these studies.
The theory of SNOM and evanescant waves has been introduced in this section 
and the principles behind near-field detection have been outlined. A typical
50
3.11. SUMMARY
SNOM set-up has been described and the mechanisms involved in scanning have 
been discussed. The quest to further improve the resolutions achievable has 
resulted in the development of functionalised probes to facilitate FRET SNOM. 
A summary of the literature has been presented in this section.
The versatility and flexibility afforded by SNOM is the key to its success 
across a variety of disciplines. For biological applications in particular, its ability 
to provide high-resolution optical and topographical infomation, makes SNOM an 
ideal instrument to probe structure-function relationships of cellular constituents. 
FRET SNOM has vast potential to further the progress in this area of research.
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C h a p te r  4 
Cell biology
4.1 In trod u ction  to  hum an cell b io logy
The cell is the smallest functional unit of life. Living organsims may he 
composed of a single cell (such as bacteria) or cells may be the building blocks 
for more complex structures within organisms. There arc many types of cells 
found within the human body. Although they share several common features, 
these different cell types have very specific functions to perform which is reflected 
in their structure. This is exemplified in Figure 4.1 which illustrates a selection 
of cells found in the human body.
Ovum
St r i a t ed  (volunta ry)
S m o o t h  ( i nvoluntary)
Red blood cells Nerve cell
C a rd i ac
Figure 4.1: Morphology of different cell types found in the human body. Adapted 
from  [I].
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The structure of the cells is specifically designed to assist the cells in effectively 
performing their role within the body. For example, dendrites are branch-like 
structures found on nerve cells which receive electrical signals from other neurons. 
Whereas the biconcave disk morphology typical of red blood cell (also called 
erythrocytes), facilitates flow through the blood vessels. Human cells vary widely 
in shape and size depeding on their function. However a general overview of 
cellular anatomy and common components is shown in Figure 4.2.
The nucleus is the control centre of the cell. The m ajority of a cell’s genetic 
material is housed within the nucleus and is organised into long strands of DNA. 
These strands of DNA form structures called chromosomes. The nucleus is re­
sponsible for preserving the integrity of the genetic information, regulating gene 
expression and thus directing the activities of the cell.
L y so so m e
C entrio les,
R ib o so m e s
Anatomy of the Animal Cell 
M itochondria
M icrofilam ents
P ero x iso m e
R ough
E ndop lasm ic
R eticulum
P lasm a
M em brane
N ucleo lus
N ucleus
N uclear 
P o re s
Micro
T ubules
G olgi 
A p p a ra tu s
I
Cilia
S m oo th
E ndo p lasm ic
R eticulum
N uclear
E nve lope
C hrom atin
R ough 
E ndop lasm ic  
R eticulum
Figure 4.2: General anatomy o f an anim,al cell [2]
The cytoplasm is the site of most cellular activities and contains most of the 
cell’s organelles. For example; mitochondria, which are the powerhouse of the 
cell and the rough endoplasmic reticulum, which is the site of protein synthe­
sis. The cytoplasm contains many filaments, such as actin and microtubules, 
which collectively form the cytoskeleton. These filaments act as a scaffold which 
maintains the architecture of the cell and also play a vital role in cell motility
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through assembling cytoplasmic protrusions such as cilia, flagella, lamcllipodia 
and filopodia.
Animal cells differ from plant cells in that they have only a plamsa membrane, 
no cell wall is present. The plasma membrane is a lipid bilayer which surrounds 
the cytoplasm, isolating the cell from the external environment. Many proteins 
are embedded within the plasma membrane which perform a range of functions 
including transport into and out of the cell, cell adhesion and cell signalling. To 
provide cellular shape the cytoskeleton is anchored to the plasma membrane.
Cells of a particular type will often organise themselves into tissues which in 
turn combine to form organs. Tissues in humans are categorised into four main 
types: Connective, muscular, nervous and epithelial tissue. The epithelium is a 
layer of cells that forms a lining on all cavities and structures within the body 
and on exterior surfaces. The epithelium forms the basis of the investigations 
undertaken in this thesis.
4.2 Adhesion mechanisms
Cellular adhesion plays a vital role in the organisation of cells and in maintain­
ing the overall architecture and function of tissues and organs. Adhesion between 
adjacent cells and binding to the extracellular matrix are both essential compo­
nents of tissue formation. These rely on an array of adhesion receptors and the 
formation of thousands of adhesive contacts. Furthermore, cellular adhesion is a 
dynamic process and requires continuous maintenance to sustain stable contacts.
Multiple proteins are involved in any one adhesion complex, of which there 
are numerous types. Each type of adhesion complex is grouped together on 
the membrane in regions known as junctions. A schematic illustration of the 
various junctions abundant in epithelial tissues is presented in Figure 4.3. The 
basis of each junctional complex involves transmembrane proteins tha t interact 
with similar proteins on other cells to form cell-cell contacts, or directly with 
the extracellular matrix. The formation of stable adhesive contacts also requires 
interactions between the cytoplasmic domain of these transmembrane proteins
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Apical surface
Epithelial celt
Tight junction
Adherens junction
Desmosome
Basal surface
E x tr a c e llu la r  rnalrx
Focal ad hesion  H em idesm osom e
Figure 4.3: Cellular junctions present in epithelial tissues. Adhesion between 
adjacent cells and binding to the extracellular matrix are essential to maintain  
tissue architecture. Adapted from  [3j.
and the cytoskeleton, via a selection of interm ediate plaque proteins.
As mentioned previously, epithelial tissues form a lining on all interior and ex­
terior surfaces of the body. An essential property of epithelial tissues is the ability 
to selectively control their permeablity to small molecules and ions. Tight junc­
tions seal adjacent cells together and play an im portant role in the formation of 
a barrier between the apical and basal surfaces of tissues. Tight junctions divide 
tissues into two dinstinct regions th a t are biochemically seperate. The transm em ­
brane proteins responsible for t he formation of tight junctions are occludins and 
claudins, which link to the act.in cytoskeleton through ZO proteins.
The principal mediators of cell-cell adhesion are the cadherins which form ad­
herens junctions and are discussed in detail in the following section. The presence 
of adherens junctions promotes the formation of other junctional complexes [4]. 
Desmosomes are formed by desmosomal cadherins which link to the intermediate
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filaments of the cytoskclcton, labelled by IFs on Figure 4.3. They arc abundant in 
tissues which are subject to high levels of mechanical stress and act to resist the 
shearing effect of such forces [5]. Both focal adhesions and hcmidcsmosomcs arc 
responsible for the binding of cells to the extracellular matrix. Hemidesmosomes 
are similar to dcsmosomcs in tha t they resist the effects of mechanical stress tha t 
is applied to the tissue. Focal adhesions play a central role during cell m igration 
and arc continuously assembled and disassembled. Focal adhesions also serve to 
communicate information to the cell regarding the extracellular m atrix [6].
4 ,2 .1  E -cad h er in  an d  th e  a d h eren s ju n c t io n
Like other cellular junctions, the adherens junction relics on the interaction 
of numerous proteins to mediate adhesion. The adherens junction links cells 
together through transm em brane glycoproteins called cadherins and also act as 
an anchor site for the actin cytoskeleton through specialised linker molecules 
called catenins.
CELL 2
Cell
CELL 1 Extracellular m atrix
Figure 4.4: Illustration showing mechanisms o f E-cadheri,n media,ted cell-cell ad­
hesion and involvement of other proteins in adherens junction complex.
E-cadherin is the foremost eadherin present in epithelial tissues. The extracel­
lular domain of E-cadherin is responsible for mediating cell-cell adhesion via ho-
F-actin E-cadherin trans­
m em brane pro te in
a-ca ten in
mem brane (3-catenin
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motypic, Ca2+ dependent interactions with similar molecules on opposing cells [4]. 
The illustration shown in Figure 4.4 demonstrates how E-cadherin molecules are 
directed outwards from the plasma membrane and each interdigitate with two 
further E-cadherin molecules from the opposing cell.
The cytoplasmic domain of E-cadherin can associate with a number of the 
catenin family of proteins. The catenin proteins link E-cadherin to the actin 
cytoskeleton and play an important role in maintaining proper cell-cell adhesion.
4.2 .2  R ole o f  actin  filam ents and filopodia
Filopodia are cytoplasmic projections that play an active role in cell migration. 
Filopodia are thin cylindrical structures tha t are packed with parallel bundles 
of filamentous (F)-actin. These dynamic structures are rapidly assembled and 
disassembled through actin polymerisation and are found on the leading edge of 
motile cells. Furthermore, they have been observed to sweep up and down, and 
from side to side while sensing their local environment. Their highly dynamic 
nature facilitates exploration of the extracellular matrix in their efforts to guide 
the cell and promote adhesion to other cells or to the substrate.
Analysis of these cell nano-structures has revealed that filopodia are typically 
found to measure 100 — 300 nm in diameter. However the degree to which they 
protrude from the membrane varies across different cell types. Due to their small 
dimensions and their dynamic properties, filopodia are known to be difficult to 
image as they often do not survive fixation. Consequently, these structures have 
been analysed using live imaging techniques. However when coupled with fluores­
cence, imaging of live samples can be problematic since this requires transfecting 
the cells with genetic material which encodes for a fluorescent protein. When the 
protein of interest is subsequently expressed in the transfected cell, the fluores­
cent protein will also be expressed and is tagged onto that protein. This enables 
live tracking of the movements of the protein through the cell. This technique is 
difficult to implement compared to immunofluorescence labelling of fixed cells.
In addition to their role in migration, filopodia have been shown to play an 
essential role in initiating cell-cell contact and in establishing adhesion between
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adjacent cells. In a study of mouse kcratinocytes, Vasioukhin ct cl [7] reported 
th a t calcium stim ulates the formation of filopodia, which were subsequently ob­
served making contact with opposing filopodia. The filopodia were observed to 
interdigidate and form anti-parallel dimers, before eventually embedding into the 
opposing cell membrane. The formation of adherens junctions occurcd a t the tips 
of these embedded filopodia and E-cadherin was visualised to form double rows 
of puncta through immunofluorcsccnt labelling.
f i l o p o d i a
) • E - c a d h e r i n ,  ^ - c a t e n i n ,  « - c a t e m n  
• z y x i n ,  v i n c u l i n ,  V A S P ,  M e n a  
— - a c t i n  f i l a m e n t  
- a c t i n  m o n o m e r
s ,  * *'
Figure 4.5: Adjacent cells in close proximity extend filopodia across the inter­
cellular region. Upon establishing contact, filopodia interdigitate and, punctate 
adherens junctions form  (green). Anchored filopodia tug the two cells together. 
A s the gap closes, further adherens junctions are established and filopodia regress. 
F-actin (red) reorganises and aligns parallel to the sealed cells [7].
As illustrated by Figure 4.5, this initial functional contact between opposing 
filopodia physically draws the cells together, gradually forming a seal between the 
two cells. The filopodia regress via actin depolymerisation and the initial double 
row of E-cadherin puncta closes to form a single row.
The actin cytoskeleton plays an active role in the formation of intercellular 
adhesion and is required to form a seal between adjacent cells [7]. As the gap be­
tween adjacent cells is closed, filopodia regress and F-actin filaments reorganise to 
align parallel to  the sealed membranes. The actin filaments form a circumferential 
belt around the periphery of the cells [8].
4.3  C ancer
M aintenance and repair of tissues within the body requires tha t cells contin­
uously grow and divide to replace old or damaged cells. This process is regulated
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by the cell to ensure that growth takes place in a controlled manner. However 
various changes can occur during the lifetime of the cell which may result in 
the cell becoming defective in the mechanisms tha t underlie normal proliferation 
and homeostasis. These changes may be induced by numerous factors; for exam­
ple DNA mutations can result from exposure to environmental carcinogens and 
mutagens. If these mutations are not removed or repaired by the cells various 
error-checking mechanisms, these mutations will be passed down to the daugh­
ter cells. The accumulation of these mutations over many generations of cells 
will cause a gradual change in the cells phenotype. Of special importance to 
the process of carcinogenesis is the inactivation of genes that are directly or in­
directly involved with the regulation of the cell cycle. Other important genes 
include those that influence differentiation, regulate DNA repair machinery and 
maintain normal extracellular signalling, such as cell-cell adhesion.
Each case of cancer will progress in a slightly different manner but in gen­
eral, there are multiple features that the majority of cancer cells will acquire 
during carcinogenesis. While some cancers may not progress to the later stages 
of carcinogenesis, instead forming non-invasivc benign tumours, or acquire these 
features at different stages, this can be seen as a basic schematic for cancer pro­
gression.
Hanahan and Weinberg’s review [9] provides a comprehensive outline of the 
mechanisms involved at the cellular level in cancer progression. The review iden­
tifies multiple abilities that cancer cells acquire which are summaried here.
1. G ro w th  Factors: Normal cells require growth signals which instruct them 
to enter into an active proliferative state whereas this dependence appears 
reduced in tumour cells. This may be engendered through up-regulation of 
growth signalling receptors in tumour cells or the ability to synthesis their 
own growth factors to which they are responsive.
2. A n tig ro w th  signals an d  evasion o f ap o p to sis: Tumour cells arc able 
to circumvent anti-growth signals which operate in healthy tissues and are 
able to avoid apoptosis (programmed cell death).
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3. U n lim ited  rep lica tiv e  p o ten tia l: Although properties 1 and 2 enable 
tumour cell populations to proliferate without inhibition, healthy cells have 
in-built mechanisms which limit the number of times they can divide. Thus 
for cancer cells to develop into much larger masses, cells must overcome this 
barrier and acquire the ability to replicate indefinitely.
4. A ngiogenic ab ility : As a tumour develops the demand for oxygen and 
nutrients increases and the mass must acquire the ability to form new blood 
vessels.
5. Invasion  a n d  m e tasta s is : Of particular interest to this study is the down- 
regulation of surface proteins which mediate cell-to-cell adhesion and bind­
ing to the extracellular matrix in late-stage cancerous cells. This leads to 
their being able to invade the local tissue. Ultimately they can become de­
tached from the main tumour mass (primary tumour) and travel to a new 
region within the body through the blood or lymph nodes where secondary 
tumours will form (metastases).
The responsiveness of cancer to treatment will depend on the type of can­
cer and its stage of progression. However, in general the prognosis of a patient 
is significantly poorer when metastases are formed. Diagnosis of cancer is usu­
ally confirmed by histological examination of a biopsy specimen and histological 
markers can be helpful in determining the prognosis and in tailoring treatments 
for individual cases.
Prostate cancer is one of the most common malignancies in males and approx­
imately 35,000 new cases are diagnosed every year in the UK. Prostate cancer can 
be a relatively slow growing disease and often patients will show no symptoms 
and require no treatment. However, prostate cancer has a propensity to metasta- 
sise, leading to poor patient prognosis especially when secondary tumours occur 
on the bones or lymph nodes.
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4.3.1 A berrent adhesion in prostate cancer
Normal cellular adhesion is essential for proper functioning of tissues and or­
gans. Aberrant adhesion has implications in the development of many illnesses 
and diseases. A large body of research has been produced in an effort to bet­
ter understand the mechanistic relationship between cellular adhesion and the 
metastatic capacity of tumours. E-cadherin is one of the principal mediators in 
epithelial cell-cell adhesion and its role in the progression and metastasis of can­
cer has been extensively studied. E-cadherin has been shown to act as a tumour 
invasion suppressor of numerous carcinomas [10-12].
Significant efforts have been made to find a clinical marker which would enable 
differentiation between relatively benign and invasive tumour types. Furthermore, 
a reliable prognostic marker would assist in tailoring medical treatment of indi­
vidual patients. Numerous clinical studies have been undertaken to develop a 
deeper understanding of the role that E-cadherin and its associated proteins play 
in the progression of prostate cancer.
Umbas et al. [13, 14] reported that E-cadherin downregulation is linked to 
loss of prostate cancer tumour differentiation and more aggressive tumour grade. 
Furthermore, a reduced level of E-cadherin was shown to inversely correlate with 
poor patient survival rate. These results were confirmed in a later study by Cheng 
et al. [15]. E-cadherin’s potential as a prognostic marker in prostate cancers was 
proposed as a result of these findings.
Subsequent clinical investigations have explored the relationship between E- 
cadherin and a-catenin and their role in maintaining adhesion. It was shown 
that a-catenin plays a vital role in the cadherin complex and its presence is 
required for E-cadherin function. Aberrant expression of a-catenin was found to 
be concomitant with abnormal E-cadherin levels. This was found to correspond 
with more aggressive prostate cancers and lower survival rates [16-18].
Numerous studies have since been undertaken which confirm E-cadherin’s 
prognostic value. These studies indicate that a combination of the proteins in­
volved in the cadherin complex may be more effective than E-cadherin alone as 
prognostic indictators [19-21]. Utilising a combination of these cadherin complex
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proteins as prognostic markers has also been suggested for cancers originating 
in other organs, such as colorectal [22] and bladder cancer [23]. However a con­
tradictory report by Bryden et al. [24], suggested that E-cadherin may not be 
critically related to metastasis following investigations which revealed E-cadherin 
to be strongly expressed in bone metastases. Furthermore, a study by McWilliam 
et al. [25] found no relationship between E-cadherin expression and tumour pro­
gression to bone metastases and overall survival of patients. It should be noted 
tha t McWilliam et al. [25] did find tha t E-cadherin expression was linked with 
tumour grade and invasion in prostate cancer.
Further investigations have been undertaken to investigate the role of adhesion 
in cancer metastasis. In vitro studies of human cancer cells have been undertaken 
in order to assess the phenotype of highly invasive prostatic cell lines. PC-3 is hu­
man prostate adenocarcinoma cell line which was derived from bone metastases. 
PC-3 cells have been shown to be highly invasive and metastatic, and form loose 
cell-cell contacts when cultured in a monolayer [26, 27].
Analysis of the phenotype of PC-3 cells has shown inconsistent information 
regarding E-cadherin expression. Morton et al. showed down regulation of E- 
cadherin expression in PC-3 cells compared to normal prostate epithelial cells. 
Furthermore, it was reported that a-catenin was completely absent at the pro­
tein and RNA levels suggesting aberrant a-catenin is responsible for the loss of 
adhesion (RNA is a nucleic acid that carries coding information from the DNA 
and instructs the cell to produce the associated protein). In contrast, other stud­
ies have shown through immunohistochemistry that E-cadhcrin is not present in 
PC-3 cells [28, 29]. However in two consecutive studies, Lang et al. reported para­
doxical findings. The first report [27] found that PC-3 did not express E-cadhcrin. 
Lang et al. subsequently reported [30] E-cadherin was expressed in PC-3 but was 
not found localised in regions of the cell that confer cell-cell adhesion.
Additionally, the role of the cadherin complex in the invasive potential of PC- 
3 cells has been demonstrated by numerous studies. Ewing et al. [31] transfected 
PC-3 cells with a-catenin and observed dramatic alterations in cell morphology 
and increased cell-cell contact. The report suggested that re-exprcssion of a-
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catenin restored E-cadherin function. In a recent 2009 study, Zhou et al. [32] 
demonstrated that up-regulation of E-cadherin could be induced through treat­
ment with luteolin, a dietary flavanoid which reduced the invasiveness of PC-3 
cells.
Overall, these findings from clinical studies and in vitro analysis of prostate 
adenocarcinoma cell lines suggest a clear link between the aberrant expression 
and functioning of the cadherin complex and more aggressive prostate cancers. 
However, further research into the mechanisms of adhesion is necessary in order 
to provide more conclusive identification of potential prognostic markers. In­
vestigations into the localisation and expression levels of E-cadherin are key to 
understanding its role in prostate cancer. Hence a high-rcsolution study which 
compares the localisation and expression in different cell lines through immunoflu­
orescence labelling of E-cadherin is necessary.
4.4 Fluorescent labelling of target proteins in  
situ
Immunocytochcmistry, or fluorescent labelling, is routinely employed to iden­
tify and examine cellular components. The technique reveals valuable information 
regarding the molecular make-up of the structures under scrutiny by localising 
specific, constituent proteins.
Immunocytochcmistry relies on antibodies that can recognise and bind to 
specific cellular components. Antibodies are generated by injecting the molecule 
of interest, called an antigen, into a host species. The host’s immune system 
responds by producing antibodies, also called Immunoglobulin G (IgG), tha t are 
specific to the injected antigen. These antibodies are then extracted from the 
host and purified. Thus an antibody produced in a rabbit to target antigen X, 
would be called rabbit anti-X IgG antibody. These antibodies may be directly 
conjugated to an indentification marker, such as a fluorophore or quantum dot 
and applied to tissue samples or cells to locate the antigen on the sample.
Alternatively, a more versatile approach is afforded by employing indirect
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labelling. Primary antibodies arc generated as described for the direct method 
and are then injected into a second host of different species. Antibodies are 
generated by the secondary host which specifically target the primary antibodies. 
These secondary antibodies are subsequently extracted and can be coupled to 
biomolccules such as biotin or fluorophorcs. Thus a secondary antibody produced 
in a goat to target a prim ary antibody produced in a rabbit, would be called goat 
anti-rabbit IgG secondary antibody. The process of indirectly labelling a sample 
with quantum  dots is shown in Figure 4.6 via two mechanisms.
a.)
Target molecules 
on sample
h. )
P r im a r y
antibody > »
A
Figure 4.6: Indirect method o f immunofluorescent labelling. Target molecules (a) 
on cell membrane are first labelled by specific primary antibodies (b). Primary 
antibodies maybe conjugated to other molecules such as biotin. (c) Identification 
markers (for example quantum dots) maybe conjugated to secondary antibodies 
which seek out and attach to primary antibody. Alternatively, marker molecules 
can be conjugated to other biomolccules, such as strcptavidin which have a high 
affinity to biotin.
One dem onstrates the use of prim ary and secondary antibodies, the other ex­
ploits the high affinity nature of biotin and streptavidin. The prim ary advantage 
of employing indirect labelling is th a t resulting fluorescent signals arc enhanced. 
When using the direct method, only one fluorophore can bind to the prim ary 
antibody. In the indirect process, multiple secondary antibody conjugates can 
bind to the primary antibody which effectively amplifies the fluorescent response.
The use of antibodies in fluorescent labelling enables highly sensitive detection 
of biomolccules and proteins. Furtherm ore, multiple types of biomolecules on the 
same sample can be differentially labelled to allow simultaneous detection. This 
enables a more extensive investigation into the molecular make-up of a sample as
c.)
Quantum dot conjugated to 
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dem onstrated by Figure 4.7. In this image (taken from [33]), three cellular targets 
are identified on the same cell and an overlay of the three colours is produced.
Figure 4.7: Multicoloured immunofluorescent image of human HeLa cells. A nti­
bodies and labelling agents used to locate cadherin proteins (green), F-actin (red) 
and nucleus (blue) [33].
4.5 Sum m ary
This chapter outlines the biological theories which provide the foundation for 
the studies contained in this thesis. Particular emphasis has been drawn to the 
roles th a t numerous cellular components play in establishing and m aintaining 
cell-cell adhesion. The impact of abnormal cell-cell adhesion m ediated by E- 
cadherin and its associated proteins has been discussed, specifically in relation to 
the progression and m etastasis of prostate cancer.
A large body of research has been produced in order to develop a deeper un­
derstanding of the m etastatic process. Numerous studies have shown E-cadherin 
to be lacking in both clinical specimens and cell lines deriving from prostate ade­
nocarcinomas. Furtherm ore it has been dem onstrated th a t the loss of E-cadherin 
expression or function is linked to increased invasiveness, m etastatic potential 
and poorer patient prognosis. However, a small body of studies have argued 
against this consensus. These findings suggest additional investigations into the 
mechanisms involved in E-cadherin function are required before any conclusions
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can be drawn about whether E-cadhcrin can be utilised effectively as a prognostic 
marker in prostate cancer.
This chapter has also introduced the priciples behind fluorescence labelling 
techniques that are routinely used to study cell biology and the function of cellular 
components. The process of immunocytochcmistry and the use of antibodies have 
been outlined as the method of choice for the sensitive detection of biomolecules 
and proteins.
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Chapter 5 
Experim ental procedures
5.1 Introduction
This chapter describes the instrument developments required to facilitate the 
study of biological samples using scanning near-field optical microscopy (SNOM). 
Adaptations were made to standard sample handling configurations which en­
abled examination of samples using both fluorescence and SNOM techniques. 
Im portant aspects relating to the acquisition of SNOM images and subsequent 
image processing are also discussed.
Furthermore, this chapter contains full details of sample preparation method­
ologies and immunofluorescence labelling protocols that have been adapted for 
SNOM investigations. These protocols were optimised specifically to allow ex­
amination of samples with both the fluorescence microscope and the SNOM. The 
results and further optimisation of these protocols is detailed more fully in Chap­
ter 7.
5.2 Equipm ent
5.2.1 Scanning near-field optical m icroscopy
Images were obtained primarily using an Aurora 3 scanning near-field optical 
microscope (Veeco Instruments), however some topographic imaging was carried
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out using its predecessor, a Veeco Aurora 2. To illuminate samples, laser light 
was coupled to aluminium coated fibre optic probes. The fibre optic probes were 
purchased pre-mounted onto tuning forks with resonant frequency 80 — 110 kHz 
and the aperture of the SNOM probes were approximately 50 — 100 nm (Veeco 
Instrum ents). A 20 mW, 488 nm A r+ laser was used for these studies and a 
laser line filter was necessary to attenuate light at wavelengths not of this prim ary 
output wavelength. The instrum ent was operated in transmission mode and light 
was collected using a 40 x , 0.65 numerical aperture collection objective. Collected 
light was directed out of the the side of the SNOM unit and passed through a 488 
nm Raman edge filter to remove laser light from the optical signal as illustrated 
in Figure 5.1.
Tuning fork for 
shear-force contro
Specimen
j  Spectrometer
Plastic
tube
Transmission
intensitx
Raman
dge filter
Interchangeable
mirror
Figure 5.1: Graphic illustration o f experimental arrangement used when exam in­
ing biological samples with scanning near-field optical microscopy [1].
A dditional filters can be inserted into the optical path immediately after the 
Ram an edge filter if required. Band pass filters were utilised at this point in 
the optical path  when studying samples which were labelled with two different 
colour quantum  dots. This enabled fluorescence from each colour quantum  dot-
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to be collected separately, identifying the location of two separate targets on the 
sample. Details of the filters used are given in Chapter 7.
Optical signals can be focussed onto an avalanche photodiode (APD) to count 
the total intensity. Alternatively, a 50 : 50 beamsplitter can be inserted into the 
optical path (location indicated by dotted line on Figure 5.1) to direct 50 % of 
the optical signal towards a spectrometer. The latter configuration allows collec­
tion of SNOM fluorescence images and enables the user to collect spectroscopic 
information from points of interest on the sample that are identified on the SNOM 
image.
The entire SNOM system and optical components shown in Figure 5.1 are 
fully enclosed to protect the APD from exposure to ambient light. This process 
also minimises background and ensures good signal-to-noise levels are achieved. 
The SNOM enclosure is mounted onto an anti-vibration table, reducing the risk 
of damage to the SNOM tip and subsequent aperture opening.
5.2.2 F luorescence m icroscopy
The schematic illustration given in Figure 5.2 shows the standard configura­
tion used in a fluorescence microscope. Typically a mercury lamp is used as the 
illumination source. White light from the lamp is passed through an excitation 
filter which allows only the desired wavelengths of light to pass through, and 
these are then directed onto the sample. A wide range of excitation filters are 
available, these are tailored towards the requirements of a specific fluorophore. 
For example a band pass filter centred on 482 nm with a band width of 18 nm 
would provide optimal excitation for Fluorescein (also known as FITC) or Alexa 
Fluor 488 fluorophores.
Light is collected from the sample and passed through an emission filter which 
eliminates background fluorescence and allows only the desired fluorescence to 
pass through. For example a band pass filter centred on 525 nm with a band 
width of 45 nm would be used to select fluorescence from Fluorescein or Alexa 
Fluor 488 fluorophores. Fluorescence can either be viewed through the eye piece 
or captured by the built-in camera. The resulting images generated are false
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Figure 5.2: Schematic illustration depicting configuration o f a standard fluores­
cence microscope.
colour and represent the intensity of the fluorescence detected.
It should be noted th a t the filter sets installed on the available fluorescence 
microscope were not optimal for the detection of quantum  dot fluorescence. This 
is not im portant for the excitation filters since quantum  dots have a broad ab­
sorption spectrum. However for the detection of fluorescence, the use of filters 
tha t are not tailored specifically to the emission wavelength of the fluorescent 
labelling agent can result in the loss of a proportion of the optical signals.
In this study, available filters sets which were the best match to quantum  dot 
emission wavelength were utilised for all fluorescence microscopy. Specifications 
of the filters used are included in Appendix B.
5 .2 .3  M o d ific a tio n s  to  fa c ilita te  im a g in g  o f  b io lo g ica l m a-
A number of modifications were made to the SNOM arrangem ent to facilitate 
the study of biological specimens. In preparation for scanning a sample, the 
SNOM housing has a built-in light source th a t enables the user to view the sample
ter ia ls
78
5.2. EQUIPMENT
and SNOM tip on a monitor. This enables the user to select a suitable region on 
the sample to image and also to manually bring the tip into close proximity with 
the surface, while ensuring they do not make contact.
These initial stages require rather sensitive positioning of the tip and sample 
and therefore it is essential that the two are illuminated. However, this can 
become a problem when fluorescent samples are under investigation which are 
highly sensitive to light exposure and can become photobleachcd very rapidly. 
This can result in samples fading, or even becoming unusable before scanning has 
begun. For this reason light levels were kept to a minimum. Furthermore, the 
built-in white SNOM light was exchanged for a red light emitting diode (LED). 
This ensured that the incident light on the sample was largely non-bleaching to 
the fluorescent labels, which require light of higher energy/shorter wavelength to 
induce fluorescence.
The samples under investigation in this study were largely non-uniform. It 
was common to observe large areas of substrate where no cells were present, while 
in other regions the cells may be highly confluent. Where present, cells could be 
clearly visualised when samples were mounted on the SNOM sample stage and 
illuminated with the built-in SNOM light. Acquisition of SNOM images takes 
up to 3.5 hours depending on the scan size, thus a limited number of scans can 
be performed on a particular sample. It is important to ensure that the cells 
under examination arc suitable in terms of their fluorescence labelling. While 
optimisation of the labelling methodology was carried out as fully as possible to 
ensure consistency, occasionally a proportion of the cells were poorly labelled or 
subject to high levels of localised non-specific labelling. It is important to rule 
out these regions for scanning with SNOM.
In order to achieve this, a far-field illumination configuration was devised 
which allowed examination of the samples using a similar principle to tha t of 
the fluorescence microscope. A schematic of this experimental arrangement is 
illustrated in Figure 5.3. The sample is placed on the SNOM scanner stage 
and is illuminated by laser light which is directed onto the sample using a fibre 
launch. The transmission objective is used to collect light and direct it towards
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Figure 5.3: Schematic illustration o f far-field illumination set-up used to examine 
fluorescent samples by adapting SNO M  instrumentation.
the CCD, the resulting image can then be viewed on a monitor. By placing a 
Ram an edge filter between the objective and CCD, laser light is removed and 
only the fluorescent signal is observed on the monitor. The sample stage can 
then be moved in the (xy )-direction to locate a region where labelling of cells 
is mostly specific. The fibre launch can then be removed, the SNOM head unit 
(which holds the SNOM tip) can be put in place and the exact region identified 
using this far-field set-up can be imaged.
Figure 5.4 shows photographs of a sample under far-field illumination. Figure 
5.4(a) shows the sample as seen using the reflection objective to image the cells 
under standerd illumination. A cluster of cells can clearly be observed in the cen­
tre of the screen. The photograph in Figure 5.4(b) shows the corresponding view 
as seen using the transmission objective and the far-field illumination configura­
tion. Fluorescence can clearly be seen on the monitor, which aids the selection of 
suitable regions for scanning. The bright spot in the centre of the screen is due 
to a small am ount of laser light bleeding through the Ram an edge filter.
Although these adaptations allow exact regions to be selected based on their
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Figure 5.4: Photographs demonstrating far-field illumination method to identify 
fluorescence from  the sample, (a) Sample as seen by the reflection objective under 
standard illumination. A cluster o f cells is present in the centre o f the image, (b) 
Corresponding far-field illumination of the sample showing fluorescence.
fluorescence labelling, the set-up must be dismantled in order to then subse­
quently image the sample using SNOM. The far-field configuration was re-installed 
each time a new region or sample is to be investigated, which was time consum­
ing. In conjuction with long imaging times for SNOM, this made the overall 
acquisition of images a lengthy process.
A more versatile approach was afforded by the development of customised 
glass slides, as shown in Figure 5.5. This enabled all samples to be thoroughly 
examined using fluorescence microscopy prior to imaging with SNOM. For SNOM
Sam ple turned 
face  down
C ustom ised  
g la s s  slide
G la ss  coverslip
Figure 5.5: Schematic illustration o f cutomised glass slide which, facilitates exam­
ination o f samples with fluorescent microscopy prior to SNOM.
imaging, samples were prepared on 25 mm diam eter glass coverslips. Coverslips 
need to  be m ounted face-down onto glass slides in order to be examined using
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the fluorescence microscope. Subsequent imaging of these samples using SNOM 
was not possible since the mounting of coverslips results in the surface becoming 
scratched and the topographic structure being damaged.
To facilitate examing samples with both techniques, glass slides were cus­
tomised by drilling holes of approximately 20 mm in diameter as shown in Figure
5.5. This meant tha t any damage to the surface of samples due to mounting the 
coverslips face down would only occur around the outermost part of the sample. 
Each sample could then be imaged with both techniques. The use of these cus­
tomised slides resulted in a much faster imaging of samples by ensuring only the 
most consistently labelled samples were examined with SNOM.
5.3 Im age acquisition
5.3.1 Scanning param eters
The quality of the images acquired using SNOM largely depend on the scan­
ning parameters set by the user and need to be determined experimentally for 
different sample types. When imaging biological specimens, which often have a 
large height range, slow scan rates must be used to ensure the SNOM tip has 
enough time to respond to any sudden changes in topography and avoid any con­
tact between the tip and sample. The gain settings used to control the feedback 
mechanism which maintains the tip-sample distance, also greatly affect how the 
tip responds to these changes in height. A compromise must be found between 
ensuring the tip can respond rapidly to sudden changes in height while still being 
able to track finer topographic details.
This is exemplified in Figure 5.6 which shows SNOM acquisitions of human 
epithelial cells. The cells under scrutiny possess abrupt features which makes 
achieving high quality topography images using SNOM considerably difficult. 
Dramatic changes in height require very precise optimisation of scanning param­
eters. If the scan speed or gain settings are not fully optimised for the sample, the 
SNOM scanner cannot respond to such features as quickly as is required. This 
results in the tip being unable to track the surface accurately and tip crashes
82
5.3. IMAGE ACQUISITION
become more likely.
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Figure 5.6: High features often cause the tip to overcompensate fo r  sudden changes 
in height, (a) 30pm  x  30firn SNO M  topography image in the forward direction. 
Blue line in (a) corresponds to the cross-section shown in image (b) which shows 
tip overshoot (indicated by arrow) in response to abrupt topography change, (c) 
Reverse direction topography image and (d) corresponding cross-section showing 
no such overshoot.
Figure 5.6 shows two SNOM topography acquisitions of the same region, one 
in the forward direction (a) and one in the reverse direction (c). The cross-sections 
shown in (b) and (d) correspond to the lines identified on the respective topogra­
phy images (a) and (c). As can be seen in the images, increases in sample height 
occur much more rapidly in the forward direction while a more gentle gradient 
occurs due to increases in height in the reverse direction. The sudden increase 
in height in the forward direction has resulted in the tip ovcrcompensating and 
retracting from the surface further than  is necessary. This is identified by arrows 
in both Figures 5.6(a) and (b) but is more prominent in the cross-section data  
given in (b). As a result of the tip  overshooting, an artefact is present in the 
topography image shown in (a) and appears as a bright line along the m ajority 
of the cell edge.
Examination of the reverse direction in Figure 5.6(d) reveals no spike and 
no such artefact can be seen along the cell edge in topography image (c). This
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confirms that the feature is infact an artefact and not a real topographic feature. 
In this case, scanning parameters would require further adjustment.
The number of pixels that each image is composed of is defined by the user. 
This can have a great influence on the quality of the images, which is of partic­
ular importance on large scans and this can determine the resolutions which arc 
achieved. Typically, a resolution of 300 x 300 pixels was selected. Furthermore, 
when acquiring optical images with SNOM, the user must define the integration 
time for the APD. This is the length of time light is collected by the APD from 
each image pixel. A compromise must be reached in defining this parameter. 
Too short an integration time will result in poor fluorescence images, while too 
long an integration time will result in increased scan times since this setting will 
override the pre-defined scan rate. In this study, an integration time of 20 ms was 
selected when acquiring SNOM fluorescence images and scan rates were typically 
set at around 3 fim s~l .
5.3.2 Im age processing
Minimal image processing was carried out following acquisition of images using 
SNOM. Most topography images required levelling adjustment to account for 
sample tilt. Performing levelling on an image allowed accurate measurements 
of height. The effect of levelling an image is demonstrated in the cross-sections 
in Figure 5.7. The cross-section in (a) shows height infromation prior to any 
levelling. Significant sample tilt can be seen in this cross-section and height 
information is uninterpretable. 3-point levelling was then performed on the entire 
image by selecting three known flat regions on the sample, i.e. where the sample 
substrate is visible. The software applies the levelling to the image with respect to 
the user defined points. The same line is examined in both cross-sections (a) and 
(b) shown in Figure 5.7. Height information can be interpreted and individual 
features are more clearly defined in cross-section (b) which derives from an image 
that has been levelled.
Removal of system background was then typically applied to topography im­
ages to eliminate anomalous curvature that is introduced to an image due to
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Figure 5.7: (a) A cross-section obtained from an image prior to correcting for 
sample tilt, (b) Cross-section obtained following levelling the image. The same 
lines are examined in both cross-sections (a) and (b).
scanner error. In order to further enhance the definition of the image, the con­
trast was adjusted using the software’s histogram function. This enables the 
user to control the colour distribution over the height range of interest in the 
image and resolve finer features that may otherwise be masked due to a large 
height range. To enhance SNOM fluorescence images, the only function that was 
performed was adjustment of the image contrast using the histogram function.
5.4 Preparation of biological samples
5.4.1 Sam ple preparations
This section fully outlines the sample preparation methodologies employed 
during this study. The methods used to grow and sustain cells in vitro arc 
described, as are the fixation procedures.
All steps of the immunofluorescence labelling protocols were optimised from 
the basic procedures described by the manufacturers; including permeabilisation
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conditions, blocking steps, concentrations of reagents, incubation conditions and 
washing steps. The optimisation was completed for each cell line used within this 
study.
Cell Culture
Prostate epithelial cells, PNT2, and prostate adenocarcinoma cells, PC-3, 
were obtained from the European Collection of Cell Cultures. The cells were 
maintained in RPMI 1640 media supplemented with 10% fetal bovine serum, 1% 
L-Glutamine, 60 units/mL penicillin, and 60 /ig/mL streptomycin at 37 °C/5% 
C 0 2. Growth media was refreshed every other day, and the cells were sub­
cultured when they reached approximately 80 % confluency.
Growth of cells on slides/coverslips and cell fixation
For optimisation purposes, cells were grown on sterile glass slides. For imag­
ing, cells were grown on sterile 25 mm circular glass coverslips. The confluency 
of the cells was difficult to control. This can be altered by changing the con­
centration at which the cells are seeded or by changing the length of time that 
the cells arc allowed to grow before fixing. To study adhesion mechanisms, cells 
need to be confluent enough such that cell-cell contact has occurred and mature 
contact sites have had time to form. Moreover, to study the role filopodia play in 
initiating adherens junction formation, their molecular make-up should be exam­
ined at various stages of cell-cell contact, including samples where initial cell-cell 
contact has yet to be established. The cells were fixed at room temperature using 
3.7 — 4% ultra-pure methanol-free formaldehyde in PBS for 15 minutes, followed 
by three 5 minute washes in P B S /100 mM glycine and dehydrated through an 
ethanol series. Coverslips were stored at 4 °C until required for immunolabclling. 
Optimally, samples were imaged within 48 hours of preparation. Signs of degra­
dation were often observed around a week after fixation/ labelling. Samples were 
subsequently discarded when degradation was observed during imaging.
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5.4.2 P erm eabilisation , fluorescent labelling and washing
For fluorescence labelling of fixed cells, the coverslips were rinsed with PBS to 
resuscitate the cells. All subsequent incubation periods utilised a simple, home­
made humidity chamber at room temperature, unless otherwise stated. The 
humidity chamber minimises evaporation of labelling reagents and prevents sub­
sequent concentration changes during incubations. Each incubation period was 
followed by three 5 minute washes in phosphate buffered saline (PBS) solution at 
room temperature, to remove unbound reagents unless otherwise stated. Concen­
trations were optimised for all labelling protocols. Protocols are summarised in 
the flowchart shown in Figure 5.8 which shows the general method for immunoflu­
orescence labelling carried out in this thesis. Dual labelling is summarised in 
Figure 5.9.
Organic dyes for labelling E-cadherin in P N T 2 cells
Cells were permcabilised with 0.1 % Triton-X for 10 minutes, rinsed three 
times for 5 minutes each in PBS and then incubated with signal enhancer (Image- 
iT FX signal enhancer, Invitrogcn) for 30 minutes which helps to reduce back­
ground fluorescence that can arise due to nonspecific binding of secondary anti­
bodies. Cells were rinsed three times in PBS for 2 minutes each time. E-cadhcrin 
primary antibody was then applied at a concentration of 18 /ug/ml, diluted in 
1 % BSA/PBS (rabbit polyclonal anti E-cadhcrin antibody) for 1 hour [2]. Cov­
erslips were rinsed three times for 5 minutes in PBS. To label E-cadherin with 
Alexa Flour 488 goat anti-rabbit secondary antibody conjugate, the coverslips 
were incubated with 2 /ig/ml for 2 hours [3]. The coverslips were rinsed three 
times for 5 minute in PBS to remove excess unbound Alexa Fluor 488. To fa­
cilitate SNOM imaging, samples were additionally rinsed three times in water, 
dehydrated through an ethanol series and air-dried. Samples were stored at 4 °C.
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General protocol for the immunofluorescence labelling of cells
Fix cells in 3.7-4 % Ultra-pure methanol-free 
formaldehyde 15 minutes
X
Three 5 minute washes in PBS/ 100 mM Glycine
Cell fixing
Ethanol series
Rinse slides in PBS
Storage at 4 C
Permeabilisation in 0.1%Triton-X/PBS for 10 minutes
Three 5 minute washes in PBS
Incubation in signal enhancer for 30 minutes 
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Cell
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Figure 5.8: Schematic illustration showing general experimental protocol followed 
fo r  fixing and immunofluorescent labelling of cells.
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General protocol for the dual labelling of cells
Fix cells in 3.7-4 % Ultra-pure methanol-free 
formaldehyde 15 minutes
X
Three 5 minute washes in PBS/ 100 mM Glycine
Ethanol series
Rinse slides in PBS
Storageat 4 C
Permeabilisation in 0.1%Triton-X/PBS for 10 minutes
Three 5 minute washes in PBS*
Incubation in signal enhancer for 30 minutes
Three 2 minute washes in PBS*
J
Cell fixing
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ocking
Dual labelling
Application of primary antibody Step 1
Three 5 minute washes in PBS
Application of secondary antibody
Three 5 minute washes in PBS
Application of primary antibody
Three 5 minute washes in PBS
Application of primary antibody Step 2
Three 5 minute washes in PBS
Application of secondary antibody Step 3
Three 5 minute washes in PBS
Application of secondary antibody Step 4
1
Three 5 minute washes in PBS
Three rinses in distilled H,0 Washing
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Storageat 4 C
Fluorescence rnicroscopy/SNOM
Figure 5.9: Schematic illustration showing generalised experimental protocol fo l­
lowed fo r  the dual labelling o f cells with quantum dots. * for PC-S cells this stage 
is changed to three 5 m inute P B S /100 rnM glycine washes.
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Quantum  D ot labelling o f cytoskeletal proteins in PN T 2 cells
The protocol for labelling cytoskeletal proteins was optimised and provided by 
Doak et al. [4]. Following the fixation procedure coverslips were rinsed in PBS and 
permeabilised in 0.1 % Triton-X for 5 minutes. Three 5 minute washes in PBS 
were carried out then endogenous biotin was blocked using a Biotin blocking kit in 
accordance with the manufacturers’ guidelines (Invitrogen). Cells were incubated 
in signal enhancer (Image-iT FX signal enhancer, Invitrogen) for 30 minutes and 
rinsed three times in PBS for 2 minutes each time. Cells were subsequently 
incubated with 2 pM  biotinylated phalloidin for 20 minutes [3], washed three 
times for 5 minutes in PBS and then incubated with 20 nM Qdot 655-Streptavidin 
conjugate for 30 minutes [3]. Excess unbound quantum dots were rinsed by three 
5 minute washes in PBS and samples were dehydrated through an ethanol series 
before left to air dry. Samples were stored at 4 °C until required for imaging.
Quantum  D ot labelling o f M em brane proteins in P N T 2 cells
This labelling procedure applies for the labelling of E-cadherin proteins OR 
ZO-1 proteins seperately. The dual labelling protocol which labels both proteins 
on the same sample is described later in this chapter.
Coverslips were rinsed with PBS to resuscitate cells following fixation and 
subsequent storage. Cells were permeabilised with 0.1 % Triton-X for 10 minutes, 
washed three times for 5 minutes in PBS and then incubated with signal enhancer 
for 30 minutes. Cells were rinsed three times in PBS for 2 minutes each time.
This step is applicable only for quantum dot labelling of E-cadherin: Primary 
antibodies were applied at a concentration of 18 /ig/ml diluted in 1 % BSA/PBS 
(rabbit polyclonal anti E-cadherin antibody) [2]. Cells were incubated for 1 hour 
then rinsed three times for 5 minutes in PBS. Quantum dot conjugate (Qdot 
605 goat F(ab’)2 anti-rabbit IgG or Qdot 525 goat F(ab’)2 anti-rabbit IgG) was 
applied to the coverslips at a concentration of 20 nM which were subsequently 
incubated for 1 hour [3].
This step is applicable only for quantum dot labelling of ZO-1: Primary anti­
bodies were applied at a concentration of 19/zg/ml diluted in PBS (ZO-1 mouse
90
5.4. PREPARATION OF BIOLOGICAL SAMPLES
monoclonal antibody) [3]. Cells were incubated for 2 hours at 37 °C then rinsed 
three times for 5 minutes in PBS. Quantum dot conjugate (Qdot 525 goat F(ab’)2 
anti-mouse IgG conjugate or Qdot 655 goat F(ab’)2 anti-mouse IgG conjugate) 
was applied to the coverslips at a concentration of 20 nM which were subsequently 
incubated for 1 hour [3].
This step is applicable for the labelling of E-cadherin or ZO-1: Coverslips 
were rinsed three times for 5 minutes in PBS to remove excess unbound quantum 
dots. To facilitate SNOM imaging, samples were additionally rinsed three times 
in water, dehydrated through an ethanol series and air-dried. Samples were stored 
at 4 °C.
Quantum  D ots for M ultiplexing
Full details of the optimisation work carried out on the multiplexing protocols 
used to label PNT2 and PC-3 cells are provided in Chapter 7. This section gives 
details of the protocols which were successful for each cell line.
Multiplexing in PN T2 cells: Coverslips were rinsed with PBS to resuscitate 
cells following fixation and subsequent storage. Cells were permeabilised with 
0.1 % Triton-X for 10 minutes, washed three times for 5 minutes in PBS and 
then incubated with signal enhancer for 30 minutes. Cells were rinsed three 
times in PBS for 2 minutes each time.
ZO-1 primary antibodies were applied at a concentration of 31//g/ml diluted 
in PBS (ZO-1 mouse monoclonal antibody) [3]. Cells were incubated for 2 hours 
at 37 °C then rinsed three times for 5 minutes in PBS. Quantum dot conjugate 
(Qdot 525 goat F(ab’)2 anti-mouse IgG conjugate) was applied to the coverslips 
at a concentration of 30 nM which were subsequently incubated for 1 hour [3]. 
Coverslips were rinsed three times in PBS for 5 minutes each then E-cadherin 
primary antibodies were applied at a concentration of 18 pg/m \ diluted in 1 % 
BSA/PBS (rabbit polyclonal anti E-cadherin antibody) [2]. Cells were incubated 
for 2 hours at 37 °C then rinsed three times for 5 minutes in PBS. Quantum dot 
conjugate (Qdot 605 goat F(ab’)2 anti-rabbit IgG) was applied to the coverslips
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at a concentration of 20 nM which were subsequently incubated for 1 hour [3].
Coverslips were rinsed three times for 5 minutes in PBS to remove excess 
unbound quantum dots. To facilitate SNOM imaging, samples were additionally 
rinsed three times in water, dehydrated through an ethanol series and air-dried. 
Samples were stored at 4 °C.
Multiplexing in PC-3 cells: Coverslips were rinsed with PBS to resuscitate 
cells following fixation and subsequent storage. Cells were permeabilised with 
0.1 % Triton-X for 10 minutes, washed three times for 5 minutes in P B S /100 
mM glycine and then incubated with signal enhancer for 30 minutes. Cells were 
rinsed three times in P B S /100 mM glycine for 2 minutes each time.
E-cadherin primary antibodies were applied at a concentration of 18 /ig/ml 
diluted in 1 % BSA/PBS (rabbit polyclonal anti E-cadherin antibody) [2]. Cells 
were incubated for 2 hours a t 37 °C then rinsed three times for 5 minutes in PBS. 
Quantum dot conjugate (Qdot 605 goat F(ab’)2 anti-rabbit IgG) was applied to 
the coverslips at a concentration of 20 nM which were subsequently incubated for 
1 hour [3]. Coverslips were rinsed three times in PBS for 5 minutes each then 
ZO-1 primary antibodies were applied at a concentration of 31/ig/ml diluted in 
PBS (ZO-1 mouse monoclonal antibody) [3]. Cells were incubated for 2 hours 
at 37 °C then rinsed three times for 5 minutes in PBS. Quantum dot conjugate 
(Qdot 525 goat F(ab’)2 anti-mouse IgG conjugate) was applied to the coverslips 
at a concentration of 20 nM which were subsequently incubated for 1 hour [3].
Coverslips were rinsed three times for 5 minutes in PBS to remove excess 
unbound quantum dots. To facilitate SNOM imaging, samples were additionally 
rinsed three times in water, dehydrated through an ethanol scries and air-dried. 
Samples were stored at 4 °C.
5.5 Summary
This chapter has described the instrumental set-ups required to examine im- 
munofluorescently labelled cells with fluorescence microscopy, SNOM and im­
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portant developments required when using both techniques to study the same 
sample. Methodologies are provided which detail the preparation of samples to 
facilitate both microscopy techniques. Furthermore, a dual labelling protocol 
which utilises quantum dots is described. These protocols are in themselves com­
plete but provide a platform for other researchers to adapt and develop such 
tha t other proteins or cells may be studied through labelling with quantum dots. 
In particular, the protocols have addressed important preparation aspects which 
may be relevant to other SPM techniques. The reader is refered to Chapter 7, 
which discusses various aspects of sample preparation that require attention when 
developing dual labelling protocols.
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Chapter 6 
Results: SNOM  imaging of 
biological materials
6.1 Introduction
In conventional optical techniques much information is lost because of the 
limitations in spatial resolution. SNOM has the ability to overcome the diffraction 
limit by exploiting the properties of evanescent waves and utilising a nanoscale 
light soucre to achieve nanoscale resolution.
In this study, SNOM has been applied to simultaneously aquire high-resolution 
fluorescence and shear-force atomic microscopy images of biological samples. The 
aquisition of both topographic and fluorescent images yields vital information 
about the molecular make-up of cellular components.
In order to achieve high-resolution imaging, sample preparation is vital. This 
chapter is focussed on the development of a standardised methodology to provide 
reproducible and robust samples with well preserved structural detail and low 
background fluorescence.
The prostate epithelial cell line PNT2 has been used as the basis for all sam­
ple preparations. Fluorescent labelling of two protein systems has been explored: 
The targetting of membrane proteins and cytoskeletal proteins has been carried 
out. Furthermore, two fluorescent labelling agents have been tested. Comparison 
of Alexa Fluor 488 and semiconductor quantum dots for use in immunofluores-
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ccncc labelling revealed quantum dots demonstrate significantly enhanced pho­
tostability and higher quantum yield. Ultimately quantum dots proved to be the 
preferred choice of fluorescent tag for biological investigations using SNOM.
6.2 D evelopm ent of fluorescent biological 
sam ples
6.2.1 Sam ple requirem ents
The overall objective of this work was to take advantage of the benefits SNOM 
has over conventional microscopy techniques when applied to the study of biolog­
ical materials. Concurrent high resolution topography and fluorescence images 
can be obtained (the latter of which is not restricted by the diffraction limit) 
to facilitate functional analysis of specific cellular components. Initial feasabil- 
ity tests were completed to assess samples for SNOM investigation. Topography 
images of the prostate epithelial cell line PNT2 were obtained to determine the 
suitability of the cell line.
As demonstrated by the typical SNOM topography images shown in Figure 
6.1, numerous cellular components can be resolved including the nuclear region 
(circled in Figure 6.1(a) and (c)) and lamellipodia (labelled L in Figure 6.1(b)), 
which are actin-based protrusions commonly observed at the leading edge of 
motile cells [1]. The lamellipodia observed in Figure 6.1(b) are present in the in­
tercellular region between two cells initiating contact, with numerous nano-sized 
filopodia (indicated by arrows) extending beyond the lamellipodia periphery. In­
dividual filopodia with diameters ranging between approximately 300 — 500 nm, 
can be seen to extend up to 10 fim  across the intercellular area and are highly 
directed towards the opposing cell. Furthermore, filopodia from two cells in close 
proximity appear to form a network across the cell-cell boundary and interact 
with each other as seen in Figures 6.1(c) - (e). The filopodia are examined 
in closer detail in Figure 6.1(f), which shows a 3-dimensional representation. As 
first reported by Doak et al. [2], multiple dimples along their surface are detected,
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Figure 6.1: Typical SNO M  topography images o f the cell line PNT2. Various 
features can be resolved including the nucleus (circled in (a) and (c)), lamellipodia 
(indicated by L in (b)) and numereous filopodia (indicated by arrows in (b) - ([)). 
3 dimensional representation (f)  o f filopodia reveals “quilted” appearance. Scale 
bars to the left o f each image represent height o f topographical features. Scans 
(a), (b) and (c) are (30 fim )2, (d) is (14 p m )2, (e) is (20 p m )2 and (d) (7 p m )2.
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which result in a “quilted” appearance.
Narrow topographic ridges can be seen near the outer region of the cells in 
Figures 6.1(a) and (d), which most likely represent cytoskeletal microfilaments 
present beneath the surface [2]. These become visible as the membrane collapses 
down onto the underlying structures, after the cells are dried through dessication. 
The highest point of the cells was observed over the nucleus and measurements 
gave a wide range of values, from approximately 0.5 — 2.7 fim. This is likely 
to be due to the extent of confluency that the cells had achieved at the time of 
imaging. The overall size of the cells exceed the maximum scan range permitted 
by the SNOM scanning stage (30 /im )2, thus it was possible to obtain only partial 
images of any cell each time a scan was executed. Although multiple scans were 
obtained sequentially for more a complete picture to be built up, it was common 
to observe only part of the nucleus in a particular scan (as in Figure 6.1(c)). Or 
if the nucleus was fully imaged, then the cell of interest would often span the 
entire area of the image with no substrate visible for use as as zero-point when 
measuring the overall height (as in Figure 6.1(a)). Consequently, there were a 
limited number of suitable topography images to determine the height of these 
cells.
This preliminary data confirms that PNT2 cells are a suitable system for 
further investigations with SNOM. As will be discussed in the following section, 
fluorescent labelling of proteins present in this cell line will be studied.
6.2.2 Organic labelling o f m em brane proteins
Further work on developing biological samples involved labelling the adhesion 
protein E-cadherin in prostate epithelial PNT2 cells with the organic fluorophore 
Alexa Fluor 488. Optimisation of the protocol was completed with the use of a 
fluorescence microscope. However, the fragility of the SNOM tip and the depen­
dence of optical resolution on aperture size warranted additional washes to ensure 
the complete removal of any salt residues remaining on the surface following the 
labelling procedure. This eliminated any surface debris that may otherwise have 
come into contact with the tip during scanning. These additional washes also
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help to ensure thorough rinsing of any unbound labelling agents and thus help 
improve the signal-to-noise image contrast. However, it is im portant to ensure 
th a t they do not affect hybridisation and inadvertently remove specifically bound 
labels. Consequently, before imaging with SNOM all samples were observed with 
a fluorescence microscope to verify successful labelling and to ensure the fluores­
cent probes had hybridised specifically to  the target protein. Figure 6.2 shows a 
typical fluorescence microscopy image of PNT2 cells labelled against E-cadherin 
with Alexa Fluor 488. Specific filters are used to select the required excitation 
wavelength from a mercury lamp and to illuminate the sample. The resulting 
signal is passed through an emission filter to separate the fluorescence from the 
illumination source. The image is false colour and uses a black to green scale, 
such th a t the brightest green pixels represent regions where the highest intensity 
fluorescence was recorded.
Figure 6.2: Fluorescence microscopy image o f the adhesion protein E-cadherin 
labelled with Alexa Fluor 488 in PNT°2 cells. Scale bar represents approximately 
100 fim.
Samples were imaged with SNOM using an integration time of 20 ms per pixel. 
Figure 6.3 shows a typical SNOM acquisition of two cells at the initial stages of 
cell-cell contact. The vertical scale bars shown in (a) and (b) are representative 
of the height of features, and the intensity of the fluorescence recorded by the 
APD detector respectively.
The topographic structure is shown in Figure 6.3(a), with two prostate ep­
ithelial cells in close proximity. The structure is well preserved and filopodia
99
6.2. DEVELOPM ENT OF FLUORESCENT BIOLOGICAL SAMPLES
N 72 Counts
20 Counts
Figure 6.3: Simultaneously acquired (30 p m )2 topographic (a) and fluorescent (b) 
SNO M  images o f two PN T2 cells initiating cell-cell contact. Cells are labelled 
with Alexa Fluor 488 to identify E-cadherin along cell boundaries and extend­
ing throughout filopodia. Circled, region identifies a punctate E-cadherin cluster. 
Filopodia are clearly seen (arrows), some of which are observed interacting (ar­
rowheads).
from each cell can clearly be seen to  extend across the intercellular region (as 
indicated by arrows). Figure 6.4 shows an example of cross section d a ta  from 
line measurements performed on the image shown in Figure 6.3(a). The line 
analysed is indicated by a red arrowhead on the right of the figure and analysis 
was carried out following minimal image processing, as discussed in C hapter 5. 
Measurements show th a t dimensions of individual filopodia vary widely bu t typ­
ically possess diam eters ranging from approximately 110 — 270 nm, with heights 
up to 40 nm. Furtherm ore, these nano-structures were generally found to extend 
approximately 4 — 5 /mi from their originating lamellipodium, while some are 
observed to protrude over 10 fim  into the intercellular space. These observations 
concur with da ta  published by Doak [2] where very fine filopodia (100 — 150 nm 
in diameter) were found in the intercellular region between two closely positioned 
PNT2 cells. Figure 6.3(a) also indicates opposing filopodia making contact which 
appear to interdigitate (arrowheads) and eventually adhere to the neighbouring 
cell (circled region). This initial adherence provides an anchorage which is likely 
to support and encourage the establishm ent of further contact sites.
The simultaneously acquired fluorescence image shown in Figure 6.3(b) is 
presented with a scale bar which displays the da ta  such th a t the average sign al­
to-background noise is clear. Thus the signal-to-noise ratio of Figure 6.3(b) is
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Figure 6.4: Measurements o f height arid diam.eter o f filopodia. Cross-section taken 
from  line indicated by red arrow on Figure 6.3(a).
3.6. Comparison of the topography (Figure 6.3(a)) with the simultaneously 
acquired fluorescence image (Figure 6.3(b)) reveals the prcsccncc of Alexa Fluor 
488 along the cell boundaries and extending throughout the filopodia. Due to  the 
targeted labelling employed, one can conclude th a t the Alexa Fluor 488 signal is 
indicating the presence of E-cadherin in these two regions. A punctate E-cadherin 
cluster is highlighted within the circled region and corresponds to filopodia tha t 
have adhered to the neighbouring cell.
Current literature suggests filopodia have a functional role not only in motility 
and guidance during cell m igration [3] but also in cell-cell adhesion [4]. In a study 
of epidermal kcratinocytcs, Vasioukhin et al. [4] reported th a t filopodia embed 
into opposing cells. E-cadherin was found to cluster at the tips of embedded 
filopodia forming a row of puncta. It was reported th a t this anchorage promotes 
the establishm ent of additional functional contact sites and filopodia physically 
pull the two cells together. The result presented in Figure 6.3 supports these 
previous articles via a high resolution SNOM image clearly showing the targetted 
immunofluorescence signals from E-cadhcrin present a t these cell-cell contact sites 
and also within the filopodia.
Figure 6.5 shows a further SNOM acquisition of PNT2 cells. As before the
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Figure 6.5: (30 p m )2 SNOM  aquistitions o f a P N T2 cell showing (a) topogra­
phy and (b) optical images. Optical image shows E-cadherin location, revealed 
by immunofluorescence labelling with Alexa Fluor J^88. (c) Point spectroscopy
corresponding to regions highlighted in image (b).
location of E-cadherin is revealed via specific immunofluorescence labelling using 
Alexa Fluor 488. Although the quality of the topography image shown in Figure 
6.5(a) is inferior to tha t in Figure 6.3, the cell boundary can clearly be observed 
(indicated by C). The complimentary optical image shown in Figure 6.5(b), indi­
cates E-cadherin is found along the cell boundary as previously observed.
High counts are also recorded over the higher topographic regions. Point 
spectroscopy was carried out to determine the origin of these counts and eliminate 
the possibility th a t they are an artefact of the high features. Point spectroscopy 
was executed once SNOM imaging was complete. The tip was positioned above 
the sample a t user specified points and the resulting spectra were collected.
Figure 6.5(c) shows three spectra collected a t the points highlighted (within 
cirlced regions on Figure 6.5(b)). The collection time used for all spectra was 5 
minutes. All three spectra reveal sharp peaks at around 500 nm, these are due 
to the laser light bleeding through the high pass filter. The peak emission of
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Alexa Fluor 488 is indicated by the dashed line at 519 nm on Figure 6.5(c) as 
specified by the manufacturers [5]. A broad peak at the slightly higher wavelength 
of 537 nm can be seen on spectra 1 and 2 which is attributed to fluorescence 
from bound Alexa Fluor 488 flourophores. The spectra confirm the presence 
of Alexa Fluor 488 at region 2 (indicated on Figure 6.5(b)). This verifies that 
the large number of counts recorded over the high topographic feature are real 
signals originating from bound (albeit non-specifically) Alexa Fluor 488 to the 
cell membrane. Furthermore, examination of spectra 3 reveals no such peak is 
observed at 537 nm indicating no Alexa Fluor 488 fluorophores are present in this 
region of the sample. This is as expected since spectra 3 was collected above a 
region adjacent to the cell (in the intercellular space).
The success of obtaining high-resolution, concurrent topography and optical 
images obtained using SNOM has enabled a functional analysis of nanometer­
sized, sub-cellular components. However, rapid photobleaching of the already 
low fluorescence levels inhibited prolonged examination of regions of interest. 
Thus, to facilitate more extensive SNOM studies it was desirable to employ a 
brighter and more robust fluorescent label that could withstand greater exposure 
to illumination.
6.2.3 Q uantum  dot labelling o f cytoskeletal proteins
The low levels of fluorescence observed when examining samples labelled with 
the organic dye Alexa Fluor 488, coupled with the rapid bleaching when successive 
images were obtained of the same sample, prompted investigations into the use 
of semi-conductor quantum dots as an alternative fluorescent tag.
In recent years, quantum dots have been increasingly utilised in biological ap­
plications. Their many benefits over conventional fluorophores has been discussed 
in detail in section (2.5.4). Quantum dots are notably more photostable and sub­
stantially brighter owing to their high quantum yield [6, 7]. Therefore they afford 
a far more robust sample system which, in turn, facilitates the repeated scanning 
of regions of particular interest.
F-actin filaments collectively form the cytoskeleton which acts as the cell’s
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structural support network and are abundant in nearly all eukaryotic cells. Thus 
these cellular components were chosen as the target for labelling with quantum 
dots due to their relatively high abundance which ultimately facilitates the de­
tection of fluorescent signals. Quantum dot-streptavidin conjugates were used to 
indirectly target F-actin microfilaments of PNT2 cells and investigate their distri­
bution within the cytoplasm. The toxin phalloidin has a high affinity to F-actin: 
This was exploited in the labelling process by using phalloidin-biotin conjugates 
to specifically target F-actin filaments. In turn, the biotin molecules have a high 
affinity to streptavidin. Thus to complete the labelling process, quantum dot- 
streptavidin conjugates were utilised to specifically target the biotin molecules. 
The phalloidin-biotin-streptavidin labelling mechanism is routinely used in the 
fluorescent labelling of F-actin. Furthermore, this mechanism has been utilised 
by other researchers to label F-actin filaments of other cell lines with quantum 
dots [6, 8].
Figure 6.6 shows a PNT2 cell labelled with quantum dots of emission wave­
length 655 nm to reveal the prescence of F-actin within the cytoplasm of cells. 
The integration time of the SNOM optical images is 20 ms. A single cell can 
almost fully be visualised in topography image (a). The nucleus can clearly be 
distinguished (indicated by N) and was found to cover an area which measured 
approximately 200 n m 2. The simultaneously acquired fluorescent image is shown 
in (b). The scale bar presented with Figure 6.6(b) reveals a signal-to-noise ratio 
of ~  11, far superior to the signal-to-noise levels achieved through fluorescent 
labelling with Alexa Fluor 488.
An example of labelled F-actin taken from Wu et al. [6] is shown in Figure
6.7. Wu et al. examined mouse fibroblast cells which were labelled with 535 nm 
(green) emitting quantum dots to show F-actin filaments. The epifluorescence 
image clearly shows the filamentous nature of F-actin (green), while cells were 
counter-stained with Hoechst 33342 dye to show nuclei (blue).
Although the study by Wu and co-workers [6] was carried out on different cells 
to those examined in this investigation, F-actin filaments are inherent to most 
eukaryotic cells. However the results shown in Figure 6.6 do not correlate with
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Figure 6.6: SNOM  aquisitions o f P N T2 cells fluorescently labelled with red quan­
tum dots to show the distribution o f F-actin within the cytoplasm. (30 p/m)2 
topography (a) and corresponding fluorescent images (b). Boxed region in (a) 
analysed at higher resolution to generate (16 p m )2 topography (c) and fluorescent 
images (d). N  represents nucleus, white arrowheads indicate filopodia and red 
arrowheads indicate lines o f high intensity fluorescence corresponding to active 
quantum dot attached to SNO M  tip.
those observed by Wu et al. [6]. While there is some fluorescence corresponding 
to the cytoplasmic region of the cell, high counts are recorded over the nuclear 
region which is likely to correspond to heavy non-specific staining.
The boxed region in Figure 6.6(a) was sequentially scanned to reveal the 
structure a t higher resolution and generate image (c). A small number of filopodia 
are resolved and are observed to protrude from the lamellipodia and the cell edge 
(indicated by white arrowheads on Figure 6.6(c)). These filopodia were measured 
to extend up to 1.4 pm, into the intercellular space. Although this extension is 
not as far as th a t observed in Figure 6.3, this is most likely explained by the time 
at which fixation was carried out during the formation of filopodia.
The signal-to-noise ratio of the complimentary fluorescence image shown in
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Figure 6.7: Epifluorescence image o f mouse fibroblast cells stained with quantum  
dots to reveal F-actin filaments within the cytoplasm (green). Nuclei counter­
stained with Hoechst 33342 blue dye (blue). Adapted from. [6].
Figure 6.6(d) is ~  7. Exam ination of this image reveals multiple horizontal stripes 
of increased fluorescence intensity (indicated by red arrowheads in Figure 6.6(d)). 
However, there is no artefact in the corresponding topography image. The in- 
term ittency of these features are indicative th a t an individual quantum  dot has 
become attached to the apex of the tip during scanning. This blinking phenom­
ena is a characteristic signature of single quantum  dots. This streaking effect 
due to the blinking of a single dot was observed by Sonnefraud et al. [9] during 
SNOM investigations of quantum  dots embedded in a polymer matrix. These are 
also observed in Figure 6.6(b), bu t to a lesser extent.
Figure 6.8 dem onstrates the high optical resolutions achievable when SNOM 
is employed to examine samples. The cross sections shown indicate the smallest 
fluorescent features are approxim ately 60 ± 1 nm in diameter. The feature is 
indicated by arrows on Figure 6.6(d) and was analysed in the vertical and hori­
zontal directions (cross sections (a) and (b) respectively). The ability to resolve 
these nano-scale optical features is indicative of a high quality SNOM probe with 
a small aperture size. Thus, the larger fluorescent features observed in Figures 
6.6(b) and (d) are most likely to be due to a cluster of quantum  dots and not 
because of poor optical resolution.
The advantages afforded by quantum  dot labelling are exemplified by the re­
sults shown in Figure 6.6. The quality of the fluorescence signals are significantly
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Figure 6.8: Cross sections showing optical resolution o f 60 ±  1 nm from  a single 
fluorescent feature measured (a) vertically and (b) horizontally across the feature.
enhanced when quantum  dot labels arc employed in place of Alexa Fluor 488 flu­
orophores. Superior signal-to-noise levels are achieved and quantum  dots display 
enhanced photostability when regions arc repeatedly examined (Sec Appendix 8.4 
for da ta  dem onstrating inferior Alexa Fluor 488 photostability). Their use has 
provided samples th a t can be examined more thoroughly via repeated scanning 
before significant fading occurs.
However, the results of fluorescent labelling and subsequent imaging of F- 
actin distribution were not as expected and high levels of non-specific labelling 
over the nuclear region were observed. In order to realise the high-resolution opti­
cal imaging capabilities of SNOM, an optical fibre with sub-wavelength aperture 
is required to illuminate the sample. A consequence of using such a small light 
source however is th a t the illumination depth is limited and fluorescence originat­
ing from the surface of the sample will be recorded with higher resolution than 
fluorescence from within a sample. Thus it is possible th a t labelling of F-actin 
was specific, bu t th a t this was masked by the heavy non-specific labelling on the 
cell’s surface.
For this reason, it was decided to pursue quantum  dot labelling of the mem­
brane protein E-cadherin. Exam ination of E-cadherin using SNOM was demon­
strated  in Figure 6.3: As such investigations involving E-cadhcrin have the potc-
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nial to be extended to other cell lines and answer questions of biological impor­
tance.
6.3 Quantum  dot labelling of E-cadherin
Following the investigations discussed in the previous section, the decision 
was made to proceed by labelling PNT2 cells with quantum dots to study the 
expression and function of the adhesion protein E-cadherin in further detail. This 
was achieved by looking at the interactions of filopodia and E-cadherin and their 
role in establishing adherens junctions. By studying the dynamics of filopodia 
and the location of E-cadherin at various stages of cell-cell contact, a deeper 
understanding of the mechanics of cell adhesion can be developed.
6.3.1 D evelopm ent o f m ethodology
Prior to imaging with SNOM all samples were examined with a fluorescent mi­
croscope to confirm staining had been successful. Thus, the staining methodology 
had to be developed to facilitate both imaging techniques.
High levels of background fluorescence were often observed due to quantum 
dots binding non-specifically on, or within the cell, and to the substrate. In an 
attepmt to reduce the level of background signal, a series of PBS/Glycine washes 
were introduced after fixation of the cells. Aldehyde based fixatives work by re­
acting with and cross-linking proteins in order to preserve the cellular structure. 
However, this generates many tissue-bound free aldehyde groups which combine 
with any amino groups, including those present in antibodies used for fluorescent 
staining [10]. This results in antibodies that are highly specific to the antigen of 
interest, binding to other sites on the surface. The purpose of introducing the 
glycine was to block these free aldehyde groups by reduction of -CHO groups to 
-OH. The extent of fixative derived background fluorescence was further reduced 
by employing ultra-pure, methanol-free formaldehyde instead of paraformalde­
hyde. This is demonstrated in Figure 6.9 where samples fixed with ultra-pure 
mcthanol-frcc formaldehyde (Figure 6.9(a)) are compared with paraformaldc-
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hydc fixed samples (Figure 6.9(b)). The quality of the fluorescent labelling is 
enhanced when the ultra-pure methanol-free formaldehyde was used as the fixa­
tive. Paraformaldchdyc contains methanol which causes protein clumping. This 
can affect structural preservation and the quality of the fluorescent signals ob­
served from samples fixed with paraformaldehyde.
Figure 6.9: Fluorescence microscopy images o f PNT2 cells, labelled with red quan­
tum dots. Comparison o f fixatives show (a) reduced levels o f non-specific staining 
over the cell membrane on samples fixed with ultra-pure mcthanol-frcc form alde­
hyde, compared with (b) where cells were fixed with paraformaldehyde fixed cells. 
Note; sample (b) counter-stained with D API (blue overlay) to reveal nucleus. 
Scale bars represent approximately 100 pm .
6 .3 .2  F u n ctio n a l a n a ly s is  o f  E -ca d h er in  in co n flu en t P N T 2  
sa m p les
E-cadherin molecules in PNT2 cells were targetted using quantum  dot con­
jugates with emission wavelength 605 nm. Core-shell CdSe/ZnS quantum  dots 
coupled to a secondary antibody were utilised, which in turn bind specifically 
to E-cadherin via an interm ediate primary antibody. The result of this process 
can be seen in the fluorescence microscopy image (Figure 6.10) which was ac­
quired prior to analysis using SNOM. Fluorescence microscopy imaging revealed 
th a t cells are highly compact. Through targetted immunofluorescence labelling, 
E-cadherin is consistently observed at sites of cell-cell contact and in the perinu­
clear negion.
The subsequent SNOM acquisitions can be seen in Figure 6.11. The integra-
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Figure 6.10: Confluent PN T2 cells specifically labelled with red quantum dots to 
reveal E-cadherin presence at sites o f cell-cell contact and also around the nucleus. 
Scale bar represents approximately 100 pm .
tion time used for the SNOM fluorescence images (b) and (d) was 20 ms, which 
yields signal-to-noise ratios of ~  8 and 10 respectively. As can be seen in the to­
pography images (a) and (c), the cells are far more confluent than was observed 
in (Figure 6.3). Cell-cell contact has been fully established and the cells are much 
more densely packed and compact. Individual filopodia now cannot be different i­
ated and the architecture a t the cell boundaries (indicated by C) is dissimilar to 
tha t observed in Figure 6.3. M ultiple distinctive ridges can be seen to run along 
the site of contact. Furtherm ore the nucleus can clearly be distinguished in both 
images (indicated by N).
Vasioukhin et al. [4] dem onstrated th a t upon establishing contact, filopodia 
from opposing cells physically draw them together. As the seal between opposing 
cells is established, filopodia regress via actin depolymerisation and the double 
row of E-cadherin puncta at the tips of adhered lilopodia closes to form a single 
row.
The simultaneously acquired fluorescent response from quantum  dot labelled 
cells (Figures 6.11(b) and (d)) dem onstrates direct agreement with this study. 
The scans show a row of fluorescence, revealing E-cadherin is localised in areas 
corresponding to cell-cell contact (indicated by C on Figures 6.11(b) and (d)). 
E-cadherin is also present in the perinuclear region (nucleus indicated by N).
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48 Counts
6 Counts
50 Counts
5 Counts
Figure 6.11: SNOM  topography (a) and (c) and optical (b) and (d) acquisitions 
of confluent PN T2 cells labelled with red quantum dots to reveal E-cadherin local­
isation. Cell-cell contact region and nucleus indicated by C and N  respectively. 
All scans are 30 pm  x  30 pm .
A further image illustrating the change in topography at a cell-cell boundary 
of highly compact cells is shown in Figure 6.12. Again marked ridges which 
appear to run parallel to the cell-cell boundary (indicated by C on Figure 6.12) 
are seen. The multiple corrugations observed in Figure 6.12(a), were measured 
to span widths ranging approxim ately 7 — 8.7 pm . Meanwhile, analysis of the 
cell-cell boundary in Figure 6.12(b) showed a single ridge running parallel to the 
boundary between the two cells. Measurements revealed the ridge diam eter to 
range between approximately 400 — 850 nm along its length.
It is interesting to speculate on the origin of these features. It is possible 
th a t these structures arc an artefact of the highly confluent nature of the sample. 
Such th a t cells have become so compact they have begun to lift off the surface 
subsequently forming this ruffled appearance around their periphery. It is also 
possible th a t we are observing the underlying structure of the cytoskeleton. In
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Figure 6.12: SNO M  topography image o f confluent PN T2 cells. Cell-cell contact 
region and, nucleus indicated, by C and N  respectively. Scans are 30 fim  x  30 pm .
which case, these structures may well be actin filaments th a t have reorganised to 
align parallel to the boundary following cell-cell contact as described by Yonemura 
et, al. [11].
To investigate the origin of these features, further analysis of their molecular 
constituents is required. This could be achieved by examining confluent samples 
th a t are differentially labelled. Thus the location of actin, E-cadherin and other 
molecules involved in the formation of adherens junction could be analysed.
6 .3 .3  E -c a d h e r in  in n o n -co n flu en t P N T 2  sa m p le s
Fluorescence microscopy of non-confluent samples was carried out prior to 
SNOM imaging (Figure 6.9(a)). Figure 6.13 shows SNOM scans representative 
of when no cell-cell contact is established. The topographic and fluorescence scans 
shown in Figure 6.13(a) and (b) respectively reveal regions of interest th a t were 
subsequently scanned with higher resolution to generate Figures 6.13(c) and (d). 
As can be seen from the topographic images (a) and (c), the filopodia appear 
bunched and random ly orientated. This is in contrast to Figure 6.3, where the 
direction of filopodia appears to be far more driven towards the opposing cell. 
This is most likely due the cells in Figure 6.13 being fixed a t a slightly earlier 
stage of conflucncy. The filopodia in Figure 6.13 arc ju st starting  to develop and 
initiate their sensing role th a t has been previously reported [3, 12]. Filopodia 
arc often observed to extend into the intercellular m atrix by up to 5 — 35 /,tm,
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215 Counts
3 Counts
1220 Counts
163 Counts
Figure 6.13: SNO M  topography (a) and optical (b) acquisitions o f non-confluent 
PN T2 cells labelled with quantum dots to reveal E-cadherin is localised at the base 
of filopodia and to extend through their length. Boxed region indicated in (a) was 
subsequently imaged at higher resolution to generate (c) and (d). Scans (a) and 
(b) are 30 p m  x  30 pm , (c) and (d) are 10 p m  x  10 pm .
sweeping from side to side and sensing for a particular substrate or cell. Although 
fixed, the filopodia in Figure 6.13 appear to be a snapshot of them exploring the 
local environment, possibly searching for other cells. Typically, when fixation 
was carried out such th a t cells had yet to establish any contact, filopodia were 
observed to extend up to approximately 5 p m  into the intercellular matrix.
Exam ination of the fluorescence images (Figures 6.13(b) and (d)) show E- 
cadherin is predominantly located a t the membrane boundary a t the base of the 
filopodia and much weaker signals in the filopodia thcmsclcvcs. Additionally, 
in term ittent stripes of increased fluorescence intensity are discernable in Figure 
6.13(b) (indicated by arrow). Similar features were observed in Figure 6.6 and 
are attribu ted  to a single quantum  dot th a t has become attached to the apex of 
the SNOM tip during scanning.
Furthermore, a significant difference in the number of counts recorded in Fig­
ures 6.13(b) and (d) is observed. This is a ttribu ted  to slight changes in the
6.4. CONCLUSION
aperture of the SNOM tip as a result of repeated scanning. The quality of the 
optical response in Figure 6.13(d) is affected such th a t both the background and 
signal levels arc higher in (d) than (b). However, superior signal-to-noisc levels 
are evident in both images compared to those achieved through fluorescence la­
belling with Alexa Fluor 488. The observed change in the counts recorded by the 
APD is accompanied by a slight change in the resolution although this is difficult 
to quantify due to the accompanying changes in image scan step size. For the 
larger image (Figure (b)), the optical resolution is limited by the size of the image 
and the pixel resolution used during acquisition. Therefore one would expect an 
improvement on the optical resolution when imaging a smaller region. However, 
the sensitivity of the SNOM probe to interactions with the sample and tip  aper­
ture opening is one of the challenges of using SNOM to interrogate biological 
specimens.
6.4  C onclusion
Assessment of the prostate epithelial cell line PNT2 as a suitable model for 
SNOM studies proved successful, with topographic analysis resolving large mi­
crometer sized features such as the nucleus and those of nanom eter dimensions 
such as filopodia, revealing their “quilted” topology as observed by Doak et al. 
and shown in Figure 6.14 [2].
Figure 6.14: Atomic force microscopy images of a PN T2 cell, the boxed region 
in (a) was further resolved to show quilted appearance o f filopodia surface (b). 
Adapted from  [2j.
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Moreover, ridges were observed over the apical cell surface which arc most 
likely cytoskeletal proteins tha t become visible as the membrane collapses fol­
lowing drying of the sample. Further assessment of PNT2 involved labelling the 
adhesion molecule E-cadherin with Alexa Fluor 488, in order to study its location 
within the cell. The early stages of cell-cell contact was observed and E-cadherin 
was found to be at sites of cell-cell contact mediated by filopodia interactions and 
within the filopodia themselves. A punctate cluster of E-cadhcrin was observed 
where filopodia had adhered to the opposing cell. Despite these initial promising 
results, a more robust and reliable labelling technique was required to facilitate 
repeated imaging of single samples.
This led to the development of quantum dot labelled samples, which proved 
partially successful in that substantially brighter and more resilient samples were 
produced. Furthermore, an optical feature of nano-dimensions was observed with 
a diameter measuring 60 i  1 nm. This result is a direct realisation of the res­
olution capabilities afforded by SNOM that are not dictated by the diffraction 
limit.
It was also demonstrated that the high resolution imaging capacity of SNOM 
is better suited to detecting fluorescent signals which originate from the surface 
of a sample. Although it was not possible to detect specific signals from within 
the cell, it was nevertheless established tha t the use of quantum dots in future 
studies is favoured over organic fluorophores.
Thus, futher analysis of adhesion mechanisms in PNT2 cells was completed 
using quantum dots. This SNOM study required optimisation of standard sample 
methodologies with particular attention paid to preserving the ultra-structural 
components in order to achieve high resolution topographic images and ensuring 
low background fluorescence levels. This enabled detection of small fluorescent 
signals arising from the specific labelling of molecular targets together with high 
quality imaging.
Analysis was undertaken at two stages of sample confluency. When cells were 
highly compact E-cadherin was predominantly found along the cell periphery 
but also to localise in the perinuclear region. Examination of the topology of
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these samples revealed numerous corrugations running parallel to the cell-cell 
boundary. The origin of these structures needs further investigation, however 
it is proposed tha t these are circumferential F-actin filaments as described by 
Yonemura et al. [11]. When samples were prepared such tha t contact had yet to 
be established, E-cadherin was found to concentrate at the base of filopodia with 
some extension through their length. Filopodia appeared randomly oriented and 
seemed to be sensing the local environment.
This preliminary study provides a platform for further analysis of the mech­
anistic roles E-cadherin, accompanying adhesion molecules and filopodia play in 
establishing cell-cell adhesion. Moreover, the use of quantum dots as fluorescent 
labels has proved successful and superior signal-to-noise level were consistently 
observed for samples labelled with quantum dots compared to those labelled with 
Alcxa Fluor 488. Signal-to-noise levels remained high (> 7) even when repeated 
scanning was undertaken on quantum dot labelled samples. Quantum dot la­
belling in conjunction with SNOM will play a continued role in developing a 
deeper understanding of how aberrations influence the behaviour of diseased cells 
and the impact of such abnormalities on cancer progression and metastasis. In 
particular, extending this study to examine different cancerous cell lines where 
E-cadhcrin expression levels are reported to vary and are associated with in­
creased invasive capacity would enable the development of a more comprehensive 
understanding of the processes involved.
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Chapter 7
Results: M ultiplexing w ith  
sem iconductor quantum dots
7.1 M otivation for m ultiplexing
Investigations into adhesion mechanisms in the normal prostatic epithelial cell 
line PNT2 discussed in Chapter 6 have laid the foundations for studies involving 
carcinoma cells. A comparative study of the prostate adenocarcinoma cell line 
PC-3, was undertaken to determine further functional information. Current re­
search suggests E-cadherin expression is at reduced levels in PC-3 cells compared 
to that which is observed in normal epithelial tissues [1-4]. E-cadherin has been 
reported to play a significant role in suppressing tumour invasion of numerous 
cancers [5-7]. Furthermore, studies have shown that by chemically stimulating 
the expression of E-cadherin in PC-3 cells, their invasive potential is reduced [8]. 
Although such studies have improved our understanding of the role E-cadherin 
plays in cancer progression, many gaps in our knowledge remain. To this end, 
high-resolution SNOM imaging of cells has been undertaken to assess the extent 
of functional E-cadherin present in PC-3 cells. This has been determined through 
immunofluorescence labelling of E-cadherin.
As described previously in Chapter 6, investigations of E-cadherin expression 
have used immunofluorescent labelling in cells derived from normal prostate ep­
ithelial tissue. In anticipation of observing reduced E-cadherin levels in PC-3
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cells and concomitant diminished fluorescence response, it was decided a suitable 
control would be needed to facilitate imaging.
When imaging with SNOM, very weak fluorescence signals are produced. Cor­
rect alignment of these weak signals onto the detector is crucial to ensure tha t 
maximum levels of fluorescence is recorded. Thus, observations of weak-to-non 
existant signals, can be the result of signal misalignment rather than a true reflec­
tion of the samples properties. It was therefore vital to develop a reliable control 
method to deduce that a decrease in fluorescence signals is due to reduced levels 
of fluorophore, and not due to misalignment of the signal path onto the detector.
To this end, dual labelling of samples allows a control signal to be established. 
Samples were dually stained against E-cadherin and an additional protein, ZO-1, 
which is involved in the formation of tight junctions. Gene expression levels of 
both E-cadhcrin and ZO-1 have been quantified using a technique called real-time 
RT-PCR (reverse transcription polymerase chain reaction) [4]. Results from this 
study indicate that E-cadherin gene expression is down-regulated in PC-3 cells 
compared to that observed in healthy prostate epithelial cells. Whilst the genes 
which encode for ZO-1 proteins were found to be expressed to approximately 
the same extent in both PNT2 and PC-3 cell lines. Labelling of an additional 
protein provides a means to ensure that optical detection in our instrument is 
fully optimised.
7.2 Developm ent o f m ultiplexed samples
Development of a protocol tha t dual labelled the proteins E-cadherin and 
ZO-1 was primarily undertaken using PNT2 cells. Both proteins are positively 
expressed in this cell line which therefore facilitated the initial optimisation of the 
protocol. E-cadherin and ZO-1 expression in PNT2 cells was first demonstrated 
individually as shown by the fluorescent microscopy images in Figure 7.1.
Immunofluorescent labelling of E-cadherin was carried out using red (605 nm) 
emitting quantum dots as shown in Figure 7.1(a). This image shows E-cadherin 
to be present in areas where cell-to-cell contact occurs as observed in Chapter 6.
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Figure 7.1: Fluorescence microscopy images o f PN T2 cells irnmunolabelled with 
semiconductor quantum dots to show (a) E-cadherin and (b) ZO-1. Scale bars 
represent approximately 100 fan.
The location of ZO-1 is identified in Figure 7.1(b) where red (655 nm) em itting 
quantum  dots were used to label ZO-1 proteins. As discussed in Chapter 4, ZO-1 
proteins arc involved in the formation of tight junctions, which play im portant 
roles in cell adhesion and regulating tissue permeability. In order to perform 
this function, ZO-1 proteins arc localised around the circumference of cells. The 
fluorescence microscopy image shows th a t ZO-1 is present around the periphery 
of cells, in regions of cell-to-ccll contact as expected.
To achieve fairly straightforward filter separation of the fluorescence signals 
produced by the dual stained samples, it was im portant to utilise quantum  dots 
which emit at separate wavelengths. For this reason quantum  dots with emission 
wavelengths of 655 nm and 525 nm were selected to label PNT2 cells as illustrated 
in Figure 7.2.
There arc many advantages to using quantum  dots over conventional fluo- 
rophores in fluorescent techniques. The multiplexing capabilities of quantum  
dots arc widely acknowledged and arc credited to such optical properties as large 
Stokes shift and broad absorption spectra [9 12]. These characteristics make 
quantum  dots attractive for use in applications where more than  one bio-molecule 
of interest can be detected simultaneously. However in practise, there are many 
difficulties th a t must be addressed when optimising a protocol which utilises 
multiplexing. Although very few of these have been reported by other research 
groups, significant difficulties were encountered in this study when attem pting  to
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Anti-ZO-1 
antibodyQdot 525 
conjugate
ZO-1
E -cadherin
Qdot 655 
conjugate
Anti -  E-cadherin 
antibody
ZO-1
PNT2 cell
E -cadherin
Figure 7.2: Graphic illustration o f dual labelling in P N T2 cells to localise E- 
cadherin and ZO-1 simultaneously.
label the proteins E-cadherin and ZO-1 simultaneously. Initial attem pts to opti­
mise the dual labelling methodology proved problematic. A significant decrease in 
the quality of the fluorescent signals was observed following dual labelling, com­
pared to tha t which was achieved when each protein was targetted separately.
There are various factors which may have affected the quality of the signals 
observed from dual labelled samples:
1. A pp lica tion  sequence
The sequence th a t quantum  dots are applied to the sample may be an 
im portant factor th a t requires consideration during optimisation of sam­
ple preparations th a t incorporate dual labelling. Sweeney e.t a.i. [13] noted 
th a t the order of application affected the brightness of the dots when mul­
tiplexing. Their findings suggested th a t when applied sequentially in a 
multiplexing protocol, quantum  dots with lowest quantum  yield should be 
applied last. This is to ensure th a t they are subject to the least am ount of 
PBS washes, minimising any removal once specifically hybridised. Further­
more in a recent study by Huang e.t, al. [14], multiplexing was performed on 
formalin-fixed, parrafin embedded tissue samples. Their findings also sug­
gest th a t the brightest quantum  dots should be applied first to offset any 
reduction in signal intensity due to additonal washing. Therefore the effect 
of the multiple washing steps should be considered in this work because of 
the more extensive rinsing the samples undergo in preparation for SNOM
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imaging.
Sweeney et al. also reported that the order of application also affected the 
results through non-specific binding. Each secondary antibody was paired 
with a specific primary antibody. However, secondary antibodies were found 
to bind to residual empty sites of other primary antibodies. In the present 
study, the possibility that significant quantities of the quantum dots were 
non-specifically binding to the wrong primary antibodies was considered. 
This theory was rejected since the quantum dot conjugates utilised were 
highly cross-adsorbed and any cross-reactivity should be minimal.
2. Steric effects
Another issue that was taken into account is tha t of steric hindrance. This 
occurs when the size of one molecule applied inhibits the hybridisation 
of further molecules. Although the majority of studies by other research 
groups do not observe any hindrance to quantum dot binding during mul­
tiplexing [11, 13-15], this was initially considered to be the most probable 
explanation for the observed results in this work due to the physical prox­
imity of the proteins on the cell membrane. A study by Newman et al. [16] 
involving colloidal gold conjugates found that the binding efficiency de­
creased with increasing conjugate size. The findings reported by Newman 
et al. may also be relevant to multiplexing studies involving quantum dots.
7.2.1 P rotoco l tests
In order to assess whether the processes discussed in the previous section 
were affecting hybrisation of the quantum dot conjugates, the effect of changing 
the order of quantum dot application was examined. The numerous protocols 
that were tested are illustrated in Figure 7.3 for clarity. In this figure, only the 
interchangable steps have been included and labelled 1 — 4 to identify where these 
steps slot into the overall labelling proceedure given in Figure 5.9, in Chapter 
5. A key is provided at the bottom of Figure 7.3 which reveals the name and 
concentration of the reagents used during each step.
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Protocol E-cadherin ZO-1
A.
B.
C.
D.
1. ZO-1 1 1:25 Very little specific labelling observed. No images acquired.
2. E-cad 1° 1:10
3. ZO-1 2° 2:100 
4 E-cad 2 2:98
i ■" .............. ....... ............... -...................... . ■ .... ........... i
1. ZO-1 1* 1:25
2. E-cad T  1:5
3. ZO-1 2* 2:100
4. E-cad 2 3:97
Generally. E-cadherin 
specific labelling was 
weak and ZO-1 labelling 
inconsistent.
.....  —-...........  . ........-................... . " " ......... . i
1. E-cad 1*1:10
2. ZO-1 T  1:25
3. E-cad 2 2:98
4. ZO-1 2* 2:100
E-cadherin labelling was 
better than that achieved 
through B. ZO-1 labelling 
looked OK.
w m
i
1. ZO-1 1° 1:25
2. ZO-1 2° 2:100
3. E-cad 1° 1:10
4. E-cad 2 2:98
Best results: E-cadherin 
labelling most consistent. 
ZO-1 labelling also good.
■ ....... " ......... —  ■ —  . . . .
Key Step Reagent name Concentration 1 = Primary antibody 
e.g. 1. E-cad 1 1:10 2* -  Secondary antibody
(Reagent: Buffer)
Figure 7.3: Table summarising protocols tested during initial optimisation o f dual 
labelling and synopsis o f the quality o f samples produced by each. Example fluo ­
rescence microscopy images showing ZO-1 (red) and E-cadherin (green) labelling 
fo r  each protocol. Scale bars represent approximately 100pm .
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Corresponding fluorescence microscopy images of dual labelled PNT2 cells 
are also provided where possible. E-cadherin location is indicated by fluorescence 
from green emitting quantum dots and the location of ZO-1 is revealed by the 
presence of fluorescence from red emitting quantum dots. The protocol steps 
have been colour coded appropriately to reflect this. Red and green fluorescence 
microscopy images portray the same region of the sample but different filter sets 
were utilised to separately capture the fluorescence from each colour quantum dot. 
It should be noted that the fluorescence microscopy images represent regions of 
the sample where immunolabelling has been most successful, in terms of strong 
specific and low background labelling. However the labelling protocols have been 
evaluated on how successful the labelling proccedure was over the whole of the 
sample, which is summarised in Figure 7.3.
Protocol (A) resulted in very little specific labelling and as such no fluo­
rescence images could be acquired. In an attem pt to improve the fluorescence 
labelling, the concentration of reagents used to label E-cadherin were increased 
as given in protocol (B). However this gave little improvement on the results. 
The specific labelling of E-cadherin remained weak and ZO-1 labelling was incon­
sistent. Additionally, high levels of non-specific staining was observed on samples 
prepared with protocol (B). Therefore E-cadherin primary and secondary anti­
body dilutions were reverted back to their original values for subsequent protocols, 
to avoid such high levels of non-specific labelling.
It was anticipated tha t steric effects maybe taking place during protocols (A) 
and (B). In which case the application of ZO-1 primary antibodies in step 1 
would inhibit the subsequent binding of E-cadherin primary antibodies in step 2. 
Similarly, step 3 would hinder step 4. This cumulative effect would result in a 
strong fluorescent response from ZO-1 bound quantum dots and a weak response 
from E-cadherin.
In order to test whether E-cadherin hybridisation was being hindered by ZO- 
1 antibodies, protocol (C) was carried out. It was expected that by revising 
the order of steps such that E-cadherin reagents are applied before ZO-1, steric 
interference of E-cadherin would be minimised. Protocol (C) was expected to
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produce samples with stronger E-cadherin fluorescence which would likely result 
in weaker signals from ZO-1 due to steric hindrance effects.
However, protocol (C) gave improved labelling of E-cadherin and ZO-1 pro­
teins. This suggests steric hindrance may have been responsible for the poor E- 
cadherin fluorescence labelling from protocols (A) and (B). Furthermore, the im­
proved ZO-1 labelling observed when protocol (C) was used, may be explained by 
steric hindrance of ZO-1 secondary antibodies due to the presence of E-cadherin 
primary antibodies in (A) and (B).
Protocol (D) was carried out to further test the possibilities of steric hin­
drance. Additionally, protocol (D) would test whether repeated washing was 
affecting the fluorescence signals. The protocol was amended such that the green 
emitting quantum dots with lowest quantum yield, were applied last making them 
subject to less washing steps.
Comparison of samples produced by protocols (C) and (D) revealed that 
protocol (D) provided slightly more consistent labelling for both E-cadherin and 
ZO-1 proteins. This is reflected in the fluorescence microscopy images. This may 
be in part due to the E-cadherin quantum dots being subject to less washing 
steps. These results suggest tha t steric hindrance of E-cadherin reagents is not 
the primary reason for the poor fluorescence signals observed.
However, there was not a great difference in the quality of fluorescence la­
belling arising from each of these methods. The quality of the fluorescence la­
belling from dual labelled E-cadherin and ZO-1 was poorer compared to the 
fluorescence labelling of E-cadherin and ZO-1 independently. These findings sug­
gested that there may be other processes occuring which had not been considered 
previously.
It is vital th a t fluorescence signals which enable identification of E-cadherin 
arc fully optimised. This is to ensure tha t immunolabelling accurately reflects 
the prescence of E-cadherin. For this reason the decision was made to attem pt 
labelling of E-cadherin with longer wavelength quantum dots and ZO-1 with the 
shorter wavelength, as illustrated by Figure 7.4. This appeared to be the most 
practical resolution since ZO-1 labelling is required to act as a  detection control.
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Anti-ZO-1 
antibodyQdot 605 
conjugate
Z O -1
E-cadherin
Qdot 525 
conjugate
Anti -  E-cadherin 
antibody
Z O -1
PNT2 cell
E-cadherin
Figure 7.4: Graphic illustration o f dual labelling in PN T2 cells to localise E- 
cadherin and ZO-1 simultaneously.
7 .2 .2  F u rth er  o p tim isa t io n
As illustrated in Figure 7.4 the quantum  dots used to label E-cadherin and 
ZO-1 were revised such th a t E-cadherin proteins were labelled with the brighter, 
red quantum  dots. It is im portant to emphasise again tha t labelling of ZO- 
1 proteins is purely to ensure th a t detection equipment is fully aligned. Thus 
detection of ZO-1 is only necessary when E-cadhcrin levels arc reduced or not 
detectable.
Numerous protocols were tested using this new arrangement, and the effect of 
altering the concentration of reagents and reversing the order of application of 
reagents were examined. For clarity, these protocols are summarised in Figure 
7.5 and a key is provided to explain each step. The steps are again labelled 1 —4 
to indicate where they slot into the complete protocol which is provided in full in 
Figure 5.9, in C hapter 5. W here it was possible to obtain fluorescent microscopy 
images these are provided and a synopsis of the effectiveness of the labelling 
is given. E-cadherin is identified by red fluorescence and ZO-1 by green. The 
fluorescent dye DAPI was used as a positive control to  isolate nuclei (blue fluo­
rescence), this step was taken to aid detection of the desired targets by making it 
easier to identify cells. It was also found tha t imaging the samples through triple 
channel filters provided superior quality images of the samples, most likely due to 
the filters being a more suitable match to the fluorescence emission wavelength 
of the quantum  dots. As with previous protocol tests, the fluorescence micoscopy
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Protocol
A. 1. z o -1 1 1:15
2. ZO-1 2 J 3:100
3. E-cad 1° 1:10
4. E-cad T  2:98
r* E-cadherin and ZO-1 labelling OK.
0  #M m  t
B.
C.
1. ZO-1 1° 1:15
2. ZO-1 2 2:100
3. E-cad 1° 1:10
4. E-cad T  2:98
No images obtained. Poor labelling.
D.
F.
1. ZO-1 r  1:25
2. ZO-1 2° 3:100
3. E-cad 1° 1:10
4. E-cad T  2:98
1. E-cad 1° 1:10
2. ZO-1 1° 1:15
3 E-cad T  2:98
4. ZO-1 2° 3:100
1. E-cad V 1:10
2 ZO-1 1° 1:15
3. E-cad 2* 2:98
4. ZO-1 2 2:100
1. E-cad 1 * 1:10
2 ZO-1 1° 1:25
3. E-cad 2° 2:98
4. ZO-1 2 ; 3:100
Q  1. E-cad 1° 1:10
2. E-cad 2° 2:98
3. ZO-1 1° 1:15
4. ZO-1 2° 3:100
E-cadherin specific labelling was very 
inconsistent and little specific ZO-1 
labelling.
No images obtained. E-cadherin and ZO-1 specific labelling 
was weak but consistent.
E-cadherin labelling was good . ZO-1 labelling was not as 
good as D.
Very little ZO-1 specific labelling. E-cadherin appeared 
mostly around nucleus, little labelling at cell-cell contacts 
(this has been seen previously and was most likely a true 
reflection of E-cadherin location rather than non-specific E- 
cadherin labelling).
&
■
Very consistent and 
specific labelling, 
albeit weak in the 
case of ZO-1
E-cadherin labelling 
is strong although 
not as consistent as 
A. Weak ZO-1 
labelling.
Key Step Reagent name Concentration 1 = Primary antibody
1. E-cad 1° 1:10 2 = Secondary antibody
(Reagent: Buffer)
Figure 7.5: Tabic summarising protocols tested during final optimisation o f dual 
labelling of PN T2 cells and synopsis of the quality o f samples produced by each. 
Example fluorescence microscopy images showing ZO-1 (green) and E-cadherin 
(red) labelling fo r each protocol.
128
7.3. RESULTS OF MULTIPLEXING IN PNT2 CELLS
images represent regions of the sample where labelling was most successful. How­
ever, the protocols were evaluated on how effective labelling was over the entire 
sample.
Initially, protocols (A)-(F) were carried out and it was found that using the 
higher concentration of ZO-1 primary and secondary antibodies (1:15 and 3:100 
respectively) gave superior and more consistent labelling of ZO-1 with green quan­
tum dots. Protocols (A) and (G) were then carried out in parallel to ensure 
that the order of application chosen did provide the best possible result for both 
E-cadherin and ZO-1 labelling. These final tests confirmed that protocol (A) 
produced the most specific and consistent labelling of both proteins when tar- 
gctted simultaneously. Thus protocol (A) was selected for subsequent sample 
preparations for further investigation using SNOM.
7.3 R esults o f m ultiplexing in P N T 2 cells
7.3.1 Spectral analysis
In order to distinguish between red and green fluorescence when examining 
dual labelled samples with SNOM, a selection of band pass filters were tested to 
assess their efficiency at spectrally separating the two signals. Using data pro­
vided by the manufacturers, the transmission spectra of numerous filters were 
compared and plotted against emission spectra for the quantum dots. The spec­
tra  shown in Figure 7.6 shows the the results for a 525 nm band pass filter and 
a 609 nm band pass filter. These filters were selected because their transmission 
properties and spectral bandwidth ensures they can adequately separate fluores­
cence originating from the two different colour quantum dots, while allowing a 
large proportion of the required colour to pass through.
Experimentally acquired data to validate the performance of the optical filters 
when used with different colour quantum dots is shown in Figure 7.7. Two 
solutions were prepared by diluting 525 nm or 605 nm quantum dots in a 6% 
BSA/PBS buffer. The solution containing red emitting, 605 nm quantum dots 
was examined by depositing a small amount onto a clean, glass coverslip and
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Figure 7.6: Spectra showing emission of green and red quantum dots (dashed 
lines) [17] and tranmsission properties o f optical band pass filters (solid lines).
illuminating with a 488 nm A r + laser. The resulting fluorescence was collected, 
passed through a 488 nm Ram an edge filter to remove light from the laser and 
directed into a spectrometer.
The spectrum  shown in Figure 7.7(a) is the result of a 10 minute acquisition. 
The spectrum  reveals a narrow, Gaussian peak which is centred a t approximately 
605 nm, corresponding to the fluorescence originating from the red quantum  dots. 
The 609 nm band pass filter was then introduced into the optical path and the 
collection was repeated generating spectra (b). The filter allows the fluorescence 
to pass through with little reduction in intensity. The optical filter was then 
exchanged for a 525 nm band pass filter which is suited towards the collection of 
fluorescence from green quantum  dots. As can be seen in the resulting spectra
(c), none of the fluorescence from the red quantum  dots passes through this filter. 
This dem onstrates the effectiveness of the 525 nm band pass filter a t eliminating 
red light from the total signal collected when only green fluorescence is required. 
A small am ount of laser light bleed-through is present in all of the spectra, this 
can be seen as a sharp peak at around 488 nm, as identified on spectra (c).
The sample was then removed and the process repeated for green em itting,
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Figure 7.7: Fluorescence spectra o f quantum dots with, 605 nm (a) and 525 nm
(d) emission. Spectra repeated with 609 nm optical band pass filter (b) and (e) 
and 525 nm  optical band pass filter in place (c) and (f) for each colour quantum  
dot.
525 nm quantum  clots. The resulting spectrum  is shown in Figure 7.7(d). The 
spectrum  reveals an asymmetric peak which is centred a t approximately 525 
nm, corresponding to the fluorescence originating from the green quantum  dots, 
which tails ofT into the red end of the spectrum. The 609 nm hand pass filter was 
then introduced into the optical path  and the collection was repeated generating 
spectra (c). The filter allows a small amount of the red-tail of the fluorescence to 
pass through. The optical filter was then exchanged for a 525 nm band pass filter 
and as can be seen in the resulting spectra (f), this filter allows a large proportion 
of the green fluorescence to  be collected .
7 .3 .2  M u lt ip le x in g  in  P N T 2
Upon completion of optim isation work, dual labelled samples were observed 
using a fluorescence microscope. The images shown in Figure 7.8 represent the 
same region but viewed with different filter sets to allow seperate exam ination 
of (a) ZO-1 and (b) E-cadherin localisation. Image (c) represents an overlay of
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images (a) and (b). The fluorescence microscopy images dem onstrate successful 
labelling of both E-cadherin (red) and ZO-1 (green) simultaneously and both 
proteins arc predominantly found a t regions of cell-cell contact.
Figure 7.8: Result of dual labelling PN T2 cells to simultaneously examine the 
location o f ZO-1 (a) and E-cadherin (b). Images were obtained by fluorescence 
microscopy, (c) represents an overlay o f the images shown in (a) and (b). Scale 
bars represent approximately 100pm .
Samples were subsequently examined using SNOM and the images presented 
in Figure 7.9 were generated. Topography information can be seen in Figures 
7.9(a) and (b), which were acquired to dem onstrate th a t the extensive dual la­
belling protocol does not result in changes to the structure of the sample. As 
can be seen in image (a), the cellular structure remains well preserved and fea­
tures previously observed in topography images of individually labelled PNT2 
samples (Figures 6.3 and 6.13 in Chapter 6) can clearly be distinguished. Nu­
merous filopodia can be seen to extend across the intercellular region between two 
neighbouring cells (indicated by arrows), and many can be seen interacting with 
opposing filopodia. Although most cellular features are difficult to distinguish in 
image (b), the cell boundaries can clearly be seen.
Corresponding optical images were acquired for the topography image shown 
in Figure 7.9(b) which reveal the location of E-cadherin and ZO-1. ZO-1 locality 
is revealed by fluorescence from green em itting quantum  dots as shown in Figure 
7.9(c). Green fluorescence was selectively filtered using a 525 nm band pass filter 
and recorded by an APD using a collection time of 20 ms per pixel. Although 
the signal-to-noise attained in this image does not result in great contrast, signals 
can be seen predominantly in regions which correspond to the cell edge. Imaging 
of ZO-1 was purely to provide confirmation tha t signals were correctly aligned so
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Figure 7.9: SN O M  acquisitions o f dual labelled P N T2 cells, (a) Topography im ­
age, filopodia indicated by arrows, (b) Topography acquisition and corresponding 
optical images (c) and (d) obtained with different filters to spectrally distinguish 
green and red fluorescence, identifying ZO-1 and E-cadherin locations respectively. 
Boxed region m  (b) subsequently scanned with higher resolution to generate (e) to­
pography and (f) optical images. Circled regions in (d) and arrows in (f)  highlight 
E-cadherin clusters, (a)-(d) measure (30 /am)2, (e) and (f) are (10 /rm )2.
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for this purpose, achieving the highest possible quality images of ZO-1 was not a 
priority.
To examine E-cadherin, the 525 nm band pass filter was removed and replaced 
with a 609 nm band pass filter to allow detection of red emitting quantum dots. 
The ensuing fluorescence image obtained is shown in Figure 7.9(d). Considerably 
enhanced signal-to-noise is achieved when examining red fluorescence. This is 
likely to be in part due to the brighter nature of the red quantum dots com­
pared to green. E-cadherin location is identified by fluorescence from specifically 
hybriscd red quantum dots. Examining Figure 7.9(d) reveals E-cadherin is pri­
marily found along the cell boundaries. Furthermore, particularly high levels of 
fluorescence arc recorded in two regions on the sample (circled in Figure 7.9(d)). 
This observation is consistent with results from single labelled PNT2 samples, 
where E-cadhcrin was predominantly found to concentrate along the cell periph­
ery. Punctate clusters of E-cadherin were also observed in regions where cell-cell 
contact had been established.
In order to examine regions with high fluorescent activity in closer detail, the 
boxed region in Figure 7.9(b) was subsequently scanned with highcr-rcsolution. 
The resulting topography image is presented in Figure 7.9(e). The colour scale 
which represents height has been set to exclude the highest features which arc 
masked by the gold coloured region in the top right of the image. This process 
enables flatter structures to be observed more clearly and as such a scries of ridges 
can be seen running vertically in the image. This likely represents a network of 
filopodia from neighbouring cells tha t have established contact and arc responsible 
for pulling the cells together, forming a tight seal
This is further demonstrated in the simultaneously acquired optical image 
(Figure 7.9(f)). A row of fluorescence corresponding to E-cadherin location can be 
seen running parallel to the edge of one cell and perpendicular to this network of 
filopodia (see arrow on image (f)). Additonal rows of fluorescence are also present 
along the length of the large filopodium in the centre of the image (identified by 
arrowhead). These results confirm that the localisation of E-cadherin can be 
successfully examined in samples tha t have been dual stained.
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7.4  S tru ctu ral an a lysis o f  P C -3  cells
The morphology of PC-3 cells has been reported in studies by other research 
groups to differ from th a t of healthy epithelial cells [8, 18]. W hen cultured in 
monolayers, healthy epithelial cells tend to be regular in shape and exhibit a 
rounded morphology, becoming more cuboidal or cobble stone-like in appearence 
when cells are more densely packed. Furthermore, healthy cells form tight cell­
cell associations with their neighbours. Healthy cells also typically tend to be 
quite flattened [18]. These features are characteristic of the normal epithelial 
cells, PNT2, th a t were examined during earlier investigations in this study, as 
shown in Figures 7.8 and 7.9. This is further dem onstrated by the bright field 
microscopy image of confluent PNT2 cells shown in Figure 7.10(a). PC-3 cells 
display a markedly different appearance as exemplified in Figure 7.10(b) which 
shows PC-3 cells examined by bright field microscopy.
Figure 7.10: Morphology o f (a) PN T2 cells and (b) PC-3 cells examined by bright 
field microscopy. PC-3 cells as seen by (c) phase contrast microscopy and (d) 
scanning electron microscopy, rnv indicates microvilli on the cell surface, cp indi­
cates cell projection and P  indicates elongated pseudopodia-like projection. Images 
(c) and (d) taken from  Lang et al. [18].
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Figure 7.11: Typical SNO M  topography acquisitions o f non-confluent PC-3 cells. 
Some cells display a rounded morphology (as in (a) and (b)), while others appear 
more fibroblast-like (as in (e)). N  denotes the nucleus and filopodia are indicated 
by arrowheads. Arrows indicate elongated lamellipodia. Boxed regions in (a) and 
(b) correspond to software zooms shown in (d) and (c) respectively, (a), (b) and 
(e) are (30 fim )2, (c) is (10 p m )2 and (d) is (20 p m )2.
Also included in Figure 7.10 are images of PC-3 cells obtained by Lang et 
a,I. [18] using phase microscopy (c) and scanning electron microscopy (d). As in­
dicated in Figure 7.10(c), t he studies by Lang el al. showed th a t although some 
PC-3 cells display a rounded morphology, others appeared more elongated and 
libroblast-like. Their studies found PC-3 cells were not as flat as the healthy ep­
ithelial cells they examined and assumed a more 3-dimensional appearance. Lang 
et al. also noted tha t PC-3 cells often possess elongated lamellipodia (identified as 
pseudopodia by Lang et al. [18], indicated by P on Figure 7.10(d)) and numerous 
filopodia. In contrast to healthy cells, they also found th a t the cancerous PC-3 
cells form loose cell-cell contacts when confluent. The fibroblast-like appearance 
typical of PC-3 cells is also evident in Figure 7.10(b).
Prior to immunolabelling of PC-3 cells, their morphology was examined us­
ing SNOM topography acquisitions. The images shown in Figure 7.11 directly
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confirm the observations reported by Lang et al. discussed above. Some cells ap­
pear spherically shaped as demonstrated in Figures 7.11(a) and (b) while others 
exhibit a more fibroblast-likc morphology with long, branching cytoplasmic pro­
trusions (as indicated by arrows in Figures 7.11(d) and (e)). These protrusions 
arc significantly longer than the filopodia typically observed on healthy cells and 
were often found to extend to lengths greater greater than 25 — 30 /im, the size of 
the topography scans. Additionally, measurements show their diamcmtcr to be 
much wider than the finer filopodia, some of which can be distinguished protrud­
ing from the lamellipodia as indicated by arrowheads in Figure 7.11. These larger 
protrusions tend to taper as their length increases however, at their widest point 
they were found to measure up to 2 .1  /im and to reach heights of up to approxi­
mately 300 nm. Measuements on the finer protrusions observed in these images 
revealed widths ranging between 120 — 340 nm, which arc consistent with the 
filopodia observed on healthy PNT2 cells as discussed in Chapter 6  and reported 
by Doak et al. [19].
The cells’ nuclei (indicated by N) can clearly be distinguished in Figures 
7.11(a) and (b). The maximum height of the cells occured over the nuclear region 
and measurements indicate the maximum height of PC-3 cells was in the range 
(1.65 — 1.96) /im. Doak et al. reported that the height of healthy PNT2 cells 
were generally in the range 1.22 — 1.55 /im, however they noted that the height of 
the cells depended on the fixative used [19]. Thus, for a true comparison between 
the healthy PNT2 and cancerous PC-3 cells, samples prepared under the same 
fixing conditions should be used. However, analysis of PNT2 cells in Chapter 6  
gave a wide range of values for the height of PNT2 cells, even though the samples 
were subject to the same fixing conditions and dcssication prior to imaging. The 
maximum height of PNT2 samples ranged from approximately 0.5—2.7 /im, and is 
possibly due in part to the degree of confluency of the cells. As such it is difficult 
to compare between the two cell lines. However it was noted that increases 
in height across PNT2 cells usually occured gradually and over relatively large 
distances. Whereas PC-3 cells were often found to possess high features tha t were 
abrupt. These steep aspects of their structure made it considerably more difficult
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to achieve high quality topography images when scanning with SNOM. Dramatic 
changes in height required very precise optimisation of scanning param eters. The 
difficulties experienced during scanning of high features is discussed more fully in 
C hapter 5.
The morphology of confluent PC-3 cells is also noticably different to healthy 
PNT2 cells. Figure 7.12 shows typical SNOM topography aquisitions of PC-3 cells 
which were fixed at a later stage such tha t cells have become densely packed. The 
boxed regions in Figures 7.12(a) and (b) represent, areas th a t were subsequently 
zoomed in. This enabled superior contrast between features of similar height and 
exposed much more detail.
Figure 7.12: Confluent PC-3 cells show loose cell-cell associations along the
boundary between cells, as indicated by C. Fine filopodia are denoted by arrow­
heads while elongated lamellipodia are indicated by arrows. N  indicates nuclei. 
Topographic SNO M  acquisitions (a) and (b) and respective software zooms (c) 
and (d). (a) and (b) are (25 fim )2, (c) and (d) are (16.7 /im )2.
In contrast to confluent PNT2 cells, PC-3 cells do not appear to  form very 
close associations with neighbouring cells. This is exemplified by the images 
shown in Figure 7.12 but is particularly clear in image (c). Gaps of up to 2.1 /im
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around the periphery of the cells arc observed and no seal along the boundary 
between adjacent cells has been established (cell-cell boundary is indicated by 
C). This observation is consistent with reports by Lang et al. who noted similiar 
morphological differences between healthy and cancerous prostate epithelial cell 
lines [18].
Numerous fine filopodial extensions can also be seen to protrude across these 
gaps, however few appear to interact with those from opposing cells. This is 
remarkably different to PNT2 cells where filopodia from adjacent cells were ob­
served to intcrdigitate across the intercellular region. When PNT2 cells achieved 
the high confluency as is reached by the PC-3 cells in Figure 7.12, the PNT2 cells 
were fully scaled together and no gaps could be distinguished, as was shown in 
Figure 6.11 in Chapter 6 . The lack of contact between the PC-3 cells observed 
in Figure 7.12 is possibly due to a lack of functional E-cadhcrin proteins. As dis­
cussed in Chapter 4, previous studies that have assessed E-cadherin expression 
and localisation in PC-3 cells have not reached a consensus [1-3, 8 , 18, 20]. This 
study aims to determine whether E-cadherin is functionally expressed in PC-3 
cells and found in regions which confer cell-cell adhesion using the high-rcsolution 
fluorescence capabilites of SNOM.
7.5 O ptim isation o f dual labelling in PC-3
Following extensive optimisation of the dual labelling protocol using PNT2 
cells as discussed in Section 7.2, samples consisting of PC-3 cells were prepared 
and treated in the same way. Initial results showed extremely high levels of non­
specific labelling with quantum dots present within the cytoplasm of cells and 
attached arbitrarily to the slide surface. Furthermore, PC-3 cells often appeared 
to become completely removed from the surface following application of the la­
belling protocol. Very few cells were typically observed when the samples were 
examined by fluorescent microscopy, even though when viewed prior to and after 
fixation, the same samples appeared highly confluent.
Significant work was completed in an attem pt to optimise the dual labelling
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procedure for PC-3 cells. The following measures were taken in an attem pt to 
improve the quality of the samples:
• Introducing additional PBS/Glycine washes to the protocol in an effort to 
reduce non-sepcific binding of antibodies to the surface by blocking free 
aldehyde groups.
• Coverslips were coated with poly-l-lysine before deposition of cells. This 
coating is commonly used to improve cell adherance to surfaces and was 
used here in an effort to reduce the number of cells that were detaching 
during the extensive labelling procedure.
• Changing the concentration of labelling reagents
• Changing the order of application of labelling reagents
These measures varied in their effectiveness: Coating the coverslips to improve 
cell adherance unexpectedly had the most detrimental effect and actually resulted 
in fewer cells remaining at the end of the protocol. The protocol was eventually 
optimised by finding a compromise between the concentration of reagents that 
consistently produced the highest levels of specific labelling and minimising non­
specific binding through additional blocking washes.
7.6 R esults of m ultiplexing in PC-3
Dual labelled PC-3 cells were imaged with a fluorescence microscope, results 
obtained were typical of those shown in Figure 7.13. The image shown in Figure 
7.13(a) identifies ZO-1 proteins around the circumference of the cells as observed 
for the healthy PNT2 cells. E-cadherin proteins were targetted by red emitting 
quantum dots, however as seen in Figure 7.13(b) very little fluorescence can be 
seen in regions which correspond to the cell-cell boundaries. The image shown in 
Figure 7.13(c) represents both red and green fluorescent images overlaid.
The poor quality of the fluorescence microscopy images obtained however 
made it difficult to correlate fluorescence and cellular regions, making a strong 
case for a detailed SNOM study.
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m n
Figure 7.13: Fluorescence microscopy images o f PC-3 cells, (a) ZO-1 proteins are 
identified by green fluorescence, (b) E-cadherin identified by red fluorescence, (c) 
Composite image showing relative position of proteins. Scale bar approximately 
100 pm.
Samples were then examined using SNOM to acquire the topography and 
optical images. Typical SNOM acquisitions of dual labelled PC-3 cells are shown 
in Figure 7.14. The topographic image is shown in Figure 7.14(a) and reveals a 
single cell whose nucleus (labelled by N) is clearly distinguished. Measurements 
show tha t the maximum height of this cell is reached over the nuclear region 
which equates to approximately 890 nm. The lamellipodium (labelled by L) can 
be seen and was found to span an area of approximately 90 p m 2. A large cellular 
protrusion is visible on the cell and is identified by the label L on the image. Large 
branch-like structures were also present in other scans of PC-3 cells (Figure 7.11). 
Measurements indicate a width of 6.2 ± 0 .1  pm  at i t ’s point of origin.
Corresponding SNOM fluorescence acquisitions are shown in Figures 7.14(b) 
and (d). These images were obtained using the optical band pass filters to spec­
trally separate the fluorescence originating from each colour quantum  dot and 
distinguish between E-cadherin and ZO-1. Subsequent zooms were generated by 
the software to enable regions of interest to be resolved in more detail as seen in 
Figures 7.14(c) and (e).
To image the location of E-cadherin proteins, which were labelled by red em it­
ting quantum  dots, the to tal signal was collected and passed through a Ram an 
edge filter to eliminate the light from the laser. The remaining light was subse­
quently passed through a 609 nm band pass filter to remove any unwanted green 
fluorescence and directed towards an APD. An APD collection time of 20 ms 
per pixel was used to obtain the resulting image of E-cadherin which is shown in
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Figure 7.14: (a), (b) and (d) (25 / i m ) 2 SNO M  acquisitions o f dual labelled PC- 
3 cells, (a) Topography image showing nucleus (labelled by N), lamellipodium  
(labelled by L) and cellular protrusion (labelled by P). Corresponding fluorescence 
images showing (b) E-cadherin and (d) ZO-1 localisation. Boxed regions in (b) 
and (d) zoomed in to produce images (c) and (e) respectively. ZO-1 clearly present 
along edge o f cellular protrusion (identified by arrows), (a), (b) and (d) arc 
(25 fim)2, (c) and (e) are (16.7 nm)2.
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Figure 7.14(b). The image shows a strong fluorescence response from the sample 
with good signal-to-noise levels. This demonstrates the efficiency of the chosen 
filter at eliminating unwanted background without affecting the quality of the 
desired fluorescence signals.
Strong fluorescence signals are evident predominantly around the perimeter 
of the nucleus but are also found to extend some way along the length of the pro­
trusion. This can be seen more clearly in Figure 7.14(c) which represents a zoom 
of the boxed region in Figure 7.14(b). This fluoresence represents the specific 
labelling of E-cadherin. Although present in this cell, the correct functioning of 
E-cadherin requires that it be located in regions where cell-cell contact will occur. 
However there appears to be no obvious E-cadhcrin labelling pattern around the 
boundary of the cell. During the study of the healthy epithelial cell line PNT2, 
although E-cadherin was observed to some degree around the nucleus, it was pri­
marily found along the cell boundaries and to extend throughout the length of 
their numerous filopodia. This was typically observed even when contact between 
neighbouring cells had yet to be established.
A further SNOM acquisition was obtained to examine the localisation of ZO-1 
proteins which were immumolabelled by green emitting quantum dots. Thus the 
609 nm band pass filter was exchanged for a 525 nm band pass filter in order to 
eliminate unwanted red fluorescence from the optical signal. The APD collection 
time remained at 20 ms per pixel and the resulting image of ZO-1 is shown in 
Figure 7.14(d). The signal-to-noise levels achieved with the green quantum dots 
arc noticably reduced compared to tha t achieved by red quantum dots. This is 
likely to be due to the green quantum dots having a slightly lower quantum yield.
Comparison of the ZO-1 fluorescence image (Figure 7.14(d)) with the topogra­
phy (Figure 7.14(a)) reveals large amounts of non-specific labelling, particularly 
over the region of the cell tha t corresponds to the nucleus. Closer inspection of 
the boxed region in (d) was facilitated by generating the software zoom shown in 
image (c). This region corresponds to the large cellular protrusion that was iden­
tified in the associated topographic image. Fluorescence can now more clearly 
be identified along both edges of the structure and is identified by arrows in the
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image. This fluorescence along the edge of the cellular protrusion reveals the 
localisation of ZO- 1  on the cell membrane.
7.7 Conclusion
Following investigations of adhesion mechanisms in the healthy epithelial cell 
line PNT2 in Chapter 6 , a dual labelling methodology has been developed to fa­
cilitate the study of adhesion molecules in other cell lines. Although publications 
by numerous other groups have successfully applied quantum dots to multiplexing 
studies [11, 13-15], significant difficulties were encountered in this work. Exten­
sive optimisation of this protocol was necessary in order to generate high-quality 
fluorescent samples and many preparation aspects were taken into consideration 
during this procedure.
For the purpose of this study, labelling of ZO-1 was carried out purely to 
ensure optical detection in our SNOM instrument was optimal in the event E- 
cadherin was not detected. Thus to address the difficulties encountered during 
dual labelling, E-cadherin proteins were immunolabelled with brighter red emit­
ting quantum dots.
Dual labelling was subsequently achieved and used to study the localisation 
of E-cadherin and ZO-1 proteins in two prostate epithelial cell lines. Analysis of 
dual labelled PNT2 cells revealed E-cadherin to be localised predominantly along 
the cell periphery which appeared enhanced in regions where cell-cell contact 
had been established (Figure 7.9). This was consistent with studies discussed 
in the previous chapter, where only E-cadherin proteins were immunolabelled. 
Furthermore, ZO-1 proteins were found to be localised along the edge of the cell. 
This was clearly observed despite the quality of the ZO-1 fluorescent images being 
poorer than tha t observed for E-cadherin.
The study was extended to examine cancerous PC-3 cells. Initially the mor­
phology of these metastatic cells was analysed through the acquisition of SNOM 
topography images. PC-3 cells were found to differ in structure to healthy ep­
ithelial cells in numerous ways. Firstly, their overall shape was found to be more
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irregular with some cells assuming a fibroblast-like morphology in comparison to 
the more rounded appearance of healthy cells. Secondly, PC-3 cells were often 
difficult to image due to their abrupt features. The PC-3 cells commonly pos­
sessed long cytoplasmic protrusions in addition to the filopodia routinely observed 
on healthy cells. Finally, examination of more confluent samples revealed that 
PC-3 form loose associations with neighbouring cells with few opposing filopodia 
interacting. Gaps were frequently observed around the periphery of the cells, in 
contrast to the tight seals that were observed during examination of PNT2 cells.
Dual labelling was further optimised to allow examination of E-cadherin in 
PC-3 cells. Current literature suggests that E-cadherin is down-regulated in PC- 
3 cells. However reports on the extent of this down-regulation arc inconsistent. 
Furthermore, analysis of gene expression levels does not reveal information about 
the localisation of the protein for which it encodes. To this end high-resolution to­
pography imaging of PC-3 cells was achieved in parallel to SNOM optical imaging 
to reveal dual labelled E-cadhcrin and ZO-1 proteins (Figure 7.14).
E-cadherin proteins were predominantly observed in the perinuclear region. 
In contrast to healthy cells, no clear fluorescence pattern was observed around the 
circumference of PC-3 cells in regions where E-cadherin may properly function as 
a mediator of cell-cell adhesion. Fluorescence corresponding to ZO-1 localisation 
was clearly identified along both edges of the large, cellular protrusion.
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Chapter 8
Conclusions
8.1 Comparison of E-cadherin distribution in 
prostate epithelial cells.
Cellular adhesion plays an important role in maintaining the architecture of 
tissues and organs and is vital for their correct functioning. Abnormal cell-cell 
adhesion has implications in the onset of many illnesses and diseases. A concerted 
effort has been made by many researchers to determine the relationship between 
cellular adhesion and the metastatic capacity of many cancers [1 ].
E-cadherin is one of the principle mediators of cell-cell adhesion in epithe­
lial tissues and has been extensively examined to determine its role in cancer 
progression and metastasis [2-4]. This relationship may be particularly relevant 
to prostate cancers which have a propensity to metastsise and form additional 
tumours in the bones and lymph nodes, resulting in a poor patient prognosis. 
As such E-cadherin has been proposed as a potential histological marker to help 
evaluate the prognosis of patients affected by prostate cancer and determine the 
most appropriate course of treatm ent [3-6]. Additionally, a more detailed under­
standing of adhesion mechanisms could lead to the development of novel cancer 
treatments as indicated by the preliminary studies carried out by Zhou et al. [7]
Although significant efforts have been made towards understanding the role 
of E-cadherin in the progression of prostate cancer, researchers have not reached
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a consensus [8 , 9]. Additional studies are required to develop a deeper under­
standing of the mechanisms involved in E-cadherin mediated adhesion.
To this endeavour, this investigation has examined and compared the local­
isation of E-cadherin in two prostate epithelial cell lines using high resolution 
SNOM. Antibodies against the adhesion protein E-cadherin were utilised to in­
directly label cells.
Analysis of healthy epithelial PNT2 cells at various stages of epithelial sheet 
formation revealed tha t E-cadherin is predominantly located along the cell pe­
riphery. During the early stages of cell-cell adhesion E-cadhcrin was found to 
concentrate at the base of filopodia and with some extension through their length 
that appeared enhanced when cell-cell contact was established. This was further 
demonstrated by the punctate clusters of E-cadherin which were observed when 
filopodia established contact and appeared to embed into the neighbouring cell, 
initiating cell-cell adhesion. These results support the observations of Vasioukhin 
et al. [10] during investigations of actin and E-cadherin dynamics during epithelial 
sheet formation in epidermal cells.
High-resolution topographic analysis of PNT2 cells revealed the “quilted” na­
ture of the filopodia surface as described by Doak et al. [11]. Furthermore the 
topography images provided a snapshot of the filopodia engaged in their sensing 
and exploratory roles. No filopodia were observed when cells had established full 
contact. Instead a tight seal between neighbouring cells had developed and multi­
ple ridges were found to run parallel to the cell-cell boundaries which we propose 
represent the circumferential actin belt described by Yonemura et al. [12].
These results are in contrast with the observations of PC-3 cells. Examina­
tion of the morphology of PC-3 cells through topographic SNOM acquisitions 
revealed a markedly different appearance to tha t which was observed on PNT2 
cells. Their overall shape was more irregular, and PC-3 cells did not form the 
typical cobblestone appearance tha t is characteristically seen in epithelial tissues.
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Moreover, some cells appeared more fibroblast-like with long cytoplasmic pro tru­
sions, while few fine filopodia were observed. W hen confluent PC-3 cells were 
examined, the cells were found to form very loose contacts with their neighbours 
and large gaps were observed between cells. This was in contrast to the tight 
seals formed by the healthy PNT2 cells. The morphology of PC-3 cells observed 
in this study using SNOM confirms earlier work by Lang et al. [13]. Fluorescence 
SNOM acquisitions revealed E-cadhcrin to be predominantly localised around the 
nuclear region of cells, with 1 10 obvious E-cadherin labelling pattern  around the 
periphery of the cells. These results arc exemplified by Figure 8.1 which shows a 
direct comparison of the distribution of E-cadherin in PNT2 and PC-3 cells.
Topography E-cadherin
PNT2
PC-3
Figure 8.1: Typical SNO M  acquisitions comparing E-cadherin localisation in
prostate epithelial cell lines P N T2 and P C S . PN T2 topography (a) and fluo­
rescence SNO M  (b) images showing E-cadherin proteins are found along the cell 
edge and is enhanced when cell-cell contact has been established. PC-3 topogra­
phy (c) and fluorescence (d) images showing E-cadherm predominantly localised 
around the nuclear region o f the cell. No obvious E-cadherin labelling pattern is 
observed at the cell boundary in PC-3 cells.
As presented in C hapter 7, E-cadherin can clearly be observed around the
369 Counts
9 Counts
815 Counts
56 Counts
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periphery of the PNT2 cells in Figure 8.1(b) and is enhanced in regions of cell- 
cell contact. Whereas in PC-3 cells, E-cadherin is primarily found around the 
nuclear region of the cell. This lack of functional E-cadherin in PC-3 cells is 
likely to be the reason that confluent cells were not observed to form tight cell­
cell associations with their neighbours.
This study has lead to a greater understanding of the cell-cell adhesion mech­
anisms in epithalial tissues and how aberrations manifest in the morphology 
and phenotype of cancer cells. This research further highlights the role that 
E-cadherin plays in the development of invasive, metastatic cancer.
8.2 M ultiplexed detection  using quantum  dots
In order to fully exploit the high-resolution capabilities afforded by SNOM, 
sample preparation methods proved to be vital. The protocols developed dur­
ing this study were fully optimised and rigorously tested. Multiple fluorescence 
labelling methodologies were evaluated.
Two fluorescent labelling routes were explored; Alexa Fluor 488 and semi­
conductor quantum dots. The Alexa Fluor labelled samples demonstrated poor 
signal-to-noise levels of appromiately 3.6 and were subject to rapid fading, lim­
iting the extent of analysis of any one region. The quantum dots proved to be 
significantly brighter and more robust and facilitated multiple scans of the same 
region, with minimal degradation. Consistently high signal-to-noise levels were 
observed for samples labelled with quantum dots, even following repeated exam­
ination. Signal-to-noise values of greater than 10 were frequently observed.
Adhesion mechanisms in PNT2 cells were successfully analysed through la­
belling of E-cadherin. However to analyse PC-3 cells using SNOM, a dual labelling 
approach was neccesary to confirm detection instruments were fully optimised. 
This was particularly important because reduced levels of fluorescence, due to 
reduced expression of E-cadherin, were expected. As discussed in Chapter 4, 
E-cadherin expression levels in PC-3 cells have been analysed in numerous other 
studies. Work by Doak et al. [14] has shown through real-time RT-PCR, tha t
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E-cadherin gene expression is downregulated in PC-3 cells. A study by Morton 
et al. [15] detected reduced amount of E-cadherin proteins in PC-3 cells com­
pared to normal expression using Western blotting. The techniques used in these 
studies show the presence of either RNA (real-time RT-PCR) or the presence 
of the protein itself (Western blotting). However, neither of these techniques 
yield information about the location of E-cadherin, and consequently whether 
it is functional in its role as a cell-cell adhesion mediator. While fluorescence 
techniques have been employed in other studies in an effort to determine the lo­
calisation of E-cadherin in PC-3 cells [13, 16]. However, the techniques utilised 
do not provide the high-resolution fluorescence imaging afforded by SNOM, nor 
do they yield the complimentary ultra-structural information required to assess 
functionality.
This investigation has combined quantum dot dual labelling and the high- 
resolution imaging capabilities of SNOM to compare E-cadhcrin localisation in 
two cell lines. A clear difference has been observed in the morphology and phe­
notype between healthy PNT2 cells and cancerous PC-3 cells. However, other 
proteins involved in the formation of adherens junctions, for example a , /3, 7 - 
catcnins, have not been assessed. As such the reason for the loss of E-cadherin 
function has not been determined.
8.3 Difficulties addressed
Few reports in the literature have described the potential problems tha t may 
be encountered when attempting to multiplex with quantum dots. Reports by 
other research groups indicate that the major obstacle when utilising multiplex­
ing techniques is the length of time it takes to generate samples. Significant dif­
ficulties were encountered during this study when optimising the dual labelling 
protocol and poor fluorescence signals were observed, particularly from the green 
fluorescent quantum dots. Numerous routes were explored in an effort to deter­
mine the cause of this. This problem was addressed by switching to red emitting
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quantum dots for the labelling of E-cadherin, the protein of interest. Red emit­
ting quantum dots are more efficient at absorbing the excitation wavelength used 
in this work and have a higher quantum yield than quantum dots which emit 
green fluorescence. This provided a suitable solution and enabled the study of 
E-cadherin to procede. However, in other dual labelling studies where a quantita­
tive analysis of protein expression is required, researchers would need to consider 
the difference in absorption efficiency and emission efficiency of different colour 
quantum dots.
Preparation of samples and subsequent imaging using SNOM was labour in­
tensive. As such it was necessary to examine samples using fluorescence mi­
croscopy to confirm labelling had been successful. Two methods were devel­
oped to facilitate examination of each sample using fluorescence microscopy and 
SNOM. Both methods afforded advantages and disadvantages. The limitations 
of each of these methods are summarised below.
• C u sto m ised  slides to  fac ilita te  fluorescence m icroscopy p rio r  to  
SN O M : Enabled a fast and thorough analysis of the sample via a simple 
adaption which preserved topographic structure. However the same region 
of the sample is not imaged with both fluorescence microscopy and SNOM.
• Far-field  illu m in a tio n  o f sam ples using  SN O M  in s tru m e n ta tio n :
Enabled selection of region of interest to be scanned using SNOM. However 
the set-up is time consuming to implement. The far-field images are of a 
lower quality than the fluorescence microscopy images.
This research has highlighted important instrument requirements that would 
facilitate future studies of biological samples using SNOM. An ideal equipment 
configuration would utilise a SNOM unit directly mounted onto an inverted fluo­
rescence microscope. These requirements have been considered and incorporated 
into the specifications for SNOM instrumentation recently purchased by our re­
search group. The design of the new SNOM will greatly enhance the ease-of-use
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for other researchers pursuing SNOM studies of fluorescently labelled samples.
8.4 Future directions
Complete methodologies have been developed during this investigation to fa­
cilitate the study of adhesion mechanisms in epithelial tissues. These have been 
demonstrated in two cell lines and the results compared to assess the differences 
and similarities in morphology and phenotype of cancerous and healthy epithelial 
cells.
This study is in itself complete. However, there are areas of this work with 
the potential to be extended for a more comprehensive investigation of adhe­
sion mechanisms. Proposed avenues of future research to compliment the work 
contained in this thesis are described in this section.
• Analysis of compact PN T 2  cells revealed multiple distinct ridges running 
parallel to the cell-cell boundaries (Figure 6.12, Chapter 6 ). We proposed 
that these ridges represent the circumferential F-actin bundles described by 
Yonemura et al. [1 2 ].
To confirm this hypothesis, immunofluorescence labelling of F-actin in com­
pact PNT2 cells is necessary. However, the limitations imposed by SNOM’s 
low depth of illumination require an alternative method for high-resolution 
fluorescence imaging of such samples (e.g. PALM microscopy).
• Many protocol variations were attem pted during the optimisation of a dual 
labelling approach. However, the cocktail method described by Sweeney et 
al. and Huang et al. [17,18] was not. This “all-in-one” antibody application 
method may have clarified whether steric effects or repeated washing steps 
were having a detrimental effect on the quality of the samples. Furthermore 
the cocktail method would also have reduced the overall sample preparation 
time, making dual labelling more feasible for larger studies.
• The role of other proteins involved in the formation the adherens junction 
could be determined through immunofluorescence labelling. For instance
154
8.4. FUTURE DIRECTIONS
the expression and localisation of a -, /?-, 7 -catenins could be examined in 
PNT2, PC-3 and other prostate epithelial cell lines.
• The optical resolution achieved by SNOM largely depends on size of the 
probe aperture and can also be limited by the number of pixels used to 
acquire an image. However, the sensitivity of the SNOM probe to inter­
actions with sample often resulted in the probe aperture opening during 
repeated scanning of samples. Thus, the loss of resolution due to opening 
of the SNOM probe aperture was common when attempting to zoom in in 
order to achieve increased resolution.
Samples could be assessed using a novel imaging approach which utilises 
a nanometer-sized light source to illuminate a sample. This approach is 
known as FRET SNOM and is realised by functionalising a SNOM probe 
with particles which act as FRET donors. The principles of FRET SNOM 
were described in more detail in Chapter 3. The use of a functionalised 
probe to perform FRET SNOM has been demonstrated to generate im­
proved resolutions which are governed by the FRET radius, instead of the 
size of the SNOM probe aperture [19, 20]. Thus FRET SNOM could be 
utilised in future investigations to interrogate samples with even higher res­
olution than is afforded by conventional SNOM.
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A ppendix A
Approxim ate Quantum  dot sizes (nm).
D ata provided by Invitrogen *.
Q do t 525 Q d o t 605 Q d o t 655
C o re /sh e ll 3 - 4 Ellipsoids: 
4 x 9.4
Ellipsoids: 
6  x 1 2
C o re /sh e ll com position CdSe/ZnS CdSe/ZnS CdSe/ZnS
C arboxy l Q do t
N an o cry s ta l
core /  shell /  p o lym er
1 2 16 17
C arboxy l Q do t 
N an o cry s ta l
co re /sh e ll /  p o ly m e r/P E G
13 16 2 0
Private communication; Invitrogen, Paisley, UK. Specification of CdSc/ZnS quantum dots.
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A ppend ix  B
Optical properties of FITC, TR ITC  and PI filter sets installed on fluorescence 
microscope. D ata provided by Zeiss Ltd.
ZEISS
,|rm |
Filter set
I N  FITC
100
(typical cu rves)
excitation:
beam splitter:
em ission :
BP 450 - 490 
FT 510 
BP 515-565
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excitation: BP 545 / 25
beam splitter: FT 570 
em ission : BP 6 0 5 1 70
Filter set 
tiki TRITC 
100
(typical cu rv es)
650 700 750 '.[nm]
TIM
300
Filter set 
Texas red/PI
(typical cu rv es)
excitation: BP 530 - 585
b eam sp litter: FT 600 
em ission : I P  615
100
60
40
400 450 500 550 600 650 700 750 M'W)
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A ppendix C
Photostab ility  o f A lexa Fluor 488
Figure 8.2 illustrates the poor quality of samples fluorescently labelled with Alexa 
Fluor 488. SNOM topography and fluorescence acquisitions (Figures 8.2(a) and 
(b) respectively) are shown. The fluorescence image reveals a typical signal-to- 
noisc value of ~  3.6. Subsequent topography and fluorescence acquisitions were 
generated to examine the boxed region in further detail. A reduction in the 
already low fluorescence signals is observed in fluorescence image (d). Figure 
8.2 demonstrates th a t Alexa Fluor 488 fluorophores are unsuitable for studies 
requiring repeated examination of samples.
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Figure 8.2: SNO M  acquisitions o f P N T2 cells labelled with Alexa Fluor 488. 
Boxed region in topography image (a) is further resolved in image (c). Corre­
sponding fluorescence acquisitions (b) and (d) demonstrate a reduction in the 
already low signal-to-noise levels when repeated scanning o f a single area is per­
formed.
1G2
A ppendix D
M echanism s o f cell-cell adhesion identified by im m unofluo- 
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A bstract
Scanning near-field optical microscopy (SNOM) has been employed to simultane­
ously acquire high-resolution fluorescence images along with shear-force atomic 
force microscopy from cell membranes. Implementing such a technique over­
comes the limits of optical diffraction found in standard fluorescence microscopy 
and also yields vital topographic information. The application of the technique 
to investigate cell-cell adhesion has revealed the interactions of filopodia and 
their functional relationship in establishing adherens junctions. This has been 
achieved via the selective tagging of the cell adhesion protein, E-cadherin, by im­
munofluorescence labelling. Two labelling routes were explored; Alexa Fluor 488 
and semiconductor quantum dots. The quantum dots demonstrated significantly 
enhanced photostability and high quantum yield making them a versatile alterna­
tive to the conventional organic fluorophores often used in such a study. Analysis 
of individual cells revealed that E-cadherin is predominantly located along the 
cell periphery but is also found to extend throughout their filopodia. We have 
demonstrated that with a fully optimised sample preparation methodology, quan­
tum dot labelling in conjunction with SNOM imaging can be successfully applied 
to interrogate biomolecular localisation within delicate cellular membranes.
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